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Packaging of DNA into chromatin
The genome of higher eukaryotes is organized in a complex structure consisting of DNA and 
proteins. In human cells the DNA has a length of two meters, divided over 46 chromosomes. 
Since the nuclear diameter is only 10Pm, DNA is folded and compacted by protein, forming the 
FKURPDWLQ¿EHU7KHEDVLFXQLWRIWKHFKURPDWLQLVWKHQXFOHRVRPHWKDWLVFRQVWLWXWHGE\'1$
and positively charged proteins called histones. The nucleosome core consists of 146bp DNA 
wrapped around a histone octamer formed by two molecules of each H2A, H2B, H3, and H4 
histone proteins (Luger, Mader et al., 1997). Each of these histones has an N-terminal amino 
acid tail which extends out from the DNA-histone core and represents a site for numerous post-
WUDQVODWLRQDOPRGL¿FDWLRQVLQFOXGLQJDFHW\ODWLRQPHWK\ODWLRQSKRVSKRU\ODWLRQXELTXLWLQDWLRQ
DQGVXPR\ODWLRQ7KHVHPRGL¿FDWLRQVUHJXODWHGLIIHUHQWDVSHFWVRIWKHFKURPDWLQVWUXFWXUH
such as accessibility of the DNA to regulatory proteins like transcription factors. Core 
nucleosomes are linked by a small stretch of DNA known as the linker. This arrangement 
can be visualized by electron microscope as “beads on a string” (Oudet, Gross-Bellard et 
DODQG LVNQRZQDV WKHQPFKURPDWLQ¿EHU EDVHGRQ LWVDSSUR[LPDWHGLDPHWHU




Ching et al., 2011). 
Concept of euchromatin and heterochromatin
Light microscopy studies revealed that in interphase the chromatin exists in two compaction 
states called euchromatin and heterochromatin. 
Euchromatin comprises decondensed and in general more genetically active regions while 
heterochromatin is formed by more condensed and in general transcriptionally inactive areas. 
+HWHURFKURPDWLQ ZDV ¿UVW GH¿QHG DV WKH VWUXFWXUH WKDW GRHV QRW FKDQJH LWV FRPSDFWLRQ
level during the cell cycle and can be divided into constitutive heterochromatin, formed by 
highly repetitive regions like telomere and centromere, and facultative heterochromatin 
involving chromatin regions that can adopt the structural and the functional characteristics 
of a heterochromatic state in certain cells and tissues. Each of these chromatin types can be 
DVVRFLDWHGZLWKVSHFL¿FKLVWRQHWDLOPRGL¿FDWLRQVWKDWNHHSWKHDFWLYHRUUHSUHVVLYHVWDWHE\
regulating the accessibility of regulatory proteins to the chromatin (Kouzarides, 2007).
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Accessibility to the DNA to regulate genome functions
7KHSDFNDJLQJRIWKH'1$LQWRWKHFKURPDWLQLVQHFHVVDU\WR¿WWKHHQWLUHJHQRPHLQWKHVPDOO
nuclear volume and it is therefore very important to precisely regulate the accessibility to the 
DNA for various protein involved in gene regulation. Despite the high degree of compaction, 
chromatin structure has to be highly dynamic to allow access to the DNA by the complex 
protein machineries involved in gene transcription, DNA replication and DNA repair (reviewed 
LQ/XJHU'HFKDVVDHWDO7KLVSURFHVVLVFDUULHGRXWE\GLIIHUHQWPRGL¿FDWLRQVZKLFK
cause conformational changes that regulate accessibility to the DNA. 
Chromatin remodeling complexes can change the structure of the nucleosome temporarily by 
loosening the DNA from the histones or displacing a nucleosome, thereby making the DNA 
accessible for other factors. 
0RGL¿FDWLRQVRI WKHKLVWRQH WDLOVSOD\DQ LPSRUWDQW UROH LQDOWHULQJ WKHFKURPDWLQVWDWHDQG
accessibility of the DNA by loosening the histone-DNA interaction and enabling binding of 
VSHFL¿F UHJXODWRU\ SURWHLQV .RX]DULGHV  (UQVW .KHUDGSRXU HW DO  +LVWRQH
acetylation is mainly associated with transcription activation, for instance histone 3 lysine 
9 acetylation (H3K9ac) and lysine 27 acetylation (H3K27ac) are associated with active 
regulatory regions in the DNA. Histone methylation can be implicated in both transcriptional 
DFWLYDWLRQDQGUHSUHVVLRQGHSHQGLQJRQWKHUHVLGXHWKDW LVPRGL¿HG LQSDUWLFXODUKLVWRQH
O\VLQHPHWK\ODWLRQ+.PHFRUUHODWHVZLWKHQKDQFHUVKLVWRQHO\VLQHGLPHWK\ODWLRQ
(H3K4me2) with enhancer and promoter regions, histone 3 lysine 4 tri-methylation (H3K4me3) 
with promoter regions and histone 3 lysine 27 tri-methylation (H3K27me3) with transcriptionally 




with transcriptional repression and on histone 2B lysine 20 (H2BK20) in association with 
transcriptional activation. Sumoylation has been shown to take place on all four core histones 
(reviewed in Kouzarides, 2007).
0RGL¿FDWLRQVRIWKH'1$LWVHOIFDQDOVRPRGXODWHH[SUHVVLRQ2QHFODVVLFDOH[DPSOHLVWKH
methylation of cytosines in CpG islands that causes repression of gene transcription by 
preventing the transcription machinery to associate with the DNA. 
Transcription and regulatory elements
The achievement of different biological processes depends on the correct spatial and temporal 
expression of genes. Gene transcription is performed by RNA polymerase and it is a process 
tightly controlled by transcription factors and transcriptional regulatory elements such as 
promoters, enhancers, silencers, Locus Control Regions (LCR) and insulators (reviewed in 
Maston, Evans et al., 2006). 
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7UDQVFULSWLRQIDFWRUVDUHSURWHLQVWKDWELQGWRVSHFL¿FUHJLRQVRIWKH'1$DQGFDQPRGXODWH
gene regulation by acting on transcriptional regulatory regions. 
Promoters are regions located at the gene start that serve as docking and assembly site for 
WKHWUDQVFULSWLRQDOPDFKLQHU\JHQHUDODQGVSHFL¿FWUDQVFULSWLRQIDFWRUVDQGVSHFL¿FDFWLYDWRU
proteins.
Enhancers are regions on the genome that markedly increase the transcription of a gene by 
acting on the respective promoters. They function independently of orientation and distance 
from the target promoter and can occasionally act over long distances. Enhancers provide 
the binding platforms for several transcription factors that work cooperatively to enhance 
transcription.
6LOHQFHUVDUHVHTXHQFHVSHFL¿FHOHPHQWVWKDWFRQIHUQHJDWLYHHIIHFWVRQWKHWUDQVFULSWLRQRID
target gene. Typically they function independently of orientation and distance from the target 
promoter and they provide the binding sites for transcription factors with a repressive function.
Locus Control Regions (LCR) are regulatory elements involved in regulating entire loci or gene 
clusters. In general they are composed of several regulatory elements comprising enhancers, 
VLOHQFHUV RU LQVXODWRUV WKDW FDQ EH ERXQG E\ JHQHUDO RU VSHFL¿F WUDQVFULSWLRQ IDFWRUV ZLWK
activating or repressing function, thereby controlling transcription. Although LCRs are typically 
located upstream of their target genes, they can also be found within the intron of their target 
gene or even in the introns of neighboring genes.
,QVXODWRUVDUHUHJXODWRU\HOHPHQWVWKDWFDQEHERXQGE\VSHFL¿FSURWHLQVFDOOHGLQVXODWRUV
proteins, and can have enhancer-blocking activity by preventing an enhancer to interact with a 
VSHFL¿FSURPRWHURUFKURPDWLQEDUULHUDFWLYLW\E\SUHYHQWLQJWKHVSUHDGLQJRIKHWHURFKURPDWLF
PDUNV LQWR DFWLYH FKURPDWLQ0XFK RI WKHZRUN WKDW GH¿QHG WKH SURSHUWLHV RI DQ LQVXODWRU





explained later in this chapter.
Functional organization of the genome in higher-order 
chromatin structure
%DVHGRQWKHREVHUYDWLRQWKDW'1$UHJXODWRU\HOHPHQWVFDQEHIRXQGTXLWHGLVWDQWIURPWKHLU
target promoters, several models have been proposed to explain how insulator proteins or 
transcription factors can function to facilitate the communication between regulatory elements 
and promoters. 
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Figure 1: Models proposed to explain the formation of long-range chromosomal interaction for gene 
regulation. 
a./LQHDUUHSUHVHQWDWLRQRIWKHJHQRPLFGLVWDQFHEHWZHHQDQHQKDQFHUJUHHQRYDODQGDSURPRWHURUDQJHVTXDUH
b. Tracking model in which the “tracking complex” (brown ovals) bound to the enhancer can slide along the chromatin 
¿EHUWRZDUGVWKHWDUJHWSURPRWHUDFWLYDWLQJWKHWUDQVFULSWLRQXSSHUPRGHO7KH³WUDFNLQJFRPSOH[´PLJKWEHDOVR
trapped by an insulator protein (grey oval) which leads to transcriptional repression (lower model). c. Linking model 
in which DNA binding proteins (brown ovals) bind to an enhancer and drive the polymerization of other proteins 
(orange ovals) towards the target promoter. d. Relocation model in which a particular gene can relocate into a nuclear 
compartment (orange oval) containing transcription factors and active polymerase (brown ovals) that favour the 
interaction between the enhancer and the target promoter. e. DNA looping model in which the regulatory proteins 
JUD\RYDOVSURPRWH WKH IRUPDWLRQRID'1$ ORRS WKHUHE\EULQJLQJ WKHHQKDQFHU LQFORVHSUR[LPLW\ WRDVSHFL¿F
promoter.
In the tracking model, DNA binding proteins bind to the enhancer, forming a “tracking complex” 
WKDW FDQ VOLGH DORQJ WKH FKURPDWLQ ¿EHU DQG UHDFK D WDUJHW SURPRWHU ZKHUH LW DFWLYDWHV
transcription. One example supporting this model was the transcription of the late genes of 
the bacteriophage T4 where the activator gp45 is loaded on the DNA and can reach the 
target promoter by sliding along the DNA (Kolesky, Ouhammouch et al., 2002). The tracking 
model could also be used to explain gene silencing mediated by chromatin insulators. The 
insulator protein would block the “tracking complex” before it reaches the target promoter, 
but so far this model is not supported by evidence (Figure 1b). In the linking model, DNA 
ELQGLQJSURWHLQVFDQELQGWRDQHQKDQFHUDQGGULYHWKHVHTXHQWLDOELQGLQJRIRWKHUSURWHLQV
towards the target promoter. This model was used to explain the action of the Drosophila Chip 
protein that interacts with several other factors to facilitate enhancer-promoter communication 





















gene to modulate the transcription. In the relocation model, a particular gene can relocate 
to a nuclear compartment in which the interaction between the enhancer and the promoter 
of the gene is favoured (Cook, 2003). This model is based on observations that active RNA 
polymerase can be found in focal sites within the nucleus (Jackson, Hassan et al., 1993) and 
that during transcription active genes are associated with this focal site (Osborne, Chakalova 
et al., 2004) (Figure 1d). In the DNA looping model, regulatory proteins can promote the 
IRUPDWLRQRI'1$ORRSVZKLFKEULQJWKHHQKDQFHULQFORVHSUR[LPLW\WRDVSHFL¿FSURPRWHUDQG
regulate transcription (Figure 1e7KLVPRGHOLVWKHIDYRXUHGRQHEHFDXVHLWDVVXPHVÀH[LELOLW\
RI WKHFKURPDWLQ¿EHU(YLGHQFH IRU WKLV W\SHRI LQWHUDFWLRQVZDV IRXQGXVLQJFKURPRVRPH
conformation capture methods, for instance at the mouse E-globin locus the locus control 
region (LCR) was found to interact with the distal E-globin promoter (Tolhuis, Palstra et al., 
2002). 
The effect of gene position
7KH HYLGHQFHV WKDW '1$ IROGV LQWR FRQ¿JXUDWLRQV WKDW EULQJ UHJXODWRU\ HOHPHQWV LQ FORVH
SUR[LPLW\WRFRQWUROJHQHH[SUHVVLRQUDLVHGWKHTXHVWLRQRQKRZWKH'QXFOHDUSRVLWLRQRI
WKHFKURPRVRPHVFRXOGLQÀXHQFHVXFKIXQFWLRQDOORQJUDQJHLQWHUDFWLRQV,QIDFWWKHJHQRPH
is not randomly positioned within the nucleus and interphase chromosomes occupy distinct 
territories in the nuclear space, termed as chromosome territories (CT) (Stack, Brown et al., 
&UHPHU&UHPHUHWDO&7VSRVLWLRQVFRUUHODWHZLWKJHQHGHQVLW\KLJKJHQHGHQVLW\
chromosomes are located in the interior of the nucleus and chromosomes with low gene density 
DUHIRXQGDWWKHQXFOHDUSHULSKHU\%R\OH*LOFKULVWHWDO)XUWKHUPRUHKHWURFKURPDWLQ
and silent genes mainly localize at the nuclear lamina while euchromatin and active genes are 
found at the nuclear interior, suggesting that the nuclear periphery is a repressive environment 
for transcription and the nuclear interior a compartment for transcriptional activation (Schneider 
and Grosschedl, 2007). Initial microscopy studies regarding the arrangement of the CTs 
VXJJHVWHGDQRUJDQL]DWLRQLQORRSGRPDLQVRIRQDYHUDJH0EVL]H0DQXHOLGLV6DFKV




genome functions: the chromosome territory-interchromatin compartment (CT-IC) model and 
the interchromatin network (ICN) model (Cremer and Cremer, 2010). 
According to the CT-IC model, the nucleus is composed of two main compartments: the CTs, 
constituted by chromatin domains, and a DNA free compartment carrying splicing speckles 
and nuclear bodies expanding in between these chromatin domains called interchromatin 
compartment (IC). The width of the IC space is highly variable depending on movements of 




of the CTs by a layer of relatively decondensed chromatin located at the domain periphery, 
called perichromatin region (PR) which might represent the main nuclear compartment for 
WUDQVFULSWLRQ(OHFWURQPLFURVFRS\HYLGHQFHKDVVXSSRUWHGWKHYLHZRIWKH35DUHD)DNDQ
and van Driel, 2007). During ongoing transcription genes are at least partially decondensed 
into the PR generating SHULFKURPDWLQ¿EULOV3)WKDWFDUU\WKHQDVFHQWWUDQVFULSWV3)DUHWKHQ
processed in nearby splicing factories located at the IC (Figure 2a). 
The ICN model predicts that loops of a particular CT can contact loops located in the same 
CT (cis interactions) or loops of a neighbouring CTs (trans interactions). These interactions 
EHWZHHQ WKH FKURPDWLQ ¿EHUV RI &7V ZHUH ¿UVW REVHUYHG E\ ),6+ H[SHULPHQWV LQ ZKLFK
different labelled chromosome painting probes revealed zones of colour overlap between the 
CTs (Branco and Pombo, 2006). In this interchromatin network, active genes are located 
on decondensed chromatin loops that extend outside of the chromosome territory and can 
localize with areas of focal concentration of RNA polymerase II, called transcription factories, 
OHDGLQJWRUHJXODWLRQRIWKHLUH[SUHVVLRQ)UDVHUDQG%LFNPRUHFigure 2b). 
Both models are mainly based on microscopy studies which have some limitations in analyzing 
the overall spatial organization of chromosomes (Rajapakse and Groudine, 2011) and in 
fact they provide only few mechanistic details about the relationship between higher-order 
chromatin structure and the genome.
Figure 2: Schematic representation of the chromosome territory-interchromatin compartment (CT-IC) model 
(a) and the interchromatin network (ICN) model (b) PRGL¿HGIURP&UHPHUDQG&UHPHU 
a. CT-IC model in which CTs are constitute by chromatin domains and a DNA free nuclear compartment carrying 
splicing speckles and nuclear body called IC. Prichromatin region (PR) located at the domain periphery is also 
LQGLFDWHG'XULQJ WUDQVFULSWLRQJHQHV LQ WKH35DUHGHFRQGHQVHGJHQHUDWLQJSHULFKURPDWLQ¿EULOV 3) WKDWFDUU\
the nascent transcripts which are then processed in nearby splicing factories. Movment of chromatin domains allow 
transient contacts of domains surface in cis or trans. b. ICN model in which loops from the same CT as well as from 
neighbouring CTs can make contacts in cis (blue dots) or trans (green dots). Transcription factories (pink ovals) 
























Insights into nuclear organization by 3C technologies
In the past decade the development of chromosome conformation capturing&WHFKQLTXHV
has made it possible to study the nuclear organization at a high resolution level. These 
WHFKQRORJLHVFDQHOXFLGDWHKRZWKHFKURPDWLQ¿EHUVDUHIROGHGLQWRWKHKLJKHURUGHUFKURPDWLQ
organizations that form the CTs and which factors are involved in promoting these contacts. 
$OOWKHVHPHWKRGVDUHEDVHGRQ¿[DWLRQRIWKHFKURPDWLQWRVWDELOL]HWKH'VWUXFWXUHRIWKH
DNA, digestion with a restriction enzyme and ligation of the cross-linked DNA fragments 
(Figure 3). In this way, DNA fragments located in close proximity in the nuclear space are 
OLJDWHGWRHDFKRWKHU7KHVXEVHTXHQWGHWHFWLRQRIWKHVHIUDJPHQWVZKLFKYDULHVLQPHWKRG
between the different 3C technologies, provides information about the 3D spatial organization 
of the genome.
Chromosome Conformation Capture (3C): The detection of the ligation product is done by 
3&5VHPLTXDQWLWDWLYHRUT3&5TXDQWLWDWLYHPHDVXULQJWKHQXPEHURIWKHOLJDWLRQHYHQWV
between the selected DNA fragment (anchor or viewpoint) and the interacting fragments. PCR 
primers are designed near the restriction ends of the anchor fragment and in all the restriction 
fragments of interest (one-to-one). 
7KHSULPHUGHVLJQUHTXLUHVVRPHNQRZOHGJHRISRWHQWLDO LQWHUDFWLRQV'HNNHU5LSSHHWDO
+DJHJH.ORXVHWDO
Chromosome Conformation Capture-on-chip (4C): The ligated 3C template is further 
digested and ligated to form small DNA circles. By using PCR primers designed in the 
fragment of interest (viewpoint), it is possible by inverse PCR to amplify all unknown fragments 
OLJDWHGZLWKWKHYLHZSRLQW7KHDPSOL¿HGIUDJPHQWVFDQEHLGHQWL¿HGE\PLFURDUUD\RQHWRDOO
(Simonis, Klous et al., 2006).






Chromosome Conformation Capture Carbon copy (5C): The 3C template library is 
hybridized with a mix of oligos covering a particular region of interest and designed in the 
OLJDWLRQ MXQFWLRQVRI WKH& IUDJPHQWV$IWHU3&5 WKHDPSOL¿HG IUDJPHQWVDUHGHWHFWHGE\
PLFURDUUD\RUQH[WJHQHUDWLRQVHTXHQFLQJWHFKQRORJ\PDQ\WRPDQ\'RVWLH5LFKPRQGHW
al., 2006). 
By using this technology, the spatial organization of the mouse regulatory X-inactivation 
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centre (Xic) was analyzed demonstrating that the region was partitioned in a series of 200Kb 
to 1Mb topologically associated domains (TAD) (Nora, Lajoie et al., 2012). The TADs spatially 
segregated the promoters of the non-translated RNA genes Xist/Tsix sense/antisense which 
lay in adjacent domain pointing to their role in shaping regulatory landscape.
Hi-C: In this case the procedure to obtain the template is different: before ligation of the 
FURVVOLQNHG '1$ IUDJPHQWV WKH OLJDWLRQ HQGV DUH ¿OOHG ZLWK ELRWLQ\ODWHGQXFOHRWLGHV 7KH
ligation occurred then via the blunt-ends and the interacting fragments are enriched by a 
ELRWLQSXOOGRZQ7KH IUDJPHQWVDUHDPSOL¿HGE\3&5DQGGHWHFWHGXVLQJQH[WJHQHUDWLRQ
VHTXHQFLQJWHFKQRORJ\DOOWRDOO/LHEHUPDQ$LGHQYDQ%HUNXPHWDOYDQ%HUNXP
Lieberman-Aiden et al., 2010). 
This technology was used to study chromatin structure in mammalian cells and revealed that 
the genome is partitioned into large mega-based self-associated domains. These so called 
topological domains are conserved between tissues and to some extend also between mouse 
and human (Dixon, Selvaraj et al., 2012). The different topological domains are linked by 
narrow segments, called boundaries, which delimit the transition between domains.
Figure 3: Schematic overview of chromosome conformation capturing methods. 






































Factors promoting higher-order chromatin structure
Several studies on the 3D organization of the genome by using the “C” methods have 
highlighted important factors that play a central role in promoting higher-order chromatin 
structure. 
,QWKHVHVHFWLRQV,ZLOOIRFXVRQWKHFRKHVLQFRPSOH[DQG&7&)&&&7&ELQGLQJIDFWRU
The cohesin complex 
Structure of the cohesin core complex
Cohesin is a chromosome-associated multisubunit protein complex which is highly conserved 
in eukaryotes. In somatic vertebrate cells, the core cohesin complex consists of four subunits: 
SMC1, SMC3, RAD21 and SA1 or SA2 (Table 1 for nomenclature in different species). 
The two core subunits of the complex, SMC1 and SMC3, are members of the Structural 
Maintenance of Chromosomes (SMC) family. The polypeptide chain of SMC proteins folds 
back on it-self forming a long anti-parallel coiled-coil structure of 45 nm with the hinge domain 
at one end and the N- and C-terminal domains assembling into a functional ATPase (ATPase 
head). 
SMC1 and SMC3 in the cohesin complex interact via the hinge domain and the ATPase heads 
are connected by the alpha-kleisin subunit, RAD21, resulting in the formation of a tripartite 
molecular ring which can be visualized by electron microscopy (Anderson, Losada et al., 
+DHULQJ/RZHHWDO
The N-terminus of RAD21 binds to the SMC1 subunit while the C-terminus binds to SMC3. A 
fourth subunit, either SA1 or SA2 (stromalin antigens 1 and 2), binds to RAD21 (Figure 4a). 
S. Cerevisiae S. pombe D. melanogaster X. leavis M. Musculus H. Sapiens
SMC
Smc1 Psm1 Smc1 Smc1 Smc1 SMC1
Smc3 Psm3 Smc3 Smc3 Smc3 SMC3
Kleisin Scc1/Mcd1 Rad21 Rad21 Rad21 Scc1 RAD21
Kleisin





Mis4 Nipped-B Scc2 Scc2 NIPBL
Ssl3 Scc4 Scc4 Scc4 Mau2
Regulatory
proteins
Pds5 Pds5 Pds5 Pds5A, Pds5B APRIN PDS5A, PDS5B
Rad61/Wapl Wapl Wapl Wapl Wapal WAPAL
- - Dalmatian Sororin/cdca5-b Sororin/Cdca5 Sororin/CDCA5
Acetyl-transferase Eco/Ctf7 Eso1 Deco, San Esco1, Esco2 Esco1, Esco2 ESCO1, ESCO2
Deacetylases Hos1 - - - - HDAC8
Table 1: Cohesin complex subunits and cohesin-regulatory proteins in different species.
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Figure 4: Schematic representation of the cohesin complex (a) and the transiently associated regulatory 
proteins (b). 
a. SMC3 and SMC1are bound via the hinge domain and the ATPase heads are connected by RAD21 which in turn 
can bind either SA1 or SA2. 
b. Cohesin regulatory protein PDS5, WAPL and Sororin: PDS5/Sororin act during S phase to stabilize cohesion while 
PDS5/WAPL act during prophase to facilitate cohesin dissociation from chromatin arms.
Cohesin and transiently-associated regulatory proteins
RAD21 and SA subunits are transiently associated with three main regulatory proteins: 
PDS5 (“Precocious Dissociation of Sisters”), WAPL (“Wings Apart-like”) and Sororin (Figure 
4b). PDS5, which in vertebrates exists in two isoforms PDS5A and PDS5B, is a protein that 
associates with SA subunit of the cohesin complex and is characterized by several HEAT 
repeats. 
:$3/FRQWDLQVDWWKH1WHUPLQDOUHJLRQWKUHH)*)PRWLIVWKDWSURPRWHLQWHUDFWLRQZLWK3'6
and a HEAT repeat that might favour the interaction with SMC3 or SA subunits. The complex 
PDS5/WAPL is very important during prophase to facilitate the dissociation of cohesin from 
chromatin arms. 
6RURULQ FRQWDLQV )*)PRWLIV WKDW ELQG WR 3'6 ,Q SDUWLFXODU GXULQJ 6 SKDVH6RURULQ FDQ
displace WAPL from PDS5, thereby avoiding the dissociation of cohesin from chromatin and 














Functions of the cohesin complex
$OO FRKHVLQ IXQFWLRQV ZHUH LQLWLDOO\ VWXGLHG LQ \HDVW DQG VXEVHTXHQWO\ LQ YHUWHEUDWHV 7KH
FRKHVLQFRPSOH[ZDV¿UVWGLVFRYHUHGE\DJHQHWLFVFUHHQ LQ\HDVW IRU LWVUROH LQPHGLDWLQJ
cohesion between sister chromatid during cell division (Michaelis, Ciosk et al., 1997) and 
later on this function was also studied in XenopusDQGKXPDQ/RVDGD+LUDQRHWDO
6XPDUD9RUODXIHU HW DO &RKHVLQZDVDOVR IRXQG WR EHHVVHQWLDO IRU HI¿FLHQW'1$
GRXEOHVWUDQGEUHDNUHSDLU6MRJUHQDQG1DVP\WK.LP.UDVLHYDHWDOUHYLHZHG
in Watrin and Peters, 2006). 
Recently it has become increasingly clear that the complex has roles in regulating gene 
expression, mediating chromatin insulation and promoting the formation of higher-order 
FKURPDWLQVWUXFWXUHUHYLHZHGLQ:HQGWDQG3HWHUV5HPHVHLURDQG/RVDGD
Canonical function of cohesin: sister chromatid cohesion
To ensure genome stability and accurate inheritance of genetic information, DNA has to be 
replicated and a correct and complete set of chromosomes has to be distributed onto the 
daughter cells. The cohesin complex plays an important role in this process by holding the 
replicated sister chromatids together until they are properly attached to the mitotic spindle.
Loading of cohesin
In vertebrates, cohesin is loaded onto DNA in telophase after the formation of the nuclear 
envelope. This process depends on the cohesin-loading factors, NIPBL and MAU-2 (Figure 
5a). It is not clear how cohesin is exactly loaded and bound onto DNA but observations in yeast 
suggest that the binding depends on ATP hydrolysis by SMC1 and SMC3 globular ATPase 
heads that is somehow linked to the opening of the hinge domain, allowing the passage of the 
chromatin strand into the cohesin ring (Gruber, Arumugam et al., 2006). 
Establishment and maintenance of cohesion
The cohesion between the sister chromatid is established during DNA replication in S phase 
DQGLWUHTXLUHVWKHDFHW\ODWLRQRIWZRO\VLQHUHVLGXHVORFDWHGDWWKH$73DVHJOREXODUGRPDLQRI
the SMC3 subunit by an acetyltransferase enzyme called ESCO, a protein that exists as two 
isoforms in human cells, ESCO1 and ESCO2 (Unal, Heidinger-Pauli et al., 2008). 
Cohesion between the sister chromatid is maintain by a protein called Sororin (Schmitz, Watrin 
et al., 2007). In particular, SMC3 acetylation and the DNA replication recruit Sororin (Lafont, 
Song et al., 2010). Sororin binds to PDS5 and it displaces WAPL from PDS5, thus stabilizing 
cohesin binding and maintaining stable cohesion (Nishiyama, Ladurner et al., 2010) (Figure 
5b). 
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Removal of cohesin: prophase pathway
In vertebrates, the bulk of cohesin at the chromosome arms is removed during prophase, 
while it is preserved at the centromeres (Waizenegger, Hauf et al., 2000). Cohesin removal 
UHTXLUHV3ROROLNHNLQDVH3ON WKDW LVDFWLYDWHG LQHDUO\PLWRVLVDQGLV WUDQVORFDWHGIURP
the cytoplasm into the nucleus at the end of prophase. In mitosis, the RAD21 and SA1/SA2 
subunits of cohesin are phosphorylated and, based on observations in mitotic Xenopus egg 
H[WUDFWV3ON LV UHTXLUHG IRU WKHVHPRGL¿FDWLRQV 6XPDUD9RUODXIHUHWDO $QRWKHU
SURWHLQUHTXLUHGIRUWKHGLVVRFLDWLRQRIFRKHVLQIURPFKURPRVRPHDUPVLVWKHPLWRWLFNLQDVH
Aurora B (Losada, Hirano et al., 2002). Since this protein is unable to phosphorylate cohesin 
VXEXQLWVLQYLWURLWLVSRVVLEOHWKDW$XURUD%FDQLQÀXHQFHFRKHVLQLQGLUHFWO\E\SKRVSKRU\ODWLQJ
other regulators. One possible candidate is Condensin I whose association with chromosomes 
is depending on Aurora B (Lipp, Hirota et al., 2007) and cohesin dissociation (Hirota, Gerlich 
et al., 2004) (Figure 5c7KHSKRVSKRU\ODWLRQRI WKH FRKHVLQ FRPSOH[ LV UHTXLUHGEXW QRW
VXI¿FLHQW WR GLVVRFLDWH FRKHVLQ IURPFKURPRVRPHVDUPV6HYHUDO VWXGLHV LGHQWL¿HG:$3/
as a key regulator of cohesin dissociation. In fact, depletion of WAPL prevents removal of 
cohesin from chromosome arms in prophase (Kueng, Hegemann et al., 2006). 
At this stage, phosphorylation of Sororin by cyclin-dependent kinase1 (Cdk1) (Dreier, Bekier 
et al., 2011) allows the binding of WAPL to PDS5, promoting the dissociation of cohesin 
from chromosome arms (Nishiyama, Ladurner et al., 2010) (Figure 5d). At this phase, 
centromeric cohesin is protected by binding of shugoshin (Sgo1) which in turn recruits the 
protein phosphatase 2A complex (PP2A). It was proposed that the Sgo1/PP2A complex 
might dephosphorylate centromeric cohesin, thereby preventing its removal by the prophase 
SDWKZD\.LWDMLPD6DNXQRHWDO7DQJ6KXHWDOFigure 5d). 
Removal of cohesin: cleavage by separase
Sister chromatid cohesion at the centromere persists until the chromatids are properly attached 
to the opposite poles of the mitotic spindle. At this point the remaining cohesin is removed 
by proteolytic cleavage of its RAD21 subunit by the protease separase. The proper timing 
RI WKHVHHYHQWV LVHQVXUHGE\WKHXELTXLWLQ OLJDVHDQDSKDVHSURPRWLQJFRPSOH[F\FORVRPH
$3&& ZKLFK DFWLYDWHV VHSDUDVH E\ XELTXLW\ODWLRQ RI WKH VHSDUDVH LQKLELWRU F\FOLQH %
securine, thereby targeting it for degradation by the proteasome. Cleavage of RAD21 leads 
to the release of cohesin from chromatin and segregation of the sister chromatid (Figure 5e). 
Re-cycle of cohesin
In order to be reused in the next cell cycle, the cohesin SMC3 subunit is deacetylated by Hos1 
in yeast (Borges, Lehane et al., 2010) and HDAC8 in human cells (Deardorff, Bando et al., 
2012) (Figure 5f)DLOXUHRIGHDFHW\ODWLRQSUHYHQWVWKHGLVDVVHPEO\RIWKHFOHDYHGFRKHVLQ
complex and reduces the level of cohesin available for the next cell cycle. This acetylated 
FRKHVLQ FRPSOH[ FDQ EH ORDGHG RQWR'1$EXW FKURPDWLQ LPPXQRSUHFLSLWDWLRQ VHTXHQFLQJ
analysis has shown a decreased enrichment of cohesin at the its sites (Deardorff, Bando et 
al., 2012). 
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Figure 5: Schematic representation of the canonical function of the cohesin complex. 
a. Loading of cohesin by NIPBL/MAU-2. b. Establishment of sister chromatid cohesion via acetylation by ESCO and 
maintenance of stable cohesion by Sororin/PDS5. c-d. Removal of cohesin from chromatids arms by Plk1, Aurora 
B and WAPL/PDS5 and protection of centromeric cohesin by Sgo1/PP2A. e. Cleavage of centromeric cohesin by 
Separase and chromatin segregation. f. De-acetylation of cohesin by HDAC8. 
How does cohesin mediate sister chromatid cohesion?
Several models have been proposed to explain how cohesin can tether sister chromatids but I 
will only focus on the two most popular ones: the ring model and the hand-cuff model.
The Ring model proposes that cohesion between the sister chromatid is mediated by the ring-
like structure of the cohesin complex that can topologically entrap the replicated DNA strands 
+DHULQJ/RZHHWDO*UXEHU+DHULQJHWDOLQYROYLQJDPLQLPDOFRQWDFWEHWZHHQ
the DNA and the SMC subunits (Figure 6a). The observations that proteolytic cleavage of 
6FFRU6PFLVVXI¿FLHQWWRUHOHDVHFRKHVLQIURPFKURPRVRPHV:DL]HQHJJHU+DXIHWDO
*UXEHU+DHULQJHWDODQGWKDWOLQHDUL]DWLRQRI\HDVWPLQLFKURPRVRPHVOHDGVWR
loss of cohesin (Ivanov and Nasmyth, 2005) support this model.
In the Hand-cuff model, cohesion of the sister chromatid is established by interaction of two 
cohesin complexes via RAD21 subunits, enforced by either SA1 or SA2 (Figure 6b). Based on 
this model, single-ring cohesin complexes are loaded onto the chromosomes and during DNA 
replication the rings are distributed onto the sister chromatids. The handcuff is established 
when two RAD21 molecules are paired and tethered either by SA1 or SA2 (Zhang and Pati, 
7KLVPRGHOLVVXSSRUWHGE\RQHVWXG\XVLQJDÀXRUHVFHQFHSURWHLQFRPSOHPHQWDVVD\
























the depletion of SA1 and SA2 prevents this RAD21–RAD21 interaction causing loss of sister 
chromatid cohesion (Zhang and Pati, 2009). 
Experimental observations support both models and it is still unclear how exactly cohesin 
mediates cohesion. 
Figure 6: Possible mechanisms how cohesin can hold sister chromatids. 
a. Ring model in which the tripartite ring-like structure of the cohesin complex topologically embraces the sister 
chromatids. b. Hand-cuff model in which cohesion is established by two cohesin complexes that interact via their 
5$'VXEXQLWVWHWKHUHGE\6$RU6$(DFKULQJHQWUDSVRQHFKURPDWLQ¿EHU
Non-canonical functions of cohesin
Cohesin in Double-Strand Break (DSB) repair 
In eukaryotic cells there are two distinct mechanisms for DNA double-strand break (DSB) 
repair: the non-homologous end-joining (NHEJ) pathway and the homologous recombination 
(HR) pathway. The NHEJ pathway re-ligates the two free ends of DNA created at the DSB 
while the HR pathway uses the intact sister chromatid to repair the damaged DNA. The 
function of the HR pathway depends on the ability of cohesin to tether sister chromatids. 
In yeast, de novo loading of cohesin by Scc2/Scc4 occurs after DNA damage. In human, 
the recruitment of cohesin to the damage sites depends on SMC5/SMC6, a protein complex 
UHTXLUHGIRUHI¿FLHQW+5UHSDLU3RWWV3RUWHXVHWDO5HFHQWO\LWZDVDOVRGHPRQVWUDWHG
that the cohesin loading factor NIPBL is recruited to DSB sites, leading to the hypothesis that 
NIPBL could promote de novo loading of cohesin at the damage sites, as observed in yeast 
(Oka, Suzuki et al., 2011). 
In vertebrates it was shown that after a IR DNA-damage, the cohesin subunits SMC1 and 
SMC3 are phosphorylated by several kinases, such as ATM kinase, crucial for the initiation of 
the DNA-repair signalling pathway (Yazdi, Wang et al., 2002). Different studies suggested that 




DQG60& SKRVSKRU\ODWLRQ IXQFWLRQV LQ WKH'1$ GDPDJH UHVSRQVH LV VWLOO WR EH FODUL¿HG
Based on the fact that the phosphorylations occur in a region of the coiled-coil next to the 
JOREXODU$73DVHGRPDLQV LWZDVSURSRVHGWKDWWKHVHPRGL¿FDWLRQVFRXOGDOWHUWKH$73DVH
DFWLYLW\DQG WKHDELOLW\ WRRSHQDQGFORVH WKH ULQJRU WR ODWHUDOO\PRYHDORQJ WKH'1$¿EHU
(reviewer by Watrin and Peters, 2006).
Cohesin in gene regulation
Several studies demonstrated that cohesin might have a function in gene regulation in addition 
to its roles in chromosomal cohesion and DNA damage repair. The initial evidence came 
from the observation in yeast that cohesin can block the spreading of the Silent Information 
Regulatory complex (SIR) that represses transcription by occupying the boundaries of the 
HRM silent mating-type locus (Donze, Adams et al., 1999). Studies in Drosophila demonstrated 
WKDWFRKHVLQDQGWKHFRKHVLQORDGLQJIDFWRU1LSSHG%DUHUHTXLUHGIRUSURSHUWUDQVFULSWLRQYLD
long-range contacts of the homeobox genes cut and 8OWUDELWKRUD[but with opposite effects: 
cohesin decreases cut expression (Rollins, Korom et al., 2004) while Nipped-B activates 
ERWKJHQHV 5ROOLQV0RUFLOORHWDO)XUWKHUPRUHPXWDWLRQVRIFRKHVLQVXEXQLWV OHG
WRGHIHFWVGXULQJGHYHORSPHQWIRU LQVWDQFH LQ=HEUD¿VKPXWDWLRQRIWKH5DGJHQHZDV
found to reduce the expression of Runx JHQHV GXULQJ HPEU\RQLF GHYHORSPHQW +RUV¿HOG
Anagnostou et al., 2007) and in Drosophila, mutations of Smc1 and SA led to defects in axon 
pruning of the mushroom body neurons (Schuldiner, Berdnik et al., 2008). These defects 
cannot be explained by a sister chromatid cohesion defect but point to a role of cohesin in 
regulation of gene expression.
Moreover, the observations that cohesin binding to DNA persists during the cell cycle and that 
cohesin is expressed in different tissues (Monnich, Banks et al., 2009) including post-mitotic 
FHOOV OLNHQHXURQVZKHUHFKURPDWLGFRKHVLRQ LVQRW UHTXLUHG:HQGW<RVKLGDHWDO
support the idea of other roles of cohesin besides cohesion. 
Cohesinopathies
Different studies have shown that mutations in cohesin regulatory proteins or cohesin subunits 
are associated with severe developmental disorders also termed Cohesinopathies such as 
Roberts/SC phocomelia syndrome (RBS) and Cornelia de Lange syndrome (CdLS).
Roberts/SC phocomelia syndrome (OMIM #268300 and #269000) is an autosomal 
recessive disorder that is linked to homozygous mutations (in general truncation and 
missense mutation) of the acetyltransferase enzyme ESCO2. This syndrome is characterized 
by severe developmental defects, such as limb and facial abnormalities, mental and growth 
retardation as well as defects in centromeric cohesion and other heterochromatic areas 
EXWQRWDORQJWKHHXFKURPDWLFDUPV9HJD:DLV¿V]HWDO6LPLODUGHIHFWVZHUHDOVR
observed in Drosophila after mutation of the acetyltransferase deco, WKHÀ\KRPRORJRI(6&2
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(Williams, Garrett-Engele et al., 2003). In this mutant the association of the Rad21 subunit 
with centromeric regions was found to be reduced in comparison to the wild-type. Thus it was 
hypothesized that changes in the level or mode of cohesin binding in heterochromatic regions 
could interfere with expression of heterochromatic genes and contribute to the developmental 
GH¿FLWUHYLHZHGLQ'RUVHWW)XUWKHUPRUHDGHIHFWLQWKHPLWRWLFPHFKDQLVPPD\DOVR
be involved in the pathogenesis of RBS/SC. It was observed that the lack of cohesion at 
heterochromatic regions results in improper biorientation of the chromosomes. This might 
activate the mitotic spindle checkpoint leading the cells to divide very slowly or not divide at all 
thus contributing to the malformations associated with the syndrome (Jabs, Tuck-Muller et al., 
9HJD:DLV¿V]HWDO
Cornelia de Lange syndrome (OMIM #122470) is a disorder characterized by typical facial 
features, growth and mental retardation, upper limb malformations, hirsutism, gastrointestinal 
and other visceral system defects. In the majority of the cases (60%) this syndrome is caused 
by heterozygous mutation of the cohesin loading factor NIPBL (Krantz, McCallum et al., 2004) 
and in a smaller fraction of patients by mutations of the cohesin core subunits SMC1A (5%) or 
60&0XVLR6HOLFRUQLHWDO'HDUGRUII.DXUHWDORUE\mutations in the 
cohesin-deacetylation protein HDAC8 (Deardorff, Bando et al., 2012). NIPBL-related CdLS 
and SMC3-related CdLS are inherited in an autosomal dominantPDQQHU60&$UHODWHG
CdLS is inherited in an X-linked manner.
NIPBL mutations (in general truncation, deletion or missense mutations) are linked to a severe 
phenotype and mutations of the cohesin core subunits (in general missense or small deletion) 
to the mild phenotype. Interestingly, sister chromatid cohesion is not affected in cells derived 
from CdLS patients, likely due to a partial dosage compensation for NIPBL. This observation 
led to the hypothesis that a defect in the gene regulation function of cohesin might be the cause 
of the phenotype (reviewed in Dorsett and Krantz, 2009). Comparison of the transcriptomes 
of O\PSKREODVWRLG FHOOV OLQHV (LCLs) derived from CdLS patients with NIPBL mutation and 
FRQWUROVLGHQWL¿HGDJURXSRIVSHFL¿FJHQHVZKLFKDUHGLIIHUHQWLDOO\H[SUHVVHGDQGLQYROYHGLQ
different cellular processes (embryonic and tissue development, hematological and immune 
system development and functions, cell death, cell proliferation and cell cycle regulation). In 
the control cell lines, some of these genes have cohesin binding sites next to the transcription 
start sites (TSS) (Liu, Zhang et al., 2009). These sites are lost in LCLs with NIPBL mutation 
suggesting that the loss of cohesin due to NIPBL mutation might affect transcriptional regulation 
DWVSHFL¿FORFLDQGPLJKWFRQWULEXWHWRWKH&G/6SKHQRW\SH
Recently, mutations in the histones deacetylase 8 (HDAC8) were found in a small cohort of 
CdLS patients (Deardorff, Bando et al., 2012). These patients present similar clinical features, 
transcriptional missregulation and loss of cohesin binding sites as seen in CdLS with NIPBL 
mutations, pointing to the idea that loss of cohesin results in both cellular and clinical features 
of CdLS. It remains possible that mutations in genes encoding other cohesin subunits or 
cohesin-regulatory proteins could contribute to the disorder, but to date no such mutations 
have been found in CdLS probands. Different mouse models suggest that mutations of 
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other cohesin subunits and cohesin-regulatory proteins give a phenotype reminiscent of 
&G/6)RU LQVWDQFHPLFHZLWKKHWHUR]\JRXVPXWDWLRQVRIPds5B and Pds5A exhibit CdLS 
OLNHGHYHORSPHQWDODEQRUPDOLWLHVZLWKQRREYLRXVFRKHVLRQGHIHFW=KDQJ-DLQHWDO
=KDQJ&KDQJHW DO )XUWKHUPRUH LWZDVREVHUYHG WKDW WKHDEVHQFHRI WKH6WDJ
6$FRKHVLQVXEXQLWLQPRXVHHPEU\RQLF¿EUREODVW0()FHOOVUHVXOWVLQDUHORFDWLRQRIWKH
cohesin complex which alters the expression of genes involved in biological processes related 
to CdLS (Remeseiro, Cuadrado et al., 2012).
Co-localization of cohesin with transcription factors
Cohesin and CCCTC-binding factor (CTCF)
In mammalian cells, genome-wide mapping of cohesin binding sites revealed that cohesin 
largely colocalizes with the DNA binding protein &&&7&ELQGLQJ IDFWRU &7&) 3DUHOKR
+DGMXUHWDO:HQGW<RVKLGDHWDO
CCCTC-binding factor (CTCF)
&7&) LV D KLJKO\ FRQVHUYHG DQG XELTXLWRXVO\ H[SUHVVHG '1$ ELQGLQJ SURWHLQ FRQVLVWLQJ
RI HOHYHQ ]LQF ¿QJHUV ,W KDV EHHQ LPSOLFDWHG LQ VHYHUDO IXQFWLRQV LQFOXGLQJ WUDQVFULSWLRQDO
UHSUHVVLRQDQGDFWLYDWLRQLPSULQWLQJDQGFKURPDWLQLQVXODWLRQ&7&)ZDV¿UVWGHVFULEHGDVD
transcription factor that repressed the chicken c-mycJHQH/REDQHQNRY1LFRODVHWDO
.OHQRYD1LFRODVHWDO/DWHUVWXGLHVGHPRQVWUDWHGWKDW&7&)LVQRWRQO\LQYROYHGLQ
gene silencing but also in activation, as shown for the Amyloid E-Protein Precursor (APP) 
(Vostrov and Quitschke, 1997).
In vertebrates, it is so far the only protein with a chromatin insulator function. Its binding to DNA 
can block enhancer-promoter interactions and can also provide a chromatin barrier function, 
as demonstrated for the chicken EJORELQORFXV%HOO:HVWHWDO5HFLOODV7DUJD3LNDDUW
HWDO7KH&7&)LQVXODWLRQIXQFWLRQSOD\VDOVRDFULWLFDOUROHLQWKHHVWDEOLVKPHQWDQG
maintenance of imprinting expression patterns, as shown for the mouse and the human 
LPSULQWHG+,JIJHQHV7KHVHJHQHVDUHH[SUHVVHGLQDSDUHQWVSHFL¿FPDQQHUZLWK+19 
transcribed from the maternal allele and Igf2 from the paternal allele. Both genes are under 
the control of the same enhancer located in close proximity to the H19 gene. &7&)ZDVIRXQG
to occupy the imprinting control region (ICR) of the locus only at the unmethylated maternal 
DOOHOHZKHUHLWEORFNVWKHHQKDQFHUIURPDFWLYDWLQJWKH,JIJHQH%HOODQG)HOVHQIHOG
+DUN6FKRHQKHUUHWDO.DQGXUL3DQWHWDO7RVW-DPPHVHWDO
Role of CTCF in promoting higher-order chromatin structure
7KH IDFW WKDW&7&) FDQ ELQG WR GLVWDO UHJXODWRU\ HOHPHQWV WRPRGXODWH JHQH WUDQVFULSWLRQ
suggested that it might promote the formation of higher-order chromatin structures to bring 
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WKHVHHOHPHQWVLQFORVHSUR[LPLW\$QLPSRUWDQWVWXG\RQWKHIXQFWLRQRI&7&)LQSURPRWLQJ
long-range chromosomal interactions was performed using the mouse H19/Igf2 locus (Murrell, 
Heeson et al., 2004). Chromosome conformation capture methods revealed that in mouse 
FHOOVWKHELQGLQJRI&7&)WRWKHPDWHUQDO,&5LQKLELWVDGLUHFWFRPPXQLFDWLRQEHWZHHQWKH
enhancer and the Igf2 promoter, leading to the formation of a silent chromatin loop and to 
WKHWUDQVFULSWLRQDOLQDFWLYDWLRQRI,JI%\FRQWUDVWDWWKHSDWHUQDO,&5WKHDEVHQFHRI&7&)
facilitates the interactions between the enhancer and the Igf2 promoter forming an active 
chromatin loop and leading to Igf2 transcription 0XUUHOO+HHVRQHWDO.XUXNXWL7LZDUL
HW DO &7&)ZDVDOVR IRXQG WR EH LQYROYHG LQ RUJDQL]LQJ ORQJUDQJH FKURPRVRPDO




the mouse interferon gamma (InfJ) locus with the transcription factor T-bet (Sekimata, Perez-
Melgosa et al., 2009) and the mouse Myb locus together with the Ldb1 complex (Stadhouders, 
Thongjuea et al., 2012). Interestingly, genome-wide studies focused on elucidating the 3D 
VWUXFWXUHRIWKHPRXVHDQGKXPDQJHQRPHLGHQWL¿HGODUJHPHJDEDVHVL]HGORFDOFKURPDWLQ
interaction domains, termed topological domains, in which the boundaries are enriched for 
&7&)VLWHVLQGLFDWLQJWKDWWKHSUHVHQFHRI&7&)PLJKWEHLPSRUWDQWLQHVWDEOLVKLQJWKHRYHU
all structure of the genome (Dixon, Selvaraj et al., 2012). These observations led to the initial 
WKRXJKWRI&7&)DVWKH“master weaver” of the genome (Phillips and Corces, 2009) but how 
&7&)SURPRWHVORQJUDQJHFKURPRVRPDOLQWHUDFWLRQVLVVWLOOXQFOHDU




JHQHUDO FKURPDWLQELQGLQJ RI FRKHVLQ ZDV QRW UHGXFHG DIWHU &7&) GHSOHWLRQ &RQYHUVHO\
FRKHVLQ LV UHTXLUHG WRPDLQWDLQ&7&)GHSHQGHQWFKURPDWLQLQVXODWLRQ)RU LQVWDQFHDW WKH
KXPDQ,*)+LPSULQWHGJHQHFRKHVLQELQGVWRWKHPDWHUQDO,&5DV&7&)DQGGHSOHWLRQ
RI FRKHVLQ OHDG WR ORVVRI&7&) LQVXODWLRQ LQGLFDWLQJ WKDW FRKHVLQ LVDOVR UHTXLUHG IRU WKH
imprinting regulation of the locus (Wendt, Yoshida et al., 2008). These results led to the idea 
that also the cohesin complex might be involved in promoting long-range interactions together 
ZLWK&7&)&KURPRVRPH FRQIRUPDWLRQ FDSWXUH VWXGLHV DW WKH KXPDQ LPSULQWHG ,*)+
locus have demonstrated that both factors are helping in organizing the structure of the locus 
which results in different promoter-enhancer interaction on both alleles. In particular, for both 
DOOHOHV&7&)DQGFRKHVLQZHUHIRXQGWRFRORFDOL]HGRZQVWUHDPRIWKHHQKDQFHUV&7&)'6
LQWKH&HQWUDOO\&RQVHUYHG'1DVH,K\SHUVHQVLWLYHGRPDLQ&&'EHWZHHQ+DQG,*)DQG
LQWKHUHJLRQDGMDFHQWWRWKH,*)SURPRWHU&7&)$''05Figure 7a). As already shown, 
the binding at the ICR was found only on the maternal allele. 
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the locus interact strongly with each other, while the ICR and the enhancer have limited allele 
VSHFL¿F LQWHUDFWLRQV 7KHVH GDWD VXJJHVWHG DPRGHO LQ ZKLFK FRKHVLQ DQG&7&) ELQGLQJ
sites on the paternal allele are coming together forming an interacting region in which the 
,&5 LVH[FOXGHG WKXVHQDEOLQJ WKH ,*)JHQHSURPRWHUVDQGHQKDQFHU UHJLRQ WR LQWHUDFW
%\FRQWUDVW WKH ,&5RQ WKHPDWHUQDODOOHOHFDQ LQWHUDFWZLWK WKHRWKHUFRKHVLQDQG&7&)
VLWHV UHGH¿QLQJ WKH ORFXV VWUXFWXUHDQGSUHYHQWLQJ WKH FRQWDFW EHWZHHQ WKHHQKDQFHUDQG
WKH,*)SURPRWHUFigure 7b). Moreover, cohesin has an important role in maintaining the 
higher-order chromatin structure at this locus since the depletion of cohesin destabilizes the 
chromatin conformation and this coincides with changes in gene expression (Nativio, Wendt 
HW DO  7KHVH REVHUYDWLRQV LQGLFDWHG WKDW ERWK FRKHVLQ DQG &7&) DUH UHTXLUHG IRU

























establish the loop structure entrapping the chromatin strands, as it was suggested for its role 
VLVWHUFKURPDWLGFRKHVLRQ,QDGGLWLRQWRWKHLPSULQWHG,*)+ORFXVDQ³DUFKLWHFWXUDOUROH´
IRUFRKHVLQDQG&7&)ZDVDOVRIRXQGLQRWKHUORFL&RKHVLQDQG&7&)ZHUHIRXQGWRSURPRWH
long-range chromosomal interactions at the human Interferon gamma (InfJ) locus and at the 
human apolipoprotein gene cluster $32 DQGGHSOHWLRQ RI HLWKHU FRKHVLQ RU&7&) OHG WR
disruption of the respective locus organization and altered gene expression (Hadjur, Williams 
HWDO0LVKLUR,VKLKDUDHWDO
&RKHVLQDQGWLVVXHVSHFL¿FWUDQVFULSWLRQIDFWRUV





and the core promoter of several active genes together with the transcriptional activator 
complex mediator. In PRXVHHPEU\RQLF ¿EUREODVWV 0()V LWZDVVKRZQ WKDW FRKHVLQDQG
mediator bound to a different set of promoters when compared to mES, demonstrating the cell-
W\SHVSHFL¿FLW\RIWKHELQGLQJ.DJH\1HZPDQHWDO)XUWKHUPRUHLWZDVGHPRQVWUDWHG
WKDW FRKHVLQ DQG PHGLDWRU SURPRWH FHOOW\SHVSHFL¿F '1$ ORRSV IDYRULQJ WKH LQWHUDFWLRQV
EHWZHHQGLVWDOHQKDQFHUVDQGVSHFL¿FSURPRWHUV)RULQVWDQFHLQP(6HQKDQFHUSURPRWHU
interactions mediated by cohesin/mediator were detected for the active genes Nanog, Phc1, 
2FWDQG/HIW\7KHVHLQWHUDFWLRQVZHUHQRWREVHUYHGLQ0()VZKHUH1DQRJ3KF2FW
and Lefty1 are silent and not occupied by mediator and cohesin (Kagey, Newman et al., 2010).




FDQFHUFHOOOLQH0&)FRKHVLQZDVIRXQGHQULFKHGDW(5D binding sites that correlate with 
estrogen-regulated genes, suggesting a role of cohesin in mediating estrogen-dependent 
transcriptional responses (Schmidt, Schwalie et al., 2010). ER was already found to be involved 
in long-range interactions for proper transcription of estrogen-regulated genes (Carroll, Liu et 
DO)XOOZRRG/LXHWDODQGLQWHUHVWLQJO\FRKHVLQZDVVLJQL¿FDQWO\HQULFKHGDW(5
binding sites involved in chromatin interactions compared to ER binding events not implicated 
LQORQJUDQJHFRQWDFWV,QFRQWUDVW&7&)ELQGLQJZDVQRWREVHUYHGWREHLQYROYHGLQWKHVH





Aim of this thesis
7KHFKURPDWLQ¿EHU LVRUJDQL]HG LQ WRSRORJLFDOGRPDLQV+RZWKHFKURPDWLQ¿EHU LV IROGHG
within these domains and which proteins are responsible for the establishment of these 
LQWHUDFWLRQVLVSRRUO\XQGHUVWRRGDVZHOODVKRZWKHVHVWUXFWXUHVLQÀXHQFHJHQHV
7KH FRKHVLQ FRPSOH[ DQG WKH LQVXODWRU SURWHLQ &&&7&ELQGLQJ IDFWRU &7&) DUH IDFWRUV
involved in the formation of interactions but even though a role for both proteins in promoting 
higher-order chromatin interactions has been established at individual loci, their genome-wide 
IXQFWLRQLVVWLOOWREHFODUL¿HG7KHDLPRIWKLVWKHVLVLVWRHOXFLGDWHWKHUROHIRUFRKHVLQDQG
&7&) LQ RUJDQL]LQJ WKH DUFKLWHFWXUH RI WKH KXPDQ JHQRPH DQG WKHLU FRQWULEXWLRQ WR JHQH
regulation.
Chapter 1 provides a general overview of the current knowledge on nuclear organization 
and how gene regulation might work via formation of higher-order chromatin structure. It 
also summarizes the currently available methods to study the folding of the chromatin and 
describes in more details two of the factors involved in long-range interactions, the cohesin 
FRPSOH[DQG&7&)
Chapter 2 and 3RIWKLVWKHVLVIRFXVRQKRZFRKHVLQDQG&7&)FRRSHUDWHWRRUJDQL]HWKH
DUFKLWHFWXUH RI WKH JHQRPH:H GHYHORSHG D WHFKQLTXH WR DVVHVV ORQJUDQJH LQWHUDFWLRQV
of multiple regions of interest (viewpoints) in parallel. This method is explained in detail in 
Chapter 2. In Chapter 3 WKHXVHRI WKLVWHFKQLTXHDVDQDSSURDFKWRXQUDYHO WKHFRKHVLQ¶V
role in establishing interactions at the human chromosome 11 p15.5 region is described. In 
DGGLWLRQ WKHJOREDO IXQFWLRQVRIERWKFRKHVLQDQG&7&) LQRUJDQL]LQJ WKHVWUXFWXUHRI WKH
human genome is revealed using the genome-wide method, Hi-C. 
The fact that mutations in the cohesin-regulatory protein NIPBL and in cohesin subunits 
SMC1A and SMC3 are the causes of the developmental syndrome Cornelia de Lange reveal 
an important role of the cohesin pathway during development. In Chapter 4, the role of NIPBL 
as (co)transcription factor will be described. We propose that NIPBL can regulate gene 
expression directly on the gene where it is bound and indirectly via loading of cohesin. These 
observations suggest that NIPBL mutation might alter the transcription of developmental 
genes contributing to the CdLS phenotype.
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INTRODUCTION
In recent years, it has become evident that the 3D organization 
of genomes is not random. Numerous studies have implicated 
long-range chromosomal interactions in several crucial cellular 
processes, including the regulation of gene expression1–4. Indeed, 
chromatin coassociations mediated by chromatin looping pro-
vide a means by which distal enhancers communicate with their 
target genes and stimulate transcription5–7. Accordingly, methods 
providing efficient and sensitive detection of chromatin looping 
events with high resolution are becoming increasingly popular. 
The development of 3C technology has revolutionized the analy-
sis of spatial genomic organization by allowing the detection of 
chromatin coassociations with a resolution far beyond that pro-
vided by light microscopy–based studies8. 3C relies on the ability 
of distal DNA fragments to be ligated together when positioned 
in close proximity in the nuclear space. Over the past decade, 
several 3C variants have been developed, offering the possibility 
of analyzing chromatin looping events on a genome-wide scale 
(e.g., 4C9–12, 5C13, ChIA-PET14, Hi-C15). We describe here in detail 
multiplexed 3C-seq, a 3C variant coupled to high-throughput 
sequencing that we recently developed16,17. Multiplexed 3C-
seq allows genome-scale simultaneous detection of long-range 
chromatin interactions of numerous genomic elements in parallel 
and can be applied to low numbers of cells (from 1 × 106 cells18 
to as low as 300,000 cells (P.K. and E.S., unpublished data)). We 
recently used this technique to analyze the spatial organization of 
several loci, including the mouse B-globin (Hbb), myeloblastosis 
oncogene (Myb) and IgK loci (Igk), revealing crucial enhancer-
gene communications16–18.
Overview of the procedure
All 3C-based procedures use formaldehyde fixation of living cells 
or fresh tissues to preserve genomic architecture in its native state 
before fragmentation by restriction enzyme digestion. The digested 
cross-linked chromatin is subjected to a ligation reaction under 
dilute conditions, favoring intramolecular ligation events over 
intermolecular ligation events (proximity ligation). This step yields 
a 3C library composed of chimeric DNA molecules resulting from 
the ligation of (distal) chromatin fragments that were in physical 
proximity in the nuclear space (Fig. 1). The subsequent steps differ 
depending on the type of assay used. The 3C library can be directly 
analyzed by probing for specific interactions by PCR19,20 or further 
processed for more global analyses using bait-specific primers (e.g., 
promoter-specific primer pair9–12,16–18) or whole-genome loop-
ing assays as in Hi-C15. In the 3C-seq procedure, the 3C library is 
subjected to a second restriction enzyme digestion using a frequent 
cutter, and fragments are circularized before an inverse PCR step 
using bait-specific primers (Fig. 1), similar to the original micro-
array-based 4C protocol11. This second restriction digest is neces-
sary to decrease the size of the DNA circles, resulting in fragments 
that can be PCR-amplified efficiently. The inverse PCR products 
contain the DNA elements that were captured (i.e., ligated) by 
the bait sequence and thereby represent its native chromatin 
environment in the nucleus. The 3C-seq library is then directly 
sequenced on an Illumina HiSeq2000 platform, with the possibility 
of multiplexing sample sequencing by pooling up to 12 different 
bait-specific 3C-seq libraries in a single lane of a HiSeq2000 flow 
cell, providing marked cost reduction and increased throughput. 
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Chromosome conformation capture (3C) technology is a powerful and increasingly popular tool for analyzing the spatial 
organization of genomes. Several 3C variants have been developed (e.g., 4C, 5C, ChIA-PET, Hi-C), allowing large-scale mapping of 
long-range genomic interactions. Here we describe multiplexed 3C sequencing (3C-seq), a 4C variant coupled to next-generation 
sequencing, allowing genome-scale detection of long-range interactions with candidate regions. Compared with several other 
available techniques, 3C-seq offers a superior resolution (typically single restriction fragment resolution; approximately 1–8 kb 
on average) and can be applied in a semi-high-throughput fashion. It allows the assessment of long-range interactions of up to 
192 genes or regions of interest in parallel by multiplexing library sequencing. This renders multiplexed 3C-seq an inexpensive, 
quick (total hands-on time of 2 weeks) and efficient method that is ideal for the in-depth analysis of complex genetic loci. The 
preparation of multiplexed 3C-seq libraries can be performed by any investigator with basic skills in molecular biology techniques. 
Data analysis requires basic expertise in bioinformatics and in Linux and Python environments. The protocol describes all 































510 | VOL.8 NO.3 | 2013 | NATURE PROTOCOLS
Other sequencing platforms are, in princi-
ple, compatible with multiplexed 3C-seq, 
but the multiplexing/de-multiplexing steps 
and associated informatics tools described 
here may need further optimization and 
adjustments.
Comparison of 3C-seq with other 3C-based methods
The choice between 3C and the different derivatives strongly 
depends on the biological question under consideration (Table 1). 
Although 3C-qPCR is particularly suited to quantitatively probe 
for specific interactions and interrogate a restricted number of 
chosen chromatin coassociations, it rapidly becomes technically 
demanding when large chromosomal domains are under inves-
tigation or when numerous interactions need to be analyzed in 
parallel for de novo detection of chromatin looping events. In the 
latter cases, high-throughput 3C derivatives such as 4C, 5C, 3C-
seq or Hi-C technologies will be preferred. The 4C approach10,11 
consists of a large-scale analysis of chromatin interactions with a 
chosen bait sequence by probing the 4C library on DNA micro-
arrays. It produces chromatin interaction maps of a single bait, 
with the coverage depending on the array used. 4C has the advan-
tage of allowing unbiased detection of unknown bait-specific 
interactions, but is limited by the number of arrays needed to 
achieve genome-wide coverage and by the saturation of signals 
around the bait sequence, preventing the detection of medium- to 
close-range interactions (up to 200 kb away). The 5C variant13 
overcomes this limitation and offers the possibility of exploring 
every potential chromatin coassociation in large subchromo-
somal domains by using primer sets covering all possible inter-
actions. It is, however, difficult to reach genome-wide coverage 
using 5C, as it requires extremely large numbers of primers for 
all possible intrachromosomal and interchromosomal interac-
tions. HiC, in contrast, provides a global genome-wide analysis 
of all possible chromatin associations by coupling a modified 
3C procedure to high-throughput sequencing15. Although it is 
extremely powerful, Hi-C requires substantial computational 
resources, and the number of sequence reads needed to obtain 
high coverage of mammalian genomes renders it very expen-
sive and, as a consequence, unaffordable for a large number of 
academic laboratories.
Cell cross-linking and nuclei/chromatin isolation Chromatin fragmentation by
primary restriction enzyme 
digestion
Proximity ligation
DNA purification and secondary
restriction enzyme digestion




coupled to Illumina adapters
Multiplexed library 
sequencing
Figure 1 | Overview of the multiplexed 3C-seq 
procedure. Nuclei from cross-linked cells are 
digested (primary restriction enzyme) and ligated 
under dilute conditions to physically link in vivo 
interacting DNA fragments. After a secondary 
digestion (secondary restriction enzyme) and 
ligation, inverse PCR is performed using bait-
specific primers containing Illumina sequencing 
adapters to amplify unknown fragments 
interacting with the bait. PCR samples generated 
with different primer sets are then pooled and 
subjected to multiplexed library sequencing. 
TABLE 1 | Comparison between different 3C variants.
3C-based method Applications Advantages Limitations
3C-(q)PCR19,20 One-to-one Relatively simple analysis  
(no bioinformatics required)
Laborious, knowledge of locus required, 
proper controls are essential
3C-on-chip (4C)9–11 One-to-all Relatively simple data analysis Poor signal-to-noise ratio, difficult to 
obtain genome-wide coverage
3C sequencing  
(3C-seq or 4C-seq)12,16
One-to-all Genome-wide coverage, high  
resolution, good signal-to-noise  
ratio, allows multiplexing for  
high-throughput
Restricted to a single view point per 
experiment (except when multiplexing), 
analysis requires some bioinformatics 
expertiseMultiplexed 3C-seq17,18 Many-to-all
3C carbon copy (5C)13 Many-to-many Explores interactions between many  
individual fragments simultaneously 
(instead of using a single viewpoint)
No genome-wide coverage, primer 
design can be challenging
Hi-C15 All-to-all Explores the genome-wide interactions 
between all individual fragments  
simultaneously
Obtaining high resolution requires a 
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3C-seq provides a fast and affordable genome-scale 3C alterna-
tive (Fig. 2). The use of high-throughput sequencing eliminates 
the problems of limited coverage and saturating signals associated 
with microarray technology and markedly increases resolution and 
signal-to-noise ratios. A disadvantage of 3C-seq is that, as in 4C, 
the analysis is restricted to a single bait sequence and does not pro-
vide deep characterization of chromatin coassociations of several 
regulatory elements in parallel. The multiplexed 3C-seq protocol 
presented here (Figs. 1 and 2) addresses this limitation and shows 
that, by efficiently multiplexing bait-specific library sequencing, 
genome-scale interactions of up to 192 different genomic elements 
can be assessed in parallel on an Illumina HiSeq2000 platform, 
thereby markedly increasing the throughput of the technique and 
decreasing sequencing costs. Moreover, 3C-seq data analysis is 
facilitated by the availability of bioinformatics tools. We provide 
here a dedicated analysis pipeline facilitating the entire data han-
dling process, including de-multiplexing, alignment and visualiza-
tion. Together, this renders multiplexed 3C-seq an inexpensive and 
efficient method for in-depth analysis of complex genetic loci and 
genomic regulatory regions.
Applications of the method
3C-seq can be applied to any nonrepetitive region of a genome. It is 
generally used to unravel medium- to long-range interactions (i.e., 
few kb to hundreds of kb) of a genomic element of interest. It is 
usually applied to detect interactions between promoter elements 
and the surrounding regions, or to connect distal enhancers to their 
target gene(s). With the recent developments in high-throughput 
chromatin occupancy profiling21, large numbers of transcription 
factor binding and chromatin modification data sets are becoming 
available. Combined with this knowledge, 3C-seq can be used to 
analyze the functional relationships existing between regulatory 
elements, sites of active transcription, gene deserts or boundary 
elements where transitions in chromatin structure or transcription 
are observed (e.g., insulator elements or initiation sites for produc-
tive transcription elongation).
Limitations of 3C-seq
Similar to all 3C-based procedures, 3C-seq only provides topologi-
cal information. The control experiments discussed in Experimental 
design will help validate and ensure the specificity of the observed 
interactions. Even so, it is recommended to combine 3C-seq data 
with results from complementary experiments (e.g., fluorescence 
in situ hybridization (FISH), gene expression analysis, chromatin 
immunoprecipitation (ChIP))7,17,22 or, even better, with functional 
experiments, before drawing conclusions on the functional impact 
of chromatin coassociations.
Experimental design
Fixing cells. Cell fixation, which represents the starting point of 
the procedure, provides the template for the essential proximity 
ligation step used to capture DNA-DNA interactions. Fixation con-
ditions need to be standardized for increased reproducibility and 
efficient comparison between samples. In our hands, formaldehyde 
fixation conditions used in ChIP experiments (1–2% (vol/vol) for-
maldehyde, 10 min at room temperature (18–22 °C)) work well for 
3C-seq16–18. More extensive fixation protocols have been reported 
to improve signal-to-noise ratios in the distance range of a few kb 
(ref. 23), although this protocol utilizes more frequently cutting 
restriction enzymes to obtain such resolution and might therefore 
be difficult to compare with our protocol.
Starting material. We have used many human and mouse cell or 
tissue types in 3C-seq experiments (Table 2), although certain cell 
or tissue types (e.g., fibroblasts) can be more difficult to handle. The 
use of single-cell suspensions is essential when performing 3C-seq 
(and other 3C-based protocols, for that matter). When working 
with tissues that are difficult to dissociate (e.g., brain, heart, lung), 
consider treating them with collagenase before formaldehyde fixa-
tion (see PROCEDURE Step 1 and TROUBLESHOOTING sec-
tion). Previously published 3C (and derivate) protocols describe 
using 106 cells or more per experiment. We, however, have suc-
cessfully applied 3C-seq on much smaller numbers of cells 
(i.e., FACS-sorted cell populations, using  < 106 cells), further extend-
ing its applicability (P.K. and E.S., unpublished data, and ref. 18).
Restriction enzyme choice. The resolution of a 3C-seq experiment 
depends on the first restriction enzyme used. Ideally, the restric-
tion pattern given by the enzyme should provide evenly distributed 
- Single-cell suspension preparation
- Cross-linking and nuclei preperation
- Restriction enzyme digestion I
Ligation I and de-cross-linking
DNA purification Pause point
Restriction enzyme digestion II





































Figure 2 | Flowchart of multiplexed 3C-seq data generation and processing. 
Steps involved in the multiplexed 3C-seq procedure are shown in blue 
rectangles. Time needed to complete these steps is depicted on the left. 
Pause points are indicated together with the timing of the different quality 
checkpoints: I, primary digestion efficiency (Step 16); II, ligation efficiency 
(Step 33); III, secondary digestion efficiency (Step 44); IV, 3C-seq PCR 
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 fragments, separating the different regulatory elements of interest 
(e.g., promoter, enhancers). When possible, check for the presence of 
regulatory elements, transcription factor binding sites and histone 
modification patterns relevant for the tissue to be analyzed using 
publicly accessible databases such as ENCODE (http://genome.ucsc.
edu/ENCODE/) in order to determine the most appropriate enzyme 
for the region of interest. We suggest using 6-base-recognizing 
enzymes (referred to as a ‘six-cutter’) such as EcoRI, HindIII, BglII, 
BamHI and XhoI, which perform well on cross-linked chromatin. 
The enzymes should be insensitive to mammalian DNA methyla-
tion in order to prevent introducing digestion biases. We observed 
that the use of a six-cutter yields better reproducibility at the 
single restriction fragment level than enzymes that cut more fre-
quently (e.g., 4-base-recognizing enzymes, referred to as a ‘four-
cutter’). The latter generate many more fragments per kb, which 
may lead to a poorer signal-to-noise ratio owing to more frequent 
intermolecular ligations. This could result in interaction signals 
being spread over several restriction fragments, thereby yielding 
TABLE 2 | Performance of different cell types and tissues successfully used for 3C-seq.
Cell or tissue type Performance in 3C-seq Special requirements
Hematopoietic cell types: mouse and human erythroid 
cells (FACS sorted and cultured), mouse B and  
T lymphocytes (FACS sorted and cultured), mouse  
erythroleukemia cell lines (MEL, I11) 
Hematopoietic tissue (mouse fetal liver E12.5-15.5, 
human fetal liver) 
Mouse ES cells (IB10), ES-derived Flk1 +  cells  
(magnetic-activated cell sorting (MACS)-sorted)
HeLa cells
Excellent None
Other mouse tissues (Mouse fetal brain E12.5-15.5) 
Rat tissues (liver, heart and lung)
Good Use a collagenase treatment (PROCEDURE 
Step 1) to obtain a single-cell suspension 
for efficient cross-linking
Human primary melanocytes33
Fibroblast cells: cell lines (NIH3T3) and primary cells 





Human ES cells (H9)
Poor: extensive nuclei 
 aggregation resulting in poor 
digestion efficiencies
Ensure gentle handling of the cells and 
nuclei. Preferentially collect adherent cells 
with a scraper instead of trypsin. In case 
of aggregation, see Table 3 for additional 
troubleshooting. Melanin produced by 
melanocytes is a potent PCR inhibitor and 
can be removed using a suitable column 
purification step33
 Box 1 | 3C-seq primer design
Two primers, a P5 primer and a P7 primer, need to be designed for each bait fragment of interest:
The P5 primer must be located as close as possible to the primary restriction enzyme site (usually the six-cutter). As only the 
sequence located after the restriction site is informative for identifying interacting fragments, the distance between the primary 
restriction enzyme primer and the restriction site itself should be minimized to ensure unambiguous alignment and identification of the 
 interacting fragments (Fig. 3). This primer contains the P5 Illumina adapter sequence (5`-AATGATACGGCGACCACCGAACACTCTTTCCCTACAC 
GACGCTCTTCCGATCT-3` to be placed upstream of the annealing sequence; Fig. 3) from which library sequencing will be initiated. The  
sequencing reaction starts from the bait fragment, reads through the annealing primer sequence and extends into the unknown  
captured fragment. To allow more flexibility for primer design and to ensure optimal alignment of the sequences, we use a 76-bp 
sequencing read length (Step 64).
The second primer, located near the secondary restriction enzyme site (the four-cutter), contains the P7 Illumina adapter sequence  
(5`-CAAGCAGAAGACGGCATACGA-3`, Fig. 3), and although it is required for the inverse PCR and the Illumina sequencing chemistry it 
is not sequenced (in contrast to paired-end sequencing, for which a different adapter is required). Therefore, the location of the P7 
primer with regard to the secondary restriction site is more flexible (within 100 bp of the restriction site).
Actual primer requirements are similar to those used in standard PCR reactions. Oligo length is kept between 17 and 24 nt to facili-
tate efficient amplification and annealing temperatures are generally chosen between 54 and 59 °C. We regularly use primer design 
software (DNAMAN 5.0) to check these parameters and to ensure that primers are not prone to form dimers.
Note: Oligonucleotide sequences are copyright 2007–2012 Illumina. All rights reserved. Derivative works created by Illumina customers 
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interaction profiles that are sometimes more difficult to interpret. 
For instance, enhancer-promoter communication might be difficult 
to analyze using a small four-cutter bait fragment encompassing the 
transcription start site, as in some cases enhancers tend to associate 
with slightly more downstream or upstream sequences, which may 
not be encompassed by the four-cutter fragment used in the analy-
sis7,17,24. We suggest using a four-cutter as the primary restriction 
enzyme only when you are refining interactions initially detected 
by a six-cutter or if interactions have to be investigated within a 
narrow genomic region. For the secondary restriction enzyme, any 
four-cutter insensitive to mammalian DNA methylation and with 
good re-ligation efficiencies can, in principle, be used. We have per-
formed successful 3C-seq experiments using NlaIII, DpnII, HaeIII 
and MseI. The final combination of primary and secondary restric-
tion enzymes will ultimately depend on their compatibility in terms 
of generating a suitable bait fragment for the inverse PCR primer 
design (see below and Box 1). To maximize efficient circulariza-
tion in the second ligation step, the final bait fragment should be 
at least ~250 bp (ref. 25), although we have succeeded in obtaining 
good interaction profiles with bait fragments as small as 120–180 bp 
(ref. 18; P.K.and E.S., unpublished data). Please note that for some 
potential interacting fragments both restriction enzyme sites will 
be very close (< 50 bp). When such a fragment ligates to the bait, 
the resulting sequencing reads might be problematic to align (see 
TROUBLESHOOTING section). Such a read is not a combination 
of the bait sequence and a single interacting fragment, as it will 
also contain sequences from the other side of the bait fragment. 
By trimming the 3` end of the reads (PROCEDURE Step 75), a large 
portion of these fragments can be rehabilitated.
Primer design. The 3C-seq library is amplified using primers 
annealing to the bait sequence, facing outward. Proper design of 
both primers for the inverse PCR is crucial in the 3C-seq procedure 
(Box 1 and Fig. 3). Efficiency and reproducibility of the PCR primers 
are first tested without the addition of the Illumina adapters (Box 2). 
If performing well, oligonucleotides containing appropriate Illumina 
adapters are then tested again before being used in the final library 
amplification PCR before sequencing. For multiplexing purposes, 
the bait-specific primer sequence itself is used as a bar code to iden-
tify reads originating from each individual 3C-seq library. If identical 
bait-specific libraries need to be sequenced in parallel (e.g., the same 
promoter for different biological conditions), small bar codes (2–6 nt) 
may be added to the primers (PROCEDURE Step 62; Box 3).
Controls. 3C-seq data need to be interpreted carefully, as high interac-
tion signals are not necessarily indicators of functionally relevant chro-
matin coassociations (also see the ‘Limitations’ section). Furthermore, 
the PCR amplification step may introduce biases owing to differences 
in fragment length and GC content, which can affect amplification 
efficiencies. To ensure proper data interpretation, consider including 
several control experiments26. Whether an interaction is specific for 
a certain tissue/cell type or whether it correlates with the activity of 
a specific gene can be tested by analyzing different tissues/cell types 
or non-expressing cells, respectively. For example, we generally use 
embryonic stem (ES) cells, cell lines, tissues or FACS-sorted cells that 
do not express the gene under investigation as controls when investi-
gating promoter-enhancer interactions of an active gene. In addition, 
using a captured interaction site of interest as bait in a ‘reverse experi-
ment’ can provide excellent validation of the interaction.
Optimal primer location Suboptimal primer location
Known bait sequence 
(noninformative)




Known bait sequence 
(noninformative)














Figure 3 | 3C-seq primer design and positioning. Schematic drawing of the 
location of the inverse PCR primers used to amplify a 3C-seq library. The ring 
represents a circular DNA molecule composed of the bait fragment (blue) 
ligated to an unknown captured fragment (red). The two PCR primers are 
located on the bait fragment next to the restriction sites, with adapters shown 
as gray overhangs. The P5 primer is located next to the primary restriction site 
(black dash), and the P7 primer is located next to the secondary restriction site 
(yellow dash). Illumina sequencing is initiated from the P5 primer and extends 
into the unknown fragment (dashed arrow). If the P5 primer is located right 
next to the primary restriction site (within 50 bp), sequence reads generated 
will be long enough for highly accurate alignment ( >25 bp, left). If the 
distance between the P5 primer and the primary restriction site becomes too 
large ( >50 bp, right), accurate alignment might be compromised. 
 Box 2 | 3C-seq PCR setup and optimization 
As 3C-seq library fragments differ in length and abundance, we use the Expand long template system to minimize any biases resulting 
from these differences11. Bait-specific primers (without adapters) are first tested for proper linearity and efficiency.
1.  Test the increasing amounts of 3C-seq library DNA (up to 200 ng) using a 50-Ml PCR. Reaction components and conditions are  
described in PROCEDURE Step 57.
2.  Analyze PCR products on a 1.5% (wt/vol) agarose gel, where they should appear as a reproducible smear of DNA fragments, usually 
showing two prominent bands11. These prominent bands are the result of recircularization of the bait fragment in the first ligation step, 
and of detection of the neighboring fragment owing to incomplete digestion of the primary restriction site on the bait fragment11.
3. Assess the linear range of the individual primer pairs by quantifying prominent bands in each reaction of the dilution range.
4.  Order versions of the primer pairs that perform well, including the P5 and P7 Illumina adapter sequences (Box 1). Test these new 
primers as described in steps 1–3 of Box 2.
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MATERIALS
Freshly collected tissues, sorted populations of cells and/or cell lines  
! CAUTION Approved governmental and institutional regulations must be 
followed and adhered to.
FCS (Sigma-Aldrich, cat. no. A4781)
DMEM (Gibco, cat. no. 41966)
Glycine (1 M in PBS; Sigma-Aldrich, cat. no. G7126) M CRITICAL Glycine 
stocks should be stored at 4 °C and used cold. They can be stored for a 
maximum of 6 months.
PBS (Sigma-Aldrich, cat. no. P4417)
FCS/PBS (10% (vol/vol))
Lysis buffer (see Reagent Setup)
Sodium chloride (NaCl; Sigma-Aldrich, cat. no. S7653)
Nonidet P-40 substitute (NP-40, Sigma-Aldrich, cat. no. 74385)
Complete protease inhibitor, EDTA free (Roche, cat. no. 11873580001,  
see Reagent Setup)
Milli-Q H2O
Collagenase, 2.5% (wt/vol) (Sigma-Aldrich, cat. no. C1639), in PBS
Formaldehyde, 37% (vol/vol) (Merck, cat. no 1039992500)  
! CAUTION Formaldehyde is toxic.
Restriction enzymes with 6-bp and 4-bp recognition sites and their  
corresponding buffers (see INTRODUCTION; Roche or New England 
Biolabs)
SDS (20% (wt/vol); Sigma-Aldrich, cat. no. 05030)
Triton X-100 (20% (vol/vol); Sigma-Aldrich, cat. no. T8787)
T4 DNA ligation buffer (Roche, cat. no. 10799009001)
T4 DNA ligase, high concentration (Roche, cat. no. 10799009001)
Proteinase K (10 mg ml − 1, Sigma-Aldrich, cat. no. P2308)
RNase (10 mg ml − 1, Sigma-Aldrich, cat. no. R6513)
Phenol/chloroform/isoamyl alcohol (25:24:1 (vol/vol/vol); pH 8; Sigma-
Aldrich, cat. no. 77617) ! CAUTION Phenol/chloroform is toxic.
Glycogen (20 mg ml − 1, Roche, cat. no. 10901393001)
Ethanol (100% (vol/vol) or 70% (vol/vol); Sigma-Aldrich, cat. no. 459844)
Sodium acetate (2 M, pH 5.6; Sigma-Aldrich, cat. no. S2889)
Tris-HCl (10 mM, pH 7.5, or 1 M, pH 8.0)
Liquid N2
Agarose electrophoresis gels (0.6% and 1.5% (wt/vol))





























dNTPs (10 mM each)
Expand long template system DNA polymerase (Roche, cat. no. 11759060001)
PCR primers (see INTRODUCTION)
QIAquick gel extraction kit (Qiagen, cat. no. 28706)
TruSeq SR cluster kit v3-cBot-HS (Illumina, cat. no. GD-401-3001)
TruSeq SBS kit v3-HS (50 cycles) (Illumina, cat. no. FC-401-3002)
Python 2.6 (http://www.python.org/)




Supplementary analysis scripts (see Supplementary Data; the scripts  
findSequence.py, regionsBetween.py, alignCounter.py and libutil.py should 
be extracted to the same directory) 
EQUIPMENT
Cell strainer, 40 Mm (BD Falcon, cat. no. 352340)
Polypropylene centrifugation tubes (Greiner bio-one, cat. no. 188271)
Safe-Lock 1.5-ml centrifugation tubes (Eppendorf, cat. no. 0030120.086)
Thermomixer (Eppendorf, cat. no. EF4283)
Water bath
Microcentrifuge (Eppendorf, cat. no. 5417R)
PCR thermocycler (MJ Research, cat. no. PTC-200)
Spectrophotometer (NanoDrop 2000c, Thermo Scientific)
Agilent 2100 Bioanalyzer (Aligent Technologies, cat. no. G2938C) with the 
7500 DNA chip (cat. no. 5067-1506)
Illumina HiSeq2000 high-throughput sequencing machine (Illumina)
Excel spreadsheet software (Microsoft)
Computer with a minimum of 8 Gb RAM and 1.5 Tb attached storage  
running a Linux distribution and the software listed above
REAGENT SETUP
Complete protease inhibitor, EDTA free Dissolve one tablet in 1 ml of 
PBS to create a 50× working solution. Store the solution at  − 20 °C for up to 
2–3 months; avoid repeated freeze-thaw cycles.
Lysis buffer Prepare the following solution in Milli-Q H2O: 10 mM Tris-HCl 
(pH 8.0), 10 mM NaCl, 0.2% (vol/vol) NP-40 and 1× protease inhibitor solu-
tion. M CRITICAL Because protease inhibitors degrade quickly in solution, 
























 Box 3 | 3C-seq pooling guidelines 
The Illumina sequencers use the first four sequenced bases to locate the DNA clusters on the flow cell. When too little variation is 
present in these first bases, the DNA clusters will not be correctly recognized and base calling will be compromised. The following 
pooling guidelines are used to ensure that the sequencing process proceeds correctly.
1.  Pool at least six samples together in a single lane for multiplexing. As one sample can be sequenced in multiple lanes, there is no 
physical limit as to how many samples can be pooled. We have regularly pooled up to 12 samples in one lane.
2.  Ensure that at least one adenine and one thymine base are present in each of the first four cycles of a sample pool. The cycles with 
the highest intensity of the adenine and thymine bases are used for cluster recognition by the sequencer. Without these specific 
nucleotides in the first four bases, base calling will be compromised and the sequencing run will fail.
3.  Do not pool samples generated with the same bait-specific PCR primer, as sequences derived from these samples cannot be  
discriminated in the downstream analysis. If pooling of such samples is desired, short bar-code sequences (2–6 nt) will have to be 
added to the adapter-containing bait-specific primers in the final PCRs (Step 57).
PROCEDURE
Single-cell preparation and cross-linking L TIMING 1–2 h
1| Obtain single-cell preparations from fresh tissue, FACS-sorted cells or cell lines in 10% (vol/vol) FCS/PBS (see Table 2 
for cell types successfully used by us in 3C-seq experiments). Tissues rich in extracellular matrix (e.g., brain) can be treated 
with collagenase (0.125% (wt/vol) in PBS; incubate the tissues for 30–60 min at 37 °C) first. Filter tissue-harvested cell 
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dilute 0.3 × 106 to 10 × 106 cells (10 × 106 is preferred but substantially fewer starting cells can be used) in 12 ml of culture 
medium (e.g., DMEM) or 10% (vol/vol) FCS/PBS (15-ml polypropylene tube).
M CRITICAL STEP Cell preparations need to be single-cell suspensions in order for proper formaldehyde cross-linking to be 
achieved.
2| Add 649 Ml of 37% (vol/vol) formaldehyde to each 15-ml tube (2% (vol/vol) final formaldehyde concentration), and 
incubate it for 10 min at room temperature while tumbling.
M CRITICAL STEP 1% (vol/vol) formaldehyde can also be used, especially if digestion efficiencies are suboptimal.
3| Transfer the tubes to ice and add 1.6 ml of cold 1 M glycine (0.125 M final concentration). Immediately proceed with Step 4.
Cell lysis, nuclei preparation and first restriction enzyme digestion L TIMING 18–20 h
4| Centrifuge the mixture for 8 min at 340g (4 °C) and remove all of the supernatant.
5| Carefully add ice-cold PBS to a volume of 14 ml and resuspend the pellet.
6| Pellet the cells again as in Step 4. Remove all of the supernatant.
7| Carefully resuspend the pellet in 1 ml of cold lysis buffer and add another 4 ml of lysis buffer to obtain a total volume 
of 5 ml for each tube. Incubate the mixture for 10 min on ice.
8| Centrifuge the mixture for 5 min at 650g (4 °C) to pellet the nuclei.
J PAUSE POINT The pelleted nuclei can be washed with PBS, snap-frozen in liquid N2 and stored at  − 80 °C for several months.
9| Resuspend the nuclei in 0.5 ml of 1.2× restriction buffer and transfer them to a 1.5-ml Safe-Lock microcentrifuge tube.
10| Place the tubes at 37 °C in a thermomixer and add 7.5 Ml of 20% (wt/vol) SDS (final: 0.3% SDS).
? TROUBLESHOOTING
11| Incubate the mixture at 37 °C for 1 h while shaking (900 r.p.m.).
12| Add 50 Ml of 20% (vol/vol) Triton X-100 (final: 2% Triton X-100).
13| Incubate the mixture at 37 °C for 1 h while shaking (900 r.p.m.).
14| Take a 5-Ml aliquot (undigested control sample) of each sample and store it at  − 20 °C until analysis of digestion  
efficiency is required (see Step 16).
15| Add 400 U of the selected six-cutter restriction enzyme to the remaining samples and incubate them overnight at 37 °C 
while shaking (900 r.p.m.).
M CRITICAL STEP More unconventional primary restriction enzymes with optimal temperatures of 38–50 °C (e.g., ApoI) 
are also used at 37 °C to avoid partial de-cross-linking of the sample. Prolonged incubation times and/or addition of more 
enzyme might be required in these cases.
16| Take a 5-Ml aliquot (digested control sample) of each sample. At this point, digestion efficiencies can be analyzed by 
purifying the genomic DNA from the control samples using a standard phenol/chloroform extraction and running it on a 
0.6% (wt/vol) agarose gel (see ref. 19). A successful six-cutter restriction enzyme digestion results in a DNA smear with 
the majority of fragments located between 5 and 10 kb (Fig. 4a).
? TROUBLESHOOTING
Preparation of the 3C library: first ligation and de-cross-linking L TIMING 20–22 h
17| Add 40 Ml of 20% (wt/vol) SDS (final: 1.6% SDS) to the remaining sample from Step 15.
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19| Transfer the digested nuclei to 50-ml centrifugation tubes 
and add 6.125 ml of 1.15× ligation buffer.
20| Add 375 Ml of 20% (vol/vol) Triton X-100 (final: 1% Triton X-100).
21| Incubate the mixture for 1 h at 37 °C in a water bath while shaking gently.
22| Add 100 U of T4 DNA ligase (20 Ml of a high-concentration stock) and incubate it at 16 °C for 4 h.
J PAUSE POINT The samples can be kept overnight at 16 °C if necessary.
23| Add 30 Ml of 10 mg ml − 1 proteinase K (300 Mg in total) and incubate it overnight at 65 °C to de-cross-link the samples.
Preparation of the 3C library (DNA purification) L TIMING 7–8 h
24| Add 30 Ml of 10 mg ml − 1 RNase (300 Mg in total) and incubate the mixture for 30–45 min at 37 °C.
25| Briefly cool the samples to room temperature and add 7 ml of phenol/chloroform/isoamyl alcohol (25:24:1) and shake 
the samples vigorously.
26| Centrifuge the samples for 15 min at 3,200g (room temperature).
27| Transfer the upper aqueous phase into a new tube and add 7 ml of Milli-Q H2O. Add 1.5 ml of 2 M sodium acetate  
(pH 5.6), and then add 35 ml of 100% ethanol.
28| Mix the tubes thoroughly and place them at  − 80 °C for 2–3 h until the liquid is frozen solid.
29| Directly centrifuge the frozen samples for 45 min at 3,200g (4 °C).
30| Remove the supernatant and add 10 ml of 70% ethanol.
31| Centrifuge the mixture for 15 min at 3,200g (4 °C).
32| Remove the supernatant, air-dry the pellet for ~20 min at room temperature and dissolve the pellet in 150 Ml of 10 mM 
Tris-HCI (pH 7.5) by incubating it for 30 min at 37 °C.
J PAUSE POINT This material is referred to as the ‘3C library’ and can be stored at  − 20 °C for several months.
33| To determine ligation efficiency, run 0.5–1.0 Ml of 3C material on a 0.6% (wt/vol) agarose gel. A successful ligation of 
six-cutter–digested 3C material should result in a single band, running at a similar height as the undigested control sample 
from Step 14 (Fig. 4b).
Preparation of the 3C-seq library (determination of DNA concentration and secondary digestion of 3C material)  
L TIMING 16–18 h
34| If primary digestion and ligation were successful, the 3C library (Step 32) can either be used for 3C-qPCR experiments 
(see Hagege et al.19 for a detailed protocol) or be used to prepare the 3C-seq library as described here. First, run an aliquot 
(e.g., 1 Ml) of 3C library DNA alongside a reference sample of species-matched genomic DNA to estimate DNA concentrations. 
To obtain sharp bands suitable for accurate gel densitometry quantification, a 1.5–2% (wt/vol) agarose gel is used. Optical 












































Figure 4 | Examples of successful digestion and ligation efficiencies.  
(a) Agarose gel (0.6%, wt/vol) on which an aliquot of undigested (left lane) 
and digested (right lane) sample (primary restriction digestion, Step 16) 
was run. A six-cutter was used, showing a typical smear of DNA fragments 
(a majority of DNA fragments residing between the 12 kb and 4 kb marker 
bands). (b) After ligation (left lane, Step 33), the DNA smear has returned 
to a sharp band (~12 kb). Secondary enzyme digestion (four-cutter) of the 
ligated 3C library typically results in a DNA smear of 2–0.1-kb fragments 
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35| Digest a preferred amount of the 3C library overnight (generally 25–50 Mg) with a 4-base recognition restriction enzyme 
of choice (the four-cutter), at a DNA concentration of 100 ng Ml − 1, using 1 U of enzyme per Mg of DNA. Use buffers and 
incubation temperatures as recommended in the manufacturer’s instructions.
Preparation of the 3C-seq library (Second ligation and DNA purification) L TIMING 12–13 h
36| Transfer the sample to a 1.5-ml Safe-Lock tube. Add an equal amount of phenol/chloroform/isoamyl alcohol (25:24:1) 
and mix it vigorously.
37| Centrifuge the mixture for 15 min at 15,800g (room temperature).
38| Transfer the upper phase to a new tube and add 2 Ml of 20 mg ml − 1 glycogen. Add a one-tenth volume of 2 M sodium 
acetate (pH 5.6), mix the contents and add 850 Ml of 100% ethanol.
39| Mix the tubes thoroughly and snap-freeze them in liquid N2.
40| Directly centrifuge the frozen tubes for 20 min at 15,800g (4 °C).
41| Remove the supernatant carefully and add 1 ml of 70% (vol/vol) ethanol.
42| Centrifuge the mixture for 5 min at 15,800g (4 °C).
43| Remove the supernatant carefully, air-dry the pellet for ~15 min and dissolve the pellet in 100 Ml of Milli-Q H2O by  
incubating it for 15 min at 37 °C.
44| Analyze 5 Ml of the digested DNA on a 1.5% (wt/vol) agarose gel to check digestion efficiency. The resulting type of 
smear depends on the enzyme used, but the majority of fragments should be  <1 kb and are usually between 300 and 500 bp 
(Fig. 4b).
45| Transfer the remaining sample to a 50-ml centrifugation tube. Add the components tabulated below and incubate the 
mixture at 16 °C for 4 h.
Component Amount per reaction Final
10× ligation buffer 1.4 ml 1×
T4 DNA ligase (5 U Ml − 1) 40 Ml 200 U
Milli-Q H2O Up to 14 ml
J PAUSE POINT The samples can be kept overnight at 16 °C if necessary.
46| Add 14 ml of phenol/chloroform/isoamyl alcohol (25:24:1) and shake the mixture vigorously.
47| Centrifuge the mixture for 10 min at 3,200g (room temperature).
48| Split the upper phase into two new 50-ml tubes. Add an equal amount of Milli-Q H2O to each tube and add 1 Ml of  
20 mg ml − 1 glycogen per ml.
M CRITICAL STEP Increasing the volume before precipitation will greatly reduce the amount of coprecipitating DTT.
49| Add a one-tenth volume of 2 M sodium acetate (pH 5.6), mix the contents and add two volumes of 100% ethanol.
50| Place the tubes at  − 80 °C for 2–3 h until the liquid is frozen solid.
J PAUSE POINT The samples can be kept at  − 80 °C for several days.
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52| Remove the supernatant and add 15 ml of 70% (vol/vol) ethanol.
53| Centrifuge the mixture for 15 min at 3,200g (4 °C).
54| Remove the supernatant, air-dry the pellet for ~20 min and dissolve it in 75 Ml of 10 mM Tris-HCI (pH 7.5 (per pellet)) 
by incubating it for 30 min at 37 °C. Thereafter, samples divided over two tubes can be recombined into a single tube.
55| Purify the DNA using the QIAquick gel purification kit according to the manufacturer’s recommendations for direct cleanup 
from enzymatic reactions. Other DNA purification kits can be used, but we have obtained excellent purities with the QIAquick kit.
M CRITICAL STEP One column can bind a maximum of 10 Mg of DNA: use enough columns to avoid overloading and a 
 subsequent loss of material.
56| Determine the DNA concentration of the resulting 3C-seq library using NanoDrop OD measurements.
3C-seq inverse PCR (preparing the sample for Illumina sequencing) L TIMING 5–6 h
57| Perform several PCR reactions (we generally amplify the equivalent of 500–1,000 ng input DNA per bait fragment) using 
the primers containing the P5/P7 Illumina adapters as overhang using the PCR reaction setup and program tabulated below. 
The amount of input 3C-seq library DNA used should be the maximum amount for which the PCR reaction is still linear and 
reproducible (see tables below and Step 58), not exceeding 200 ng per reaction.
Component Amount per reaction  Final
10× buffer I 5 Ml 1×
10 mM dNTPs 1 Ml 0.2 mM
25 pmol Ml − 1 forward primer 1 Ml 25 pmol
25 pmol Ml − 1 reverse primer 1 Ml 25 pmol
Polymerase mix (5 U Ml − 1) 0.75 Ml 3.75 U
3C-seq library DNA Depends on concentration 25–200 ng
Milli-Q H2O Add up to 50 Ml
Cycle number Denature Anneal Extend
1 94 °C, 2 min
2–31 94 °C, 15 s Primer-specific,1 min 68 °C, 3 min
32 68 °C, 7 min
M CRITICAL STEP Inverse PCR primers first have to be tested for linearity and reproducibility as described in Box 2  
(also see ref. 11), first without and then with the P5/P7 Illumina sequencing adapters attached.
? TROUBLESHOOTING
58| Verify PCR success by running small aliquots (10 Ml) of each reaction on a 1.5% (wt/vol) agarose gel.
59| Pool all successful reactions from the same bait fragment and purify the DNA using 2 QIAquick gel purification columns. 
Elute the columns with 40 Ml of Milli-Q H2O and combine the samples.
60| Verify the purification procedure success by running an aliquot (5–10 Ml) on a 1.5% (wt/vol) agarose gel. The sample is 
now ready to be used for Illumina high-throughput sequencing.
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3C-seq sample pooling and Illumina high-throughput sequencing L TIMING 4 d
61| Quantify the DNA molarity of the individual samples on an Agilent Bioanalyzer with the DNA 7500 chip cartridge 
 according to the manufacturer’s instructions. Perform a ‘smear analysis’ quantification using the Bioanalyzer software.
M CRITICAL STEP Make sure to use the DNA 7500 chip cartridge, as 3C material contains large (1–5 kb) DNA fragments that 
will influence DNA molarity and may not be detected using other DNA chip cartridges.
62| Design a pool of 3C-seq samples to be sequenced together in a single lane on the flow cell using the guidelines 
 described in Box 3.
63| Pool the selected samples in equal molarities in a single tube.
64| Proceed with the sequencing procedure as described by the manufacturer in the Illumina TruSeq SR cluster kit and 
TruSeq SBS manuals. The sequencing procedure can be outsourced to a sequence service provider. We generally use 76-bp 
single-read sequencing; paired-end sequencing is not required for 3C-seq.
M CRITICAL STEP When loading the flow cell, aim for a cluster density of 750,000–850,000 clusters per mm2. In our case, 
this is usually achieved with a final template DNA concentration of 9 pM.
M CRITICAL STEP Ensure that the total number of sequencing cycles exceeds the sum of the bait-specific sequence length 
and a minimum of 36 bases for optimal alignment of the unknown interacting fragments.
Initial data processing L TIMING 1–2 d
65| Copy the whole run folder generated by the Illumina sequencer to the storage on the Linux computer.
66| Open a terminal on the Linux computer and enter the commands described after the  >  signs.
67| Convert the binary output from the sequencer to text files in the Qseq format by using the BclToQseq scripts included in 
the Illumina Offline Basecaller (available at the Illumina website http://www.illumina.com/):
 > cd Illumina_Run_Folder/Data/Intensities/BaseCalls
 > /path_to_OLB/bin/setupBclToQseq.py --in-place –b. 
 > make –j 6
68| Determine the bait-specific sequences for de-multiplexing. Note that this also includes the primer, the primary restric-
tion site and any sequence in between. To obtain the highest yield while still retaining high specificity, de-multiplexing is 
performed using only 6 bases instead of the entire bait-specific sequence. The first set of 6 bases that differ for 2 or more 
bases from the other bait sequences are used for de-multiplexing.
M CRITICAL STEP Record the unique 6-bp bait-specific sequences (6-bp-bait) and their positions (6 bp-bait-pos) in the bait 
for each sample.
69| Determine the number of bases to trim from the 5` and the 3` ends of the reads as described in Steps 70–75.  
This procedure is performed in Microsoft Excel.
M CRITICAL STEP The 5` trimming is crucial, as the remaining bait-specific sequences will prevent the read from aligning to 
the reference sequence (Fig. 3). The 3` trimming prevents the loss of short interacting fragments (see Experimental design).
70| First, extend the bait-specific primer sequence with the genomic sequence up to and including the primary restriction site.
71| Extend the bait-specific primer sequence with the genomic sequence up to and including the primary restriction site.
72| Subtract the forward Illumina P5 adapter sequence from the 5` end of this sequence (Box 1).
73| Count the number of bases in the resulting sequence using the len() function to obtain the number of bases to trim 
from the 5` end of the read (n5trim).
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75| Subtract 36 bases from the result of Step 74 to obtain the number of bases to trim from the 3` end (n3trim).
76| Create a NARWHAL27 sample sheet (Supplementary Table 1) for the lanes that contain the 3C-seq samples. In this 
sample sheet, use any profile that runs BOWTIE28 with the --best option. To de-multiplex, several options need to be set 
in the sample sheet: the bar code-read field is set to 1; the bar code-start field is set to the 6-bp-bait-pos; the bar code field 
is set to the 6-bp-bait sequence. For the trimming, the following options are added to the options field of the sample sheet 
to trim the sequences: --trim5 = n5trim,--trim3 = n3trim.
77| Copy the NARWHAL sample sheet to the Linux computer.
78| (Optional) When the flow cell does not exclusively contain 3C-seq samples, it might be necessary to analyze only specific 
lanes. This can be achieved by setting up a directory with only the Qseq files for the specific lanes to be analyzed. This can 
be performed as follows, with i as the lanes to be analyzed:
 > mkdir MyLanes/
 > ln –s /full_path_to_qseq_folder/s_[i]_1_*_qseq.txt MyLanes/
79| Run NARWHAL using the following command:
 > narwhal.sh –s samplesheet.txt Qseq_folder output_folder
After the alignment, NARWAL will generate a PDF reporting the total number of reads generated, the percentage successfully 
aligned reads, the read distribution across the chromosomes, edit rates and duplication rates27. Successful 3C-seq experi-
ments should have high duplication rates ( > 95%), with a majority of reads ( > 50%) mapped to the chromosome on which 
the bait is located.
? TROUBLESHOOTING
Bioinformatics and initial data visualization L TIMING 2 h
80| After the initial data processing, a restriction map of the genome needs to be generated as described in Steps 80–82. 
First, Search the genome for restriction sites using the findSequence.py script (Supplementary Data). This script will 
 generate a BED file containing all the occurrences of a given sequence in the genome.
 > python findSequence.py –f genome.fasta –s  
primary_restriction_sequence –b occurrences.bed
81| Create a BED file containing the regions between the restriction sites by using the regionsBetween.py script  
(Supplementary Data):
 > python regionsBetween.py –i occurrences.bed –s chromsizes.txt –o regions.bed
82| Sort the regions with the BEDtools29 sort command:
 > bedtools sort –i regions.bed  > sorted_regions.bed
83| Count the reads per target fragment using the alignCounter.py tool (Supplementary Data). The count result is a table 
that can be loaded into other tools such as R.
 > python alignCounter.py –b aln.srt.bam –r sorted_regions.bed –o output_table.txt
84| Convert the read count tables to BED files using the command below. These BED files can be loaded into a variety of 
genome browsers including the UCSC Genome Browser (http://genome.ucsc.edu/).
 > gawk '/^[#]/{ if($4  > 0){print $1 ''\t'' $2 ''\t'' $3 ''\t'' $4 ;}; }' 
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? TROUBLESHOOTING
Multiplexed 3C-seq success primarily depends on digestion efficiencies, 3C-seq PCR setup (Boxes 1 and 2) and Illumina 
sequencing. Table 3 contains 3C-seq troubleshooting advice, mainly concerning these steps. Digestion efficiencies are also 
highly dependent on the cell or tissue type used. Table 2 provides additional cell type–specific troubleshooting information. 
Other published protocols have also provided detailed troubleshooting for the 3C procedure19,30.
TABLE 3 | Troubleshooting table.
Step Problem Possible reason Solution
10 Formation of aggregates 
after addition of SDS to 
the restriction buffer
Too many nuclei are used or the 
nuclei are of poor quality
Dilute the material 2–4 times in 1.2× restriction buffer  
containing 0.3% (wt/vol) SDS. For future experiments, 
ensure gentle handling of the cells and nuclei. A more 
stringent lysis buffer and/or Douncing step can also be 
beneficial. If persistent, consider starting with fewer cells 
in future experiments
16 Poor primary digestion 
efficiency
Formaldehyde concentrations used 
are too high for the enzyme; the 
enzyme is not compatible with the 
3C protocol and/or extensive nuclei 
aggregation
Lower formaldehyde concentrations (e.g., 1% instead of 2% 
(vol/vol)) or increase Triton X-100 concentration in Step 12. 
Alternatively, consider changing to a different enzyme. 
If nuclei are forming large aggregates, see Step 10 trouble-
shooting for advice
57 Poor PCR linearity, 
 reproducibility or PCR 
failure
PCR conditions or design are 
 suboptimal
Ensure that the correct primer Tm is used. Further optimiz-
ing the Tm using a gradient can be beneficial. Often, simply 
redesigning the 3C-seq primers will greatly improve PCR 
success
Primer dimer formation PCR conditions or design are 
 suboptimal
See above. If primer dimer formation specifically occurs 
after addition of the P5/P7 adaptors, DNA purification kits 
with a  > 100-bp cutoff can be used to remove dimers before 
sequencing
79 Fewer than expected 
sequence yield for a  
particular sample
Unanticipated bait-specific sequence Compare the list of expected barcodes to the most abun-
dant sequences. To generate a list with the most abundant 
barcode sequences from a FastQ file, the following Linux 
command-line code can be used: 
  > grep '^[ACTGN]\ + $' in.fastq | sed  
's/^\(.\{6\}\).*/\1/g' |  
sort | uniq –c | sort –nr | head –n 30  
Cross-reference unexpected highly abundant sequences 
with the expected primers and if possible assign these 
reads to a sample. 
Re-do de-multiplexing with the updated barcodes
Low mapping percentage 
after sequencing
Primer dimers present in 3C-seq 
sample or the secondary restriction 
site occurs directly after the primary 
restriction site in the most abundant 
target fragments
Obtain all the non-aligning sequences from the BAM file:  
  > samtools view aln.srt.bam |  
grep -P '^\S + \t\d + \t\*.*$'  >  
not_aligned.aln  
Check these sequences for subsequences of the primers 
used in the amplification. 
Determine whether these sequences contain the restric-
tion site for the secondary restriction enzyme. This issue 
occurs more frequently with increasing read-length. For 
this reason, we strongly recommend using the 3` trimming 
procedure from Steps 70–75. If after trimming the target 
sequence is shorter than 25 bp, the secondary restriction 
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L TIMING
Steps 1–3, single-cell preparation and cross-linking: 1–2 h
Steps 4–16, cell lysis, nuclei preparation and first restriction enzyme digestion: 18–20 h
Steps 17–23, preparation of the 3C library: first ligation and de-cross-linking: 20–22 h
Steps 24–33, preparation of the 3C library: DNA purification: 7–8 h
Steps 34 and 35, preparation of the 3C-seq library: determination of DNA concentration and secondary digestion of 3C  
material: 16–18 h
Steps 36–56, Preparation of the 3C-seq library: second ligation and DNA purification: 12–13 h
Steps 57–60, 3C-seq inverse PCR: preparing the sample for Illumina sequencing: 5–6 h
Steps 61–64, 3C-seq sample pooling and Illumina high-throughput sequencing: 4 d
Steps 65–79, initial data processing: 1–2 d
Steps 80–84, bioinformatics and initial data visualization: 2 h
ANTICIPATED RESULTS 
After sequencing and data processing, the resulting BED files (Step 84) can be visualized in a genome browser (e.g., UCSC 
genome browser, http://genome.ucsc.edu/). Careful attention should be given to the particular version of the genome that 
is used for analysis, especially when different experiments are compared. Several simple but important checks can provide 
information on whether the 3C-seq experiment was successful, which are automatically provided during initial data process-
ing (Steps 65–79) by the NARWAL software27. The PDF file provided contains statistics on the chromosomal location of the 
aligned reads and the duplication percentage. These are important metrics for the initial validation of a 3C-seq experiment: 
the vast majority ( > 50%) of reads are usually found in cis (i.e., on the same chromosome), and as 3C-seq profiles consist 
of stacked reads the duplication percentage should be  > 95%. Typical alignment percentages are above 70%, although this 
can vary considerably between different primer sets. Lower percentages are often caused by the sequencing of primer dim-
ers present in the PCR samples or failure to align reads coming from the (in general) most abundant interactions (the bait 
fragment itself and the neighboring fragment, see Box 2 and Table 3). However, low alignment percentages can still provide 
informative data, as long as the total number of aligned reads is high enough (>1 million reads30) and read distribution is 
as expected (see below and Fig. 5). After uploading the BED output file (Step 84) in a genome browser, interactions with 
the chosen bait fragments can be observed. Signals are represented as bars (Fig. 5), the width of which is determined by the 
size of the actual restriction fragment. The height of the bars represents the number of reads found on the fragment and is a 
measurement of the frequency of interaction with the bait fragment. The highest signal density is always found around the 
viewpoint (typically ~40% of all reads are located within 1 Mb of the bait), with the two most abundant interactions being 
the bait and its neighboring fragment (Box 2). Signal intensity tends to rapidly decline with increasing genomic distance  
from the bait (a classic characteristic of 3C and its derivatives, see refs. 11,26), resembling a bell-shaped distribution around 
the bait (Fig. 5a). The majority (>75%) of cis interactions are normally found within a 1-Mb window around the bait, although  
bait fragments within highly complex genomic structures (e.g., immunoglobulin loci) can produce profiles that deviate from 
this general picture18. Interactions found in trans (generally about 40–50% of the reads) often show low interaction frequen-
cies and appear to be randomly scattered around the genome. Trans-interaction signals therefore need to be interpreted with 
caution, as their reproducibility may appear questionable in a number of cases. However, several studies have begun to probe 
their functional relevance in specific cases, in particular in light of chromosomal translocations, and showed correlation 
between physical proximity and sites of recombination, indicating that physical proximity in trans may be relevant31,32.
TABLE 3 | Troubleshooting table (continued).
Step Problem Possible reason Solution
84 Complete absence of 
reads at expected sites of 
 interaction
The fragment expected to interact 
with the bait is  <36 bp
Further extend the 3` trimming procedure or use a different 
six-cutter/four-cutter combination
The genome assembly has changed 
(updated)
Reanalyze older data sets using the proper version of the 
genome assembly. This may be crucial when recent data 
sets need to be compared with older ones
Weak 3C-seq interaction 
signals
Poor signal-to-noise ratio Consider using a double cross-linking procedure by using 
ethylene glycol bis-succinimidylsuccinate treatment before 
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Multiplexing 3C-seq samples greatly increases the technique’s throughput and results in a substantial cost reduction. Even 
though the total number of reads is lower in a multiplexed sample compared with a nonmultiplexed sample, interaction  
patterns remain almost identical (Fig. 6). Thus, multiplexing 3C samples seems to have little effect on the resulting interaction 
profiles (Fig. 6).
Further validation of detected interactions can be obtained by complementary experiments (e.g., 3C-qPCR, FISH) or 
by performing new 3C-seq experiments with these interactions as bait (a ‘reverse experiment’, see ‘Controls’ section of 
INTRODUCTION). Functional interpretation of 3C-seq profiles is often desired and requires correlation with other data sets, 
usually transcription factor binding and/or histone modification patterns for the locus of interest. When using 3C-seq to 
explore the regulatory elements in close proximity to a gene, strong interaction signals can often be positively correlated to 
the binding of transcription factors and the presence of specific histone modifications17. Performing 3C-seq experiments in 
different cell or tissue types can further provide valuable information on the tissue specificity of interactions and whether 
their presence can be correlated to differences in gene expression or protein binding (Fig. 5b). The 3C-seq data can also be 
further processed using dedicated tools 
and scripts (S.Thongjuea, R.S., F.G., 
E.S. and B. Lenhard, unpublished data, 
and ref. 12) for more in-depth analysis.
Figure 5 | Typical interaction profiles obtained 
from a multiplexed 3C-seq experiment.  
(a) 3C-seq interaction profiles in mouse  
fetal liver cells shown for three bait fragments 
in the Myb locus17 (1.2-Mb region shown).  
Bait signals are depicted by an arrow.  
(b) 3C-seq interaction profiles generated  
from both mouse fetal liver and brain  
using the Myb promoter as bait (shown is an 
~250-kb region encompassing the Hbs1-like 
(Hbs1l) neighboring gene). Myb is highly 
expressed in fetal liver cells, but expression 
is much lower in fetal brain cells. Several 
fetal liver–specific interactions are located 
within an intergenic region containing several regulatory (Reg.) elements (green lines and blue shading)17. Bait signals are depicted by an arrow. 
Data were visualized using the UCSC genome browser. All animal work was approved by the Netherlands Animal Experimental Committee (DEC) and the 
Institutional Ethical Review Board of Erasmus Medical Center, and was carried out according to institutional and national guidelines. 
Figure 6 | Comparison of interactions detected 
for the same 3C-seq sample after single or 
multiplexed library sequencing. (a) Interaction 
profiles around the bait fragment for a 3C-seq 
sample after multiplexed (top) or nonmultiplexed 
(bottom) library sequencing, showing highly 
similar profiles. (b) Scatter plot comparing 
read counts for 146 fragments around the 
bait fragment between nonmultiplexed and 
multiplexed data sets. 
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Note: Supplementary information is available in the online version of the paper.
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60
Recent studies of genome-wide chromatin interactions have revealed that the human 
genome is partitioned into many self-associating topological domains (Lieberman-
Aiden, van Berkum et al., 2009; Dixon, Selvaraj et al., 2012; Nora, Lajoie et al., 2012; 
Sexton, Yaffe et al., 2012). The boundary sequences are enriched for binding sites of 
CTCF and the cohesin complex, implicating these two factors in the establishment 
or maintenance of topological domains (Splinter, Heath et al., 2006; Wendt, Yoshida 
et al., 2008; Hadjur, Williams et al., 2009; Nativio, Wendt et al., 2009; Kagey, Newman 
et al., 2010). To determine the role of cohesin and CTCF in higher-order chromatin 
architecture in human cells, we proteolytically cleaved the cohesin complex from 
interphase chromatin and examined changes in chromosomal organization as well as 
the transcriptome. We observed a general loss of local chromosomal interactions upon 
disruption of cohesin complex, but the topological domains remain intact. However, we 
found that depletion of CTCF by RNA interference in these cells not only reduced intra-
domain interactions but also increased inter-domain interactions. Furthermore, distinct 
groups of genes become mis-regulated upon depletion of cohesin and CTCF. Taken 
together, these observations suggest that CTCF and cohesin contribute in different 
ways to chromatin organization and gene regulation.
5HFHQW VWXGLHV RI WKH WRSRORJLFDO RUJDQL]DWLRQ RI WKH JHQRPH VXJJHVW WKDW &7&) DQG
cohesin might be involved in establishment or maintenance of topological domains in the 




insulator function is not well understood. Several observations have led to the proposal that 
&7&)PLJKW DFW YLD UHFUXLWPHQW RI FRKHVLQ WR IDFLOLWDWH ORQJUDQJH LQWHUDFWLRQV DV ³PDVWHU
ZHDYHU´RIWKHJHQRPH3KLOOLSVDQG&RUFHV)LUVW&7&)DQGWKHFRKHVLQFRPSOH[








(Wendt, Yoshida et al., 2008). 
7RXQGHUVWDQGWKHFRQWULEXWLRQRI&7&)DQGFRKHVLQWRJHQRPHRUJDQL]DWLRQZHHPSOR\HG
an engineered HEK293T cell line (original cell line derived from human embryonic kidney) 
in which we can rapidly remove the cohesin complex from interphase chromosomes by 
proteolytic cleavage of its RAD21 subunit (Uhlmann, Lottspeich et al., 1999). This cell line 
contains an episome-based vector that allows doxycycline-inducible expression of siRNA 
61
WDUJHWLQJHQGRJHQRXV5$'DQGD5$'(*)3YDULDQWFRQWDLQLQJDUHFRJQLWLRQVLWH IRU
Human rhinovirus 3C (HRV) protease (RAD21cv) (Schockel, Mockel et al., 2011) (Figures 
1a,b). Three days after doxycycline induction, RAD21cv completely replaces the endogenous 
RAD21 and is incorporated in the cohesin complex (Supplementary Figure 16XEVHTXHQW
transfection of the cells with a construct expressing HRV protease led to full cleavage of 
RAD21cv and release of cohesin from chromatin within 24 hours (Figures 1c,d,e). 
Consistently, RAD21cv cells entering mitosis 24 hours after HRV transfection show increased 
defects in sister chromatid cohesion (Supplementary Figure 2). Cleavage of RAD21cv 
by HRV protease (RAD21cv/HRV) does not change the cell cycle distribution compared to 
transfection with a control protease from Tobacco Etch Virus (RAD21cv/TEV). Nevertheless, 
we noted that both transfected cell populations have more cells in G2 phase than untreated 
cells (RAD21cv) (Supplementary Figure 3). This rapid release of cohesin allows the study of 
the immediate effect of cohesin loss on chromatin structure, without interfering with cohesin 
function in cell division. 
To test whether removal of cohesin from chromatin affects long-range chromatin interactions, we 
SHUIRUPHG&VHTDPXOWLSOH[HG&YDULDQW6WDGKRXGHUV.RORYRVHWDOLQ5$'FY
TEV and RAD21cv/HRV cells. We examined the interior and the borders of one topological 
domain, based on previous domain assigment in the human IMR90 cells (Dixon, Selvaraj et al., 
2012), at the well characterized chr11p15.5 region comprising H19, Igf2 and other imprinted 
JHQHVUHIHUUHGWRKHUHDV+,*)GRPDLQFigures 1f-h). We have previously used this 
UHJLRQWRHVWDEOLVKWKHUROHRIFRKHVLQ LQFKURPDWLQ LQVXODWLRQE\&7&):HQGW<RVKLGDHW
al., 2008). In RAD21cv/TEV we observed, as reported before (Nativio, Wendt et al., 2009), 
WKDWWKH,*)SURPRWHUUHJLRQ93DQGDQLQWHUJHQLFUHJLRQ93LQWHUDFWVWURQJO\)XUWKHU
contacts persist over a 500kb region until the proximal keratin cluster (KRTA5) marking the 
GRPDLQERXQGDU\9LHZSRLQWV SODFHGEHWZHHQ+DQG ,*) 93 DQGXSVWUHDPRI+
93FRQ¿UPWKHVHLQWHUDFWLRQVFigure 1h). A viewpoint in the neighbouring domain at the 
centromeric side (VP6) consistently shows interactions until the domain boundary. A viewpoint 




line 1-7HB2 (abbreviated HB2) with normal karyotype, indicating their conservation between 
cell lines (Supplementary Figure 4).
Cleavage of RAD21 leads to a global loss of interactions across the entire domain at all 
viewpoints (Figure 1h). A control with a cell line lacking the HRV cleavage site in RAD21-
(*)3 5$'ZW GLG QRW VKRZ DOWHUHG FRKHVLQ ELQGLQJ DQG ORQJUDQJH LQWHUDFWLRQV DIWHU
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Figure 1: Cohesin cleavage reduces long-range interactions within the H19/IGF2 domain.
a, Endogenous RAD21 is replaced with RAD21cv using a doxycycline-inducible bidirectional promoter driving 
expression of RAD21cv and siRNA targeting the endogenous RAD21 from an episomal construct stably integrated 
in HEK293T cells. b, Outline of the experiment showing the replacement of RAD21 by RAD21cv and transfection 
of the protease HRV, which cleaves RAD21cv, and TEV, which does not. c, Time course showing full cleavage of 
5$'FYDIWHUKRXUVE\GHWHFWLQJWKH&WHUPLQDO(*)3WDJLQ5$'FY7KHVKLIWLVFRQVLVWHQWZLWKWKHORVVRID
20 kD fragment form the N-terminus of RAD21cv. Note RAD21cv gets more abundant in the lysates due to its release 
from chromatin after cleavage. d, )UDFWLRQDWLRQ RI WKH O\VDWHV IURP5$'FY7(9 7(9 5$'FY+59 +59
and uninduced cells (-dox) in soluble (Supernatant) and chromatin-bound fraction (Chromatin). Similar levels of 




against the cohesin subunits STAG1/SA1 (SA1) and SATG2/SA2 (SA2) shows that these subunits are also released 
IURPFKURPDWLQDIWHU+59FOHDYDJH&7&)ELQGLQJWRFKURPDWLQLVQRWDIIHFWHGe, Chromatin immunoprecipitation 
&K,3ZLWKDQWL60& IURP5$'FY7(9DQG5$'FY+59FHOOVDQGT3&5ZLWKSULPHUV VSHFL¿F IRU FRKHVLQ
binding sites shows a reduced signal in the SMC3 ChIP after RAD21 cleavage. (f-g) Analysis of long-range 
chromosome interactions for six viewpoints at the human chromosome 11 for in RAD21cv cells transfected with 
control protease (TEV) and cleaving protease (HRV). f.1RUPDOL]HG+L&LQWHUDFWLRQIUHTXHQFLHVGLVSOD\HGDVDWZR
dimensional heat map previously observed in human IMR90 cells showing the domains and domain boundaries (DB, 
LQGLFDWHGDVUHFWDQJOHVLQWKLVDUHD*HQHVDQQRWDWHGE\WKH5HIHUHQFHVHTXHQFHFROOHFWLRQIRUWKLVUHJLRQ5HIVHT
genes) are also indicated. g. 3RVLWLRQRISULPHUSDLUVXVHGWRWHVWFRKHVLQGHSOHWLRQLQ)LJHDQGELQGLQJVLWHVIRU
FRKHVLQ 60&GHWHFWHGE\&K,3VHTXHQFLQJ LQ5$'FY7(9FHOOVDUH LQGLFDWHGh. Chromosomal interactions 
GHWHFWHGE\&VHTIRUVL[GLIIHUHQWYLHZSRLQWV9SPDUNHGZLWKJUHHQEDUVLQ5$'FY7(9FHOOVEOXHJUDSK
line) and RAD21cv/HRV cells (red graph line). Interactions are presented as line graph with the observed interaction 
IUHTXHQF\5HDGVSHUPLOOLRQVHTXHQFHGUHDGVDVVLJQHGWRWKHFHQWHURIHDFK%JO,,IUDJPHQW
To investigate whether cohesin plays a general role in topological domain organization, we 
performed Hi-C experiments with control RAD21cv/TEV cells and RAD21cv cells after RAD21 
FOHDYDJH 5$'FY+59 :H REWDLQHG JUHDWHU WKDQ  PLOOLRQ QRQUHGXQGDQW XQLTXHO\
mapping read pairs for both control and RAD21 cleaved cells, split between two replicates 
IRUHDFKFRQGLWLRQ:HQRUPDOL]HGWKH+L&LQWHUDFWLRQIUHTXHQFLHVDFFRUGLQJWRWKHLWHUDWLYH
FRUUHFWLRQPHWKRG ,PDNDHY )XGHQEHUJ HW DO  )RU HDFK UHSOLFDWH ERWK EHIRUH DQG
DIWHU5$'FOHDYDJHZH LGHQWL¿HGWKH ORFDWLRQRI WRSRORJLFDOGRPDLQVXVLQJDSUHYLRXVO\
described algorithm (Dixon, Selvaraj et al., 2012). 
:H DOVR SHUIRUPHG &K,3VHT IRU WKH FRKHVLQ VXEXQLW 60& LQ FRQWURO 5$'FY7(9
cells to determine the cohesin binding sites in the genome in these cells. Similarly to what 
KDGSUHYLRXVO\EHHQREVHUYHGIRU&7&)FRKHVLQDSSHDUVWREHHQULFKHGDWWKHERUGHUVRU
boundaries between domains (Figure 2a1RWDEO\RQO\60&VLWHVWKDWFRORFDOL]HZLWK&7&)
VKRZHQULFKPHQWDWERXQGDULHVZKLOH&7&)LQGHSHQGHQW60&VLWHVVKRZQRHQULFKPHQWDW
boundary regions (Supplementary Figure 6a). 
7RFRPSDUH+L&LQWHUDFWLRQIUHTXHQFLHVZLWK60&ELQGLQJZHVHSDUDWHGWKHJHQRPHLQWR
NE LQWHUDFWLQJELQSDLUVDQGVWUDWL¿HG WKHPDFFRUGLQJ WR LI HDFKELQ LQ WKHSDLU LV ERXQG
by SMC3 (“SMC3 2x”), or if only one bin (“SMC3 1x”) or no bins (“None”) were bound by 
SMC3 (Figure 2b:HREVHUYHGDKLJKHULQWHUDFWLRQIUHTXHQF\LQFRQWURO+L&H[SHULPHQWV
between bin-pairs containing SMC3 sites on both ends than when only one or no SMC3 site is 
present (Figure 2c), consistent with the notion that cohesin binding could mediate long-range 
FKURPDWLQLQWHUDFWLRQIUHTXHQFLHVJHQRPHZLGH8SRQFOHDYDJHRI5$'ZHREVHUYHGDQ
RYHUDOOORVVLQORFDOFKURPDWLQLQWHUDFWLRQIUHTXHQF\SULPDULO\RFFXUULQJDWGLVWDQFHVXSWR
Mb, with a maximum in the range between 100-200kb (Figure 2d, Supplementary Figure 
6b7KHORVVLQLQWHUDFWLRQIUHTXHQF\LVKLJKHVWDIWHU5$'FOHDYDJHZKHQERWKLQWHUDFWLQJ
loci are bound by SMC3 (Figure 2d inset). 
8VLQJ'1$),6+ YDQ GH&RUSXW GH%RHU HW DO ZHREVHUYHG D VSDWLDO VHSDUDWLRQ
RIFRVPLGSUREHVSODFHGLQWKH+,*)GRPDLQFigures 2e,f) and in the HOXD domain 
(Figures 2g,h) after RAD21 cleavage, consistent with the aforementioned loss of interactions. 
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Figure 2: Cohesin cleavage reduces interactions within topological domains genome-wide
a,60&ELQGLQJIUHTXHQF\DFURVVWRSRORJLFDOGRPDLQV60&LVHQULFKHGDWWKHERUGHUVRIGRPDLQV(DFKGRPDLQ
ZDVVSOLW LQWRELQVELQVXSVWUHDPDQGGRZQVWUHDPRI WKHGRPDLQERXQGDULHV7KHIUHTXHQF\RI60&
binding sites per kb was calculated and averaged over all domains. b6FKHPDWLFUHSUHVHQWDWLRQRIWKHVWUDWL¿FDWLRQ
method of interacting loci based on SMC3 binding. Interacting loci are broken into 3 classes, regions that have at 
least one SMC3 binding site at each interacting locus (2x), regions that have at least one SMC3 binding site at either 
interacting locus (1x), and regions that have no SMC3 binding (None). c,+L&LQWHUDFWLRQIUHTXHQF\FRUUHODWHGZLWK
FRKHVLQ&RPSDULVRQRIWKHDYHUDJHQRUPDOL]HGLQWHUDFWLRQIUHTXHQF\EHWZHHQ60&[[DQGQRQHLQWHUDFWLQJ
loci at distances from 40kb to 2Mb. The inset is the fold change of the SMC3 2x and SMC3 1x categories relative 
WR WKH³1RQH´FDWHJRU\7KHODUJHVW IROGFKDQJHLQ LQWHUDFWLRQIUHTXHQF\DSSHDUVEHWZHHQNEd, Cohesin 
GHSOHWLRQOHDGVWRDORVVRIORFDOLQWHUDFWLRQIUHTXHQF\7KH\D[LVVKRZVWKDWDYHUDJHORVVRILQWHUDFWLRQIUHTXHQF\LQ
the RAD21cv/HRV (HRV) cells compared to RAD21cv/TEV (TEV) cells for distances ranging from 40kb to 10Mb. The 
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for the SMC3 2x, 1x and none categories. The SMC3 2x category is most affected by RAD21 depletion, and the 




cleavage (RAD21cv/HRV, right panel). g,&RVPLGEDVHG),6+SUREHVDWWKHWRSRORJLFDOGRPDLQRIWKH+2;'JHQH
locus. Only a subset of genes in the region is shown. The color of the cosmid probes (red, green) corresponds to 
WKH),6+LPDJHVh,'1$),6+XVLQJWKHFRVPLGSUREHVVKRZQLQJLQFRQWUROFHOOV5$'FY7(9OHIWSDQHODQG
DIWHU5$'FOHDYDJH5$'FY+59ULJKWSDQHO7KHPDUNHG),6+VLJQDOVZKLWHER[HVDUHVKRZQHQODUJHGDW
the right side of each panel. Consistent with the loss of interactions observed in the chromatin conformation capturing 
H[SHULPHQWVZHREVHUYHGDVHSDUDWLRQRI WKH),6+VLJQDOVDIWHUFRKHVLQFOHDYDJH i, The positions of topological 
GRPDLQVGRHVQRWPDUNHGO\FKDQJHZLWK5$'GHSOHWLRQ%URZVHUVKRWVKRZLQJKHDWPDSVRILQWHUDFWLRQIUHTXHQF\
in the Control and RAD21 depleted cells. Also shown are the domain calls (DC) and directionality index (DI) over 
this region. j,&RPSDULVRQRIWKHWRSRORJLFDOGRPDLQERXQGDU\FDOOVEHWZHHQUHSOLFDWHV7(97(9+59+59
and control (TEV) and RAD21 depleted cells (HRV). The differences between replicates and between control and 
knockdown experiments are comparable and largely unchanging.
We next investigated the effects of cohesin complex destruction on topological domain 
organization. Surprisingly, the positions of most topological domains do not markedly change 
upon cleavage of RAD21 (Figures 2i,j). The “triangle” pattern of topological domains is still 
readily apparent in the interaction heat maps, and, though we consistently call fewer domains 
in the RAD21 depleted cells (Figure 2j), there is a strong overlap in domain boundaries called 
between control and RAD21 depleted cells. The preservation of topological domains after 
5$' FOHDYDJH LV FRQVLVWHQW ZLWK OLYH FHOO LPDJLQJ REVHUYDWLRQV RI KLVWRQH +$5)3 LQ
RAD21cv/TEV and RAD21cv/HRV cells showing no general changes of chromatin morphology 




when one or both interacting bins is associated with a boundary region (Supplementary 
Figure 8). Taken together, these results suggest that cohesin contributes to the self-association 
within topological domains by promoting interactions between regions near the boundaries. 
However, cohesin depletion does not appear to contribute to the positioning and segregation 
of neighbouring domains from each other.
7RGHWHUPLQH&7&)¶VUROHLQPHGLDWLQJFKURPDWLQLQWHUDFWLRQVDQGWRFRPSDUHLWWRWKHHIIHFWV
RI5$'FOHDYDJHZHSHUIRUPHGWZRUHSOLFDWHVRI+L&H[SHULPHQWVIRU&7&)DQGFRQWURO
siRNA knockdowns in HEK293T cells (Supplementary Figures 9a,b). We obtained between 
DQGPLOOLRQXQLTXHUHDGVIRUHDFKUHSOLFDWH6LPLODUWR60&&7&)LVHQULFKHGDWWKH
boundaries of topological domains in control cells (Figure 3a). 
/LNHZLVH &7&) ELQGLQJ FRUUHODWHV ZLWK WKH VWUHQJWK RI +L& LQWHUDFWLRQ IUHTXHQF\ ZKHUH
LQWHUDFWLQJELQSDLUVERXQGE\&7&)RQHDFKVLGH IRUPVWURQJHU LQWHUDFWLRQVFRPSDUHG WR
UHJLRQVZLWKRQO\RQHRUQR&7&)VLWHVFigure 3b8SRQNQRFNGRZQRI&7&)ZHREVHUYHG
a loss of interactions within topological domains, but with a different pattern with respect to the 
distance between interacting loci compared to RAD21 cleavage (Figures 3c,d). 
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Figure 3: CTCF depletion reduces the function of domain boundaries 
a, &7&) ELQGLQJ IUHTXHQF\ DFURVV WRSRORJLFDO GRPDLQV 6LPLODU WR )LJ D &7&) LV HQULFKHG DW WKH ERUGHUV
of topological domains. b,8VLQJD VWUDWL¿FDWLRQ VFKHPHVLPLODU WRZKDWZDVGHVFULEHG LQ)LJ E&7&)ELQGLQJ
FRUUHODWHVZLWK LQWHUDFWLRQIUHTXHQF\7KHDYHUDJHLQWHUDFWLRQIUHTXHQF\DWHDFKGLVWDQFHZDVFDOFXODWHGIRUHDFK
FDWHJRU\RI LQWHUDFWLRQ&7&)[&7&)[DQGQRQH&7&)[VKRZVWKHVWURQJHVW LQWHUDFWLRQVc, Heat maps 
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DQG UHG LQGLFDWHV D JDLQ LQ LQWHUDFWLRQ IUHTXHQF\8SRQ5$' GHSOHWLRQ WKHUH LV SUHGRPLQDQWO\ D ORVV RI LQWUD
GRPDLQLQWHUDFWLRQIUHTXHQF\d,6LPLODUWRFEXWVKRZLQJWKHFKDQJHVLQLQWHUDFWLRQIUHTXHQF\RYHUWKHVDPHORFXV
DIWHU&7&)VL51$$VLPLODUSDWWHUQRI ORVVRI LQWUDGRPDLQLQWHUDFWLRQIUHTXHQF\LVREVHUYHGVHHEOXHWULDQJOHV
+RZHYHU XQOLNH DIWHU5$' GHSOHWLRQ&7&) VL51$ OHDGV WR DQ LQFUHDVH LQ LQWHUGRPDLQ LQWHUDFWLRQ IUHTXHQF\
(see red signal in between blue triangles). e,4XDQWL¿FDWLRQRIDYHUDJHFKDQJHLQLQWHUDFWLRQIUHTXHQF\DIWHU5$'
depletion for intra-domain interaction (blue) and inter-domain interactions (yellow). In both cases, RAD21 leads to a 
ORVVRILQWHUDFWLRQIUHTXHQF\f,6LPLODUWRHEXWVKRZLQJWKHFKDQJHLQLQWHUDFWLRQIUHTXHQF\DIWHU&7&)VL51$IRU
LQWUDDQG LQWHUGRPDLQ LQWHUDFWLRQV&7&)VL51$ OHDGV WRD ORVVRI LQWUDGRPDLQ LQWHUDFWLRQ IUHTXHQF\EXWXQOLNH
5$'GHSOHWLRQ&7&)VL51$OHDGVWRDQ LQFUHDVH LQ LQWHUGRPDLQ LQWHUDFWLRQ IUHTXHQF\g-h, Changes in inter-
GRPDLQ LQWHUDFWLRQ IUHTXHQF\DIWHU&7&)VL51$GHSOHWLRQDWVLWHVVWUDWL¿HG IRUHLWKHU&7&)ELQGLQJ JRU60&
ELQGLQJ K7KH ORFL WKDWVKRZ WKHJUHDWHVW LQFUHDVH LQ LQWHUGRPDLQ LQWHUDFWLRQVDIWHU&7&)VL51$ WHQG WRKDYH
KLJKHUIUHTXHQFLHVRI&7&)RU60&ELQGLQJ
RAD21 depletion appears to most markedly affect interacting loci separated by 100 to 200kb 
(Figure 2d ZKLOH &7&) NQRFNGRZQ DSSHDUV WR PRVW SURPLQHQWO\ DIIHFW LQWHUDFWLQJ ORFL
separated by less than 100kb (Figure 3b7KLV LPSOLHVWKDW&7&)DQGFRKHVLQPD\DIIHFW
LQWUDWRSRORJLFDOGRPDLQLQWHUDFWLRQIUHTXHQF\RQGLIIHUHQWVSDWLDOVFDOHVFigures 3e,f blue 
line). 
7KH PRUH UHPDUNDEOH GLIIHUHQFH EHWZHHQ &7&) DQG FRKHVLQ GHSOHWLRQ FRQFHUQV WKH
interactions between topological domains. RAD21 depletion leads to a loss in interactions 
within and between domains but primarily in intra-domain interactions (Figure 3e yellow 
line&7&)GHSOHWLRQRQWKHRWKHUKDQGOHDGVWRDVLJQL¿FDQWJDLQRILQWHUDFWLRQVEHWZHHQ
neighbouring domains (Figure 3f yellow line7KLVLQFUHDVHLQLQWHUDFWLRQIUHTXHQF\LVVHHQ
DWQHDUO\DOOGLVWDQFHVFDOHVEHWZHHQLQWHUDFWLQJORFLVXJJHVWLQJWKDW&7&)LVQHFHVVDU\WR
maintain topological domain boundaries throughout the genome. The interactions gained by 
&7&)GHSOHWLRQFRXOGLQYROYHGHORFDOLVHGFRKHVLQZKLFKQRZIRUPV³QRQVSHFL¿F´LQWHUDFWLRQV
as we have previously shown that cohesin is delocalised but still present on chromatin after 
&7&)NQRFNGRZQ:HQGW<RVKLGDHWDOSupplementary Figure 9c). 
,QGHHGZHREVHUYHGWKDWWKHODUJHVWJDLQVRILQWHUGRPDLQLQWHUDFWLRQIUHTXHQF\DIWHU&7&)
NQRFNGRZQRFFXUEHWZHHQELQVFRQWDLQLQJ&7&)RUFRKHVLQVLWHVFigures 3g,h). Altogether 
RXU REVHUYDWLRQV VXJJHVW WKDW FRKHVLQ DQG&7&) DUH ERWK LPSRUWDQW LQ VKDSLQJ JHQRPLF
structure on the level of topological domains in a non-redundant manner. 
7KHDERYHREVHUYDWLRQVVXJJHVW WKDW ORVVRI FRKHVLQRU&7&)DIIHFWVFKURPDWLQ VWUXFWXUH
in different ways. Given the intimate relationships between chromatin structure and gene 
regulation, we would predict that loss of these two factors would differentially affect gene 
H[SUHVVLRQ7RWHVWWKLVSUHGLFWLRQZHSHUIRUPHG51$VHTXHQFLQJ51$VHTLQWKHFRQWURO
5$'FY7(9 DQG 5$' GHSOHWHG 5$'FY+59 FHOOV DV ZHOO DV &7&) 51$L DQG
mock treated cells. In both cases we observed only modest changes in gene expression 
(Supplementary tables 1-4), consistent with earlier observations (Wendt, Yoshida et al., 2008). 
:HREVHUYHGDQGGLIIHUHQWLDOO\H[SUHVVHGJHQHV)'5IRU5$'DQG&7&)
depletion, respectively but very little overlap between these sets (Supplementary table 1, 
Figure 4a). 
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Figure 4: Transcriptional changes after cohesin cleavage and CTCF depletion
a,&KDQJHVLQH[SUHVVLRQOHYHOVIRUGLIIHUHQWLDOO\H[SUHVVHGJHQHV)DOVH'LVFRYHU\5DWH)'5DUHFRPSDUHG
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XSUHJXODWLRQZDV FRQ¿UPHGE\573&5 WR GHSHQG VROHO\ RQ&7&) NQRFNGRZQ 6XSSOHPHQWDU\ ¿J Ie, The 
SRVLWLRQRI&7&)VLWHVZDVDQDO\VHGUHODWLYHWRWUDQVFULSWLRQVWDUWVLWHVRIDOOJHQHVJUH\OLQHDQGJHQHVZLWKDOWHUHG
H[SUHVVLRQDIWHU&7&)GHSOHWLRQ EOXH OLQH(DFK OLQH UHSUHVHQWV WKDWDYHUDJH IROGHQULFKPHQWRI&7&)53.0
UHODWLYHWR LQSXW53.0RYHUDNEZLQGRZVXUURXQGLQJWKHSURPRWHUVRI&7&)UHJXODWHGJHQHV&7&)LV
clearly enriched at the TSS of differentially expressed genes. f, Similar to e, except showing the fold-enrichment of 
SMC3 (RPKM) over input (RPKM) over the promoter of genes altered after RAD21 depletion. SMC3 does not appear 
to be enriched at the promoter of the genes regulated by cohesin depletion. g, Analysis of change in interaction 
IUHTXHQF\EHWZHHQUHVWULFWLRQIUDJPHQWVFRQWDLQLQJDSURPRWHUDQGUHVWULFWLRQIUDJPHQWVFRQWDLQLQJDGLVWDO'1DVH,
hypersensitive site (DHS). Shown is the fraction of genes that display a 50% reduction or 50% increase in interaction 
IUHTXHQF\DIWHU5$'GHSOHWLRQIRUHLWKHUFRKHVLQUHJXODWHGJHQHVRUDQJHRUDOO5HIVHTJHQHVJUH\&RKHVLQ
regulated genes are enriched for a loss of interactions with restriction fragments containing distal DHS sites relative 
WRDOO5HIVHTJHQHV)LVKHU¶VH[DFWWHVW(h-j) Models describing the different changes in chromosomal interactions 
DIWHUFRKHVLQFOHDYDJHLDQG&7&)GHSOHWLRQMh,&RKHVLQDQG&7&)FRORFDOL]HDQGDUHERWKQHFHVVDU\WRVKDSH




Among the genes with reduced expression after RAD21 depletion are several Hox genes 
(HOXA11AS, HOXA-AS3, HOXB-AS3, HOXB5, HOXC9) (Figure 4b). We validated the 
UHGXFHG H[SUHVVLRQ RI +2;%$6 +2;$$6 DQG + E\ 573&5 DQG T3&5 Figure 
4c). Hox genes have been shown to be regulated by antisense transcription as well as the 
WRSRORJLFDORUJDQL]DWLRQRIWKHORFXV$OH[DQGHU1ROWHHWDO1RRUGHUPHHU/HOHXHWDO
2011), but have never been reported to depend on cohesin. 
$PRQJJHQHVZKLFKDUHGLIIHUHQWLDOO\H[SUHVVHGDIWHU&7&)GHSOHWLRQZHREVHUYHGDFOHDU
HQULFKPHQW RI&7&) ELQGLQJ DW WKHLU SURPRWHUV Figure 4e), with a median distance from 
WKH766 WR WKHQHDUHVW&7&)ELQGLQJVLWHEHLQJRQO\ES Supplementary Figure 11). 
In contrast, genes that are differentially expressed after cohesin depletion are not directly 
bound at their promoter by SMC3 (Figure 4f), though they are located closer to SMC3 binding 
sites than would be expected at random (median distance ~4kb, Supplementary Figure 
11). This indicates that altered expression of genes after RAD21 cleavage may be a product 
of higher-order chromatin structural changes, as suggested from the observed changes of 
long-range chromosomal interactions and gene expression of the HOXA and the HOXB locus 
(Supplementary Figure 10). To validate this, we analysed interactions of cohesin-regulated 
genes with DNase hypersensitive sites as markers for potential distal gene regulatory regions 
at a restriction fragment level resolution. We observed that cohesin regulated genes lose more 
LQWHUDFWLRQVZLWKGLVWDO'1DVH,K\SHUVHQVLWLYHVLWHVWKDQZLWKQRQFRKHVLQUHJXODWHG5HIVHT
genes (Figure 4g). These results suggest that cohesin may regulate gene expression by 
DIIHFWLQJWKHLQWHUDFWLRQIUHTXHQF\RIJHQHVZLWKGLVWDOUHJXODWRU\HOHPHQWVZKLOH&7&)PD\
directly regulate genes by binding at their promoters.
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,QVXPPDU\ZHVKRZHGIRUWKH¿UVWWLPHKRZFRKHVLQDQG&7&)FRQWULEXWHWRWKHWRSRORJLFDO
domain architecture of the human genome. We observed a loss of interactions within and also 
EHWZHHQGRPDLQVDIWHUFRKHVLQFOHDYDJH2QWKHFRQWUDU\&7&)GHSOHWLRQUHGXFHVWKHLQWUD
domain interactions at a somewhat shorter distance while leading to a gain of interactions 
across domain boundaries. This suggests that cohesin is mainly involved in the self-association 
SURSHUW\RIGRPDLQVZKLOH&7&)LVLPSRUWDQWIRUWKHLUVSDWLDOVHJUHJDWLRQFigures 4h-j). We 
K\SRWKHVL]HWKDW&7&)PDLQWDLQVERXQGDULHVE\GHWHUPLQLQJFRKHVLQORFDOL]DWLRQDQGLQWKH
DEVHQFHRI&7&)FRKHVLQPLJKWIRUP´ QRQVSHFL¿F´LQWHUDFWLRQVUHDFKLQJEH\RQGERXQGDULHV





with their target promoters is impaired after chromatin structural changes. This is in good 
agreement with previous observations suggesting a role for cohesin in enhancer function 
5ROOLQV.RURPHWDO:HQGW<RVKLGDHWDO.DJH\1HZPDQHWDO6HLWDQ
Hao et al., 2011). Taken together, these results provide an initial model for understanding the 
mechanisms of higher-order chromatin organization and its relationship to gene regulation. 
Methods summary
RAD21 cleavage experiments: 
HEK293T stable cell lines containing episomes coding for RAD21cv or RAD21wt were 
grown for 3 days in presence of doxycycline until the endogenous RAD21 was replaced by 
the engineered RAD21 versions, transfected with either control protease (TEV) or cleavage 
SURWHDVH+59DFFRUGLQJWR WKHPDQXIDFWXUHU¶V LQVWUXFWLRQVDQGKDUYHVWHGDIWHUKRXUV
Cells were then prepared according to the experimental protocols. A detailed description of all 
methods can be found in the Supplementary Methods.
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1. Supplementary Figures
6XSSOHPHQWDU\ ¿JXUH  5HSODFHPHQW RI WKH HQGRJHQRXV 5$' E\ 5$'FY DQG LQFRUSRUDWLRQ LQ WKH
cohesin complex.
a, Western blot showing the replacement of endogenous RAD21 by RAD21cv in a time-course until 3 days after 
doxycycline induction. Note that the chromatin-bound level of RAD21cv is similar to the endogenous RAD21 level 
)LJ Gb, ,PPXQRSUHFLSLWDWLRQZLWK DQWL(*)3 DQG DQWL60& DQWLERGLHVZDV SHUIRUPHG IURP5$'FY FHOOV
DQGWKH:HVWHUQEORWSUREHGZLWKDQWL60&7KHFRSUHFLSLWDWLRQRI60&ZLWK5$'FY(*)3WDJVKRZVWKDW
RAD21cv is incorporated in the cohesin complex.
6XSSOHPHQWDU\¿JXUH5$'FOHDYDJHFDXVHVSUHPDWXUHORVVRIVLVWHUFKURPDWLGFRKHVLRQ
Cells were treated for 2 hours with nocodazole and then spread to analyse the mitotic cells for sister chromatid 
cohesion defects. 
a, Different degrees of sister chromatid cohesion defects used to cluster observed mitotic defects. b, Bar chart 
displaying the percentage of counted mitotic cells displaying different degrees of sister cohesion defects. We analyzed 









































)$&6DQDO\VLVRI WKHFHOOF\FOHGLVWULEXWLRQRI WKHFHOOVXVHG LQ WKH5$'FOHDYDJHH[SHULPHQWVXQLGXFHGFHOOV








&VHTXHQFLQJZDVSHUIRUPHG IRU WKUHHGLIIHUHQW YLHZSRLQWV 9S LQ D EUHDVW HQGRWKHOLDO FHOO OLQHZLWK QRUPDO
karyotype (HB2, green line) and the control cells for the RAD21 cleavage experiment (RAD21cv/TEV, blue line) using 
WKHVDPHSURWRFRO7KHYLHZSRLQWSRVLWLRQVDUHPDUNHGZLWKJUH\EDUV$OOWKUHHYLHZSRLQWVLQWKH,*)+GRPDLQ























































































a, Schematic representation of the episomal construct used for the control cell line containing a doxycycline-inducible 
bidirectional promoter driving the expression of RAD21wt and siRNA targeting endogenous RAD21 simultaneously.
b, Outline of the experiment. c,&HOOVH[SUHVVLQJSURWHDVHLQVHQVLWLYH5$'(*)35$'ZWGRQRWVKRZDOWHUHG
long-range interactions for viewpoint 1 (Vp1) after HRV protease transfection (RAD21wt/HRV, red line graph upper 
panel), in contrast to cells expressing cleavable RAD21 (RAD21cv/HRV, red line graph lower panel). The respective 
transfections with control protease are shown as blue line graphs. d,7KH&K,3T3&5DVVD\XVLQJGLIIHUHQWSULPHU
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or SMC3 only binding sites per kb was calculated and averaged over all domains. b, Chromosome 2 - heat map 
RIFKDQJHV LQ LQWHUDFWLRQ IUHTXHQF\7KHKHDWPDSVKRZV WKHFKDQJHV LQ LQWHUDFWLRQ IUHTXHQF\5$'FY+59±























































6XSSOHPHQWDU\ ¿JXUH  /LYH FHOO LPDJLQJ VKRZV SUHVHUYDWLRQ RI FKURPDWLQ PRUSKRORJ\ DIWHU 5$'
cleavage.
Live cell imaging of RAD21cv and RAD21wt cells transfected with HRV or TEV protease and with a construct 
HQFRGLQJKLVWRQH+$5)37KH(*)3VLJQDORI5$'FY5$'ZWDQGWKH5)3VLJQDORIWKH+$5)3FRQVWUXFW
ZHUHLPDJHGXVLQJDVSLQQLQJGLVFPLFURVFRSH5$'FYDQG5$'ZWVKRZDVSHFNOHGSDWWHUQ(*)3ZKHQFHOOV
are transfected with TEV.
a, 7KH (*)3 VLJQDO WXUQV LQWR DQ DPRUSKRXV SDWWHUQ ZKHQ WUDQVIHFWHG ZLWK +59 FRQVLVWHQW ZLWK D UHOHDVH RI
5$'FYIURPFKURPDWLQ7KH+$5)3SDWWHUQVGRQRWFKDQJHYLVLEO\EHWZHHQWKHGLIIHUHQWSURWHDVHWUDQVIHFWLRQV
























inter-domain (yellow), non-boundary associated (”None”, blue), or where at least one bin was boundary associated 
´%RXQGDU\ ![´ JUHHQ 7KH ORVV RI LQWHUDFWLRQ IUHTXHQF\ LV KLJKHVW ZKHQ DW OHDVW RQH ELQ LV DVVRFLDWHG ZLWK
a boundary. b, Similar to panel a, but in this case also showing bin-pairs with exactly one boundary associated 
bin (”Boundary 1x”, orange) or two boundary associated bins (”Boundary 2x”, magenta). There are relatively few 
“Boundary 2x” bin pairs in the genome, which accounts for the jaggedness of the magenta line. In both cases, a 
schematic explaining the bin-pair segregation scheme is shown on the left.








































































6XSSOHPHQWDU\¿JXUH&7&)51$LGHSOHWHV&7&)EXWGRHVQRWFKDQJH WKH OHYHOVRIFRKHVLQERXQG WR
chromatin.
a,)$&6DQDO\VLVRIWKHFHOOF\FOHGLVWULEXWLRQRIXQWUHDWHG+(.7FHOOVDQGFHOOVWUHDWHGZLWK&7&)DQGFRQWURO
RNAi. b,:HVWHUQEORWIRU&7&)DQGWXEXOLQDVORDGLQJFRQWUROWRVKRZWKHGHSOHWLRQRI&7&)E\VL51$c, HEK293T 
FHOOVZHUHWUDQVIHFWHGZLWKFRQWURODQG&7&)51$LDQGWKHFHOOVIUDFWLRQDWHGLQWRWDOFHOOH[WUDFWWRWDOWKHVROXEOH
pool containing cytoplasm and nucleoplasm (soluble) and the chromatin-bound pool (chromatin) of proteins. The 
ZHVWHUQEORWIRU60&VKRZVHTXDOOHYHOVRIFKURPDWLQERXQGSURWHLQVDIWHU&7&)GHSOHWLRQ7KHFKURPDWLQERXQG
IUDFWLRQLVPDUNHGE\EORWWLQJIRU7RSRLVRPHUDVH,,7RSR,,7KLVFRQ¿UPVREVHUYDWLRQVIURPRXUHDUOLHUVWXG\:HQGW
Yoshida et al., 2008). d,7UDQVFULSWVRI60&&7&)DQG5$'ZHUHDQDO\VHGDIWHU51$LGHSOHWLRQRI5$'
DQG&7&)LQ+(.7FHOOV&RQVLVWHQWZLWKWKHGHSOHWLRQZHREVHUYHGDUHGXFWLRQRI5$'DQG&7&)DIWHUWKH
respective siRNA treatments. The fold expression compared to the control RNAi is shown. e, Validation of two genes 
&'+FDGKHULQSUHFXUVRU70& WUDQVPHPEUDQHFKDQQHOOLNH IRXQGWREHGRZQUHJXODWHGDIWHU&7&)
51$LE\T3&57KHIROGH[SUHVVLRQFRPSDUHGWRWKHFRQWURO51$L LVVKRZQf, Validation of two genes (ENPP3 - 






















































































































































































































































































































































(PSLULFDO&XPXODWLYH'HQVLW\SORWVRI WKHGLVWDQFH IURP WKH WUDQVFULSWLRQVWDUW VLWHRIDQ5$' DRU&7&) E
UHJXODWHGJHQHWRWKHQHDUHVWELQGLQJVLWHIRUHLWKHU60&DRU&7&)E
a, Shown in red is the empirical cumulative density distribution of the distance between the TSS of RAD21 regulated 
genes to the nearest SMC3 binding site. The median distance to the nearest site is ~4.1kb (shown with a vertical 
GDVKHG OLQH6KRZQ LQJUH\ LV WKHGLVWULEXWLRQ IRUDOO5HI6HTJHQHVGHPRQVWUDWLQJ WKDW5$' UHJXODWHGJHQHV
typically have an SMC3 binding site closer than would be expected at random. The inset shows the same data but 











































































































2. Supplementary Material and Methods
&OHDYDEOH+595$'(*)3FRQVWUXFW5$'FY
The construct encoding the cleavable RAD21 subunit (RAD21cv) was previously described in 
6FKRFNHO0RFNHOHWDO%ULHÀ\WKH¿UVW5$'VHSDUDVHFOHDYDJHVLWHZDVUHSODFHGE\
one for 3C protease of the human rhinovirus (HRV protease) using a PCR-based mutagenesis. 
The second cleavage site was unchanged to ensure less cell cytotoxicity. RAD21cv was then 
FORQHGLQIURQWRIDQ(*)3FDVVHWWH7KHWREDFFRHWFKYLUXVSURWHDVH7(9SURWHDVHZKLFK
does not recognize the HRV cleavage site is used as control.






The vector pRTS-1, described in (Bornkamm, Berens et al., 2005), presents a doxycycline-
responsive cassette composed of a bidirectional promoter that drives the expression of two 
JHQHV LQ D FRRUGLQDWHG IDVKLRQ 7KH FOHDYDEOH 5$'H*)3 DQG WKH VL51$ IRU 5$'
FDVVHWWHVZHUHFORQHGXQGHUWKHFRQWURORIWKHELGLUHFWLRQDOSURPRWHUWKXVDIWHUGR[\F\FOLQH
treatment both cassettes are expressed simultaneously.
Generation of HEK293T cell stably containing the episomal constructs
HEK293T cell line was cultured in DMEM supplemented with 0.2mM L-glutamine, 100 units/
POSHQLFLOOLQPJPOVWUHSWRP\FLQDQG)&6DQGZDVJURZQDW&DQG&22. 
Transfection of the episome was done by Lipofectamine 2000 (Invitrogen) according to the 
PDQXIDFWXUHU¶VLQVWUXFWLRQVDQGFHOOVFDUU\LQJWKHHSLVRPHYHFWRUZHUHVHOHFWHGE\JURZLQJ
in a medium containing 150 μg/mL hygromycin. Single clones were picked and analysed for 
expression of RAD21cv and RAD21wt constructs and depletion of the endogenous RAD21 
three days after induction with 2 μg/ml doxycycline.
RAD21 cleavage experiments
To activate transgene expression, cells were cultured for 3 days in the presence of 2 μg/ml of 
GR[\F\FOLQH$IWHUGD\VFHOOVZHUHVSOLWWRFRQÀXHQF\DQGWUDQVIHFWHGZLWK7(9RU+59
FRQVWUXFWXVLQJ/LSRIHFWDPLQH,QYLWURJHQDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV
Cells were harvested 24 hours after protease transfection.
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Spreading of mitotic chromosomes
&HOOVZHUHWUHDWHGZLWKQRFRGD]ROH6LJPDIRUKRXUVDQG¿[HGZLWKPHWKDQRODFHWLFDFLG
after hypotonic treatment. After spreading of the cells on cover slips the chromosomes were 
stained with Giemsa. 
Live cell imaging of Histone-RFP after RAD21 cleavage
To activate transgene expression, cells were cultured for 3 days in the presence of 2 μg/
PORIGR[\F\FOLQH$IWHUGD\VFHOOVZHUHVSOLWWRFRQÀXHQF\DQGWUDQVIHFWHGZLWK7(9
RU +59 FRQVWUXFWV DQG +$5)3 XVLQJ /LSRIHFWDPLQH  ,QYLWURJHQ DFFRUGLQJ WR WKH
PDQXIDFWXUHU¶VLQVWUXFWLRQV&HOOVZHUHLPDJHGKRXUVDIWHUSURWHDVHWUDQVIHFWLRQXVLQJD
SpinD1454 Roper/Nikon spinning disk microscope with temperature controller. Cells were 
imaged using the 60X Objective, 491 nm and 561 nm lasers and 700 ms exposure time. 
Image stacks were processed with ImageJ and projected in a single plane. 
RNAi depletion of CTCF and RAD21
+(.7FHOOVZHUHVHHGHGLQ'0(0VXSSOHPHQWHGZLWKP0/JOXWDPLQHDQG)&6
DQGWUDQVIHFWHGZLWKVL51$ROLJRV$PELRQGLUHFWHGDJDLQVW&7&)DQGDQRQWDUJHWLQJFRQWURO
VL51$XVLQJ /LSRIHFWDPLQH ,QYLWURJHQ DFFRUGLQJ WR WKHPDQXIDFWXUHU¶V LQVWUXFWLRQV
Cells were harvested 48 hours after transfection according to the respective protocols for Hi-C 
or western blotting. The following siRNA oligos were used:
&7&)VL51$  VHQVH  **$*&&8*&&*8$*$$$8877
antisense  AAUUUCUACGGCAGGUCCTC
Control siRNA  sense  CGUACGCGGAAUACUUCGATT
   antisense UCGAAGUAUUCCGCGUACGTT
Depletion of RAD21 in HEK293T by siRNA transfection was only performed for the transcript 
DQDO\VLVZLWKWKHVDPHSURWRFROXVHGIRU&7&)GHSOHWLRQ
RAD21 siRNA  sense  GGUGAAAAUGGCAUUACGGtt
antisense  CCGUAAUGCCAUUUUCACCtt
Fractionation in soluble and chromatin bound proteins
To prepared soluble and chromatin bound fractions cells were harvested and lysed (20mM Tris-
+&OS+P01D&OP00J&OP0&D&OJO\FHURO13P01D)
P0'77DQGSURWHDVHLQKLELWRUV$QDOLTXRWZDVWDNHQDVWRWDOO\VDWHDQGWKHUHPDLQLQJ
lysate centrifuged 10 min at 1500 rpm to collect the chromatin pellet. The supernatant was 
collected as soluble fraction. The pellet was washed 3 times with lysis buffer, resuspended in 
TBS/T and the chromatin-bound proteins solubilized by sonication and benzonase treatment. 
Antibodies
3ULPDU\DQWLERGLHVXVHGZHUHPRXVHDQWL&7&)%'IRULPPXQREORWWLQJUDEELWDQWL&7&)
0LOOLSRUH IRU &K,3 PRXVHPRQRFORQDO DQWL(*)3 6LJPD LPPXQREORWWLQJ PRXVH DQWL
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tubulin (Sigma, immunoblotting) and rabbit anti-TopoII (Millipore, immunoblotting). Polyclonal 
rabbit antibodies against RAD21 and STAG1/STAG2 (immunoblotting) were a gift from Jan-
Michael Peters and described in (Sumara, Vorlaufer et al., 2000). Rat monoclonal antibodies 






Immunoprecipitations were performed as described (Kueng, Hegemann et al., 2006) using 
DQWLERGLHVDJDLQVW60&DQG(*)3
Chromosome conformation capture sequencing (3C-seq) and analysis
&KURPRVRPH FRQIRUPDWLRQ FDSWXUH VHTXHQFLQJ ZDV SHUIRUPHG DV SUHYLRXVO\ GHVFULEHG
LQ 6LPRQLV .RRUHQ HW DO  6WDGKRXGHUV .RORYRV HW DO  %ULHÀ\ FHOOV ZHUH
FURVVOLQNHGZLWKZYIRUPDOGHK\GHIRUPLQXWHVDQGTXHQFKHGZLWKP0JO\FLQH
Crosslinked-cells were resuspended in lysis buffer (50mM Tris-HCl pH 8.0, 0.5% NP-40, 
50mM NaCL and Complete protease inhibitor (Roche) and subjected to enzymatic digestion 
using 400 units of BglII (Roche). Digested chromatin was then diluted and ligated using 5 units 
of T4 DNA ligase (Promega) under conditions favouring intramolecular ligation events. After 
UHYHUVLQJWKHFURVVOLQNDW&RYHUQLJKWWKHGLJHVWHGDQGOLJDWHGFKURPDWLQZDVVXEMHFWHG
to a second enzymatic digest using NlaIII (New England Biolabs) to produce smaller DNA 
fragment. The resulting digested DNA underwent a second ligation using 10 units of T4 DNA 
ligase (Promega) under conditions favouring self-ligation events that produce circular DNA 





human genome (hg18). 
7KHUHDGVZHUHH[WHQGHGWRESLQWKH¶GLUHFWLRQXVLQJWKHU&6HTSLSHOLQH7KRQJMXHD
6WDGKRXGHUV HW DO LQ SUHSDUDWLRQ KWWSZZZELRFRQGXFWRURUJSDFNDJHVELRFKWPO
U&VHTKWPO,QWHUDFWLRQIUHTXHQFLHVZHUHFDOFXODWHGXVLQJWKHQXPEHURIUHDGVSHUPLOOLRQ










protease inhibitor (Roche)) and chromatin was sonicated (Diagenode Bioruptor). After a 
centrifugation step to remove the debris. The lysate was diluted 1:4 with IP dilution buffer 




gelatine). The beads were washed with washing buffer I (20mM Tris-HCl pH 8.0, 0.15 M NaCl, 
P0('7$7;6'6P0306)ZDVKLQJEXIIHU,,P07ULV+&OS+
01D&OP0('7$7;6'6P0306)ZDVKLQJEXIIHU,,,P07ULV
HCl pH 8.0, 0.25 M LiCl, 1mM EDTA, 0.5% NP-40, 0.5% sodium deoxycholate) and TE-buffer 






ChIP sequencing and peak detection




generation was performed using the Illumina Cluster Reagents preparation. The libraries were 
VHTXHQFHGZLWK WKH ,OOXPLQD+L6HTV\VWHP5HDG OHQJWKVRIEDVHVZHUHREWDLQHG
Images were recorded and analyzed by the Illumina Genome Analyzer Pipeline (GAP 1.6.0. 
DQG 7KH UHVXOWLQJ VHTXHQFHVZHUHPDSSHG DJDLQVW+XPDQB8&6&KJ XVLQJ WKH
Bowtie (Langmead, Trapnell et al., 2009) alignment software, with the following parameters: 
YPEHVWVWUDWD6WLPHS8QLTXHUHDGVZHUHVHOHFWHGIRUIXUWKHUDQDO\VLV3&5




presented as the percentage of input-chromatin that was precipitated. 
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Transcript analysis by reverse transcription (RT) and qPCR
7RWDO51$ZDVSUHSDUHGXVLQJ75,]RO5HDJHQW,QYLWURJHQDFFRUGLQJWRWKHPDQXIDFWXUHU¶V
instructions. After chloroform extraction and isopropanol precipitation, pellets were 
dissolved in DEPC water. cDNA was generated by reverse transcription using oligo(dT)18 





primers. The transcripts of the housekeeping gene SNAPIN were used for normalization of the 
samples. ''Ct method was used to calculate the fold change in gene expression.
RNA-seq experiments and data analysis
Total RNA was isolated using TRIzol reagent (Invitrogen). PolyA RNA was isolated using Dynal 
EHDGVP51$SXUL¿FDWLRQNLW,QYLWURJHQDQGSDLUHGHQGOLEUDULHVZHUHSUHSDUHGDVSUHYLRXVO\
described (Parkhomchuk, Borodina et al., 2009). 






expressed genes were called using edgeR. Common and tagwise dispersions were estimated 
EDVHG RQ DOO  51$VHT H[SHULPHQWV SHUIRUPHG  UHSOLFDWHV IRU HDFK RI  FRQGLDWLRQV
5$'FY7(95$'FY+59VL51$&7&)VL51$&RQWURO'LIIHUHQWLDOO\H[SUHVVHGJHQHV
ZHUHFDOOHGE\DQ)'5
Probe labelling for Fluorescence in situ hybridization (FISH)
&RVPLGV IRU WKH KXPDQ FKURPRVRPH  *3) DQG *3% DQG IRU
WKH KXPDQ FKURPRVRPH  *3) DQG*3$ZHUH REWDLQHG IURP WKH
CHORI library. 500ng cosmid DNA was labelled with Alexa 488-5-dUTP or Alexa 594-5-dUTP 
(Invitrogen) using the BioPrime Random Prime Labeling kit (Invitrogen). After labelling, probes 
ZHUHSXUL¿HGIURPXQLQFRUSRUDWHGQXFOHRWLGHVXVLQJ6HSKDGH[*FROXPQHOXWLRQ)UDFWLRQV
containing the labelled cosmids DNA were pooled, ethanol precipitated and dissolved in 




3D DNA Fluorescence in situ hybridization (3D DNA-FISH)
''1$),6+ZDVSHUIRUPHGDVGHVFULEHGEHIRUHYDQGH&RUSXWGH%RHUHWDO,Q
EULHIFHOOVZHUHJURZQRQPPSRO\'O\VLQH6LJPDFRDWHGFRYHUVOLSV9:5¿[HGZLWK
2% (w/v) formaldehyde/1×PBS for 10 minutes and permeabilized in 1×PBS containing 0.5% 
(v/v) Triton X-100 (Sigma) and 0.5% Saponin (Sigma) for 10 minutes at room temperature. 





minutes. Coverslips were mounted with Prolong Gold contained DAPI (Invitrogen). 
Confocal Laser Scanning Microscopy
All cell samples were imaged using a Leica SP5 confocal laser scanning microscope using 
WKH/$6VRIWZDUHSURYLGHGZLWKWKHLQVWUXPHQW7KHV\VWHPZDVHTXLSSHGZLWKD[SODQ
apochromat oil NA1.4 DIC objective. The pinhole diameter was set to 1 airy unit. DAPI, Alexa 
DQG$OH[DÀXRURFKURPHVZHUHH[FLWHGZLWKDQPGLRGH ODVHUDQP$UJRQ
laser and a 594nm laser respectively and detected using a multi-track imaging mode of which 
WKHEDQGSDVV¿OWHUVZHUHQP'$3,QP$OH[DDQGQP$OH[D
ELWLPDJHVZLWKD[SL[HOVIUDPHVL]HDQG[QPSL[HOVL]HZHUHDFTXLUHG
with 400Hz scan speed, 2-times line averaging and an optical sectioning of 120nm. The point 
VSUHDGIXQFWLRQZDVPHDVXUHGXVLQJQPUHGDQGJUHHQEHDGV7KHUPR6FLHQWL¿FDQGWKH
chromatic shift was measured using 500nm TetraSpeck beads (invitrogen).
All confocal images were deconvolved using the Huygens Professional software v4.1.0p8 (SVI) 
XVLQJWKHPHDVXUHG3RLQW6SUHDG)XQFWLRQDQGWKHFODVVLFDOPD[LPXPOLNHOLKRRGHVWLPDWLRQ
algorithm. The background, signal to noise ratios and chromatic shift were corrected during 
the deconvolution process.
Hi-C experiments and data analysis
Hi-C experiments were performed as previously described (Lieberman-Aiden, van Berkum et 
al., 2009). Reads were aligned as single end reads using bwa with default parameters against 
KJUHIHUHQFHJHQRPH6LQJOHHQGUHDGVZHUH¿OWHUHGIRUXQLTXHO\PDSSLQJUHDGVDQGSDLUHG
manually using an in house pipeline. Hi-C interaction matrices were generated as previously 
described (Lieberman-Aiden, van Berkum et al., 2009) and normalized using the iterative 
FRUUHFWLRQPHWKRGHLWKHUXVLQJNEELQVRUDWDUHVWULFWLRQIUDJPHQWEDVHGOHYHOIRU)LJXUH
J,PDNDHY)XGHQEHUJHWDO7RIDFLOLWDWHFRPSDULVRQRI+L&LQWHUDFWLRQIUHTXHQFLHV
between different experiments, interaction matrices were also normalized for “depth,” with 
WKHQRUPDOL]HGLQWHUDFWLRQIUHTXHQF\Iij ) between two loci i and j, being normalized by the 
sum of all Iij in a given chromosome wide normalized interaction matrix. This is analogous to 
UHDGGHSWKEDVHGQRUPDOL]DWLRQVFKHPHVLH53.0RIRWKHUKLJKWKURXJKSXWVHTXHQFLQJ
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experiments. These normalized interaction matrices serve as the input for generating the 
directionality index and topological domain calls using previously described methods (Dixon, 
Selvaraj et al., 2012). 
To generate the “delta” interaction matrices (Figures 3c,d), we subtracted the normalized 
LQWHUDFWLRQIUHTXHQF\Iij at each locus of an experimental treatment (RAD21cv/HRV or siRNA 
&7&)IURPWKHFRQWUROWUHDWPHQW5$'FY7(9RUVL51$&RQWUROWRJHQHUDWHDQHZ'Iij for 
comparison between experiments.
)RU DQDO\VLV RI LQWHUDFWLRQV EHWZHHQ SURPRWHUV DQG GLVWDO '1DVH, +\SHUVHQVLWLYH '+6





the control (RAD21cv/TEV) and RAD21 depleted (RAD21cv/HRV) samples and calculated 
the fraction of potential promoter-to-DHS interaction that showed a 50% gain or reduction 
LQ LQWHUDFWLRQ IUHTXHQF\)LVKHU¶VH[DFW WHVWZDVXVHG WRDVVHVV WKHHQULFKPHQWRIFRKHVLQ









chr. start end strand Gene Name
chr7 142053693 142055088 + MTRNR2L6 -3.001885189 3.596146636 3.17E-11 3.63E-07 -0.260664767 -0.240044182 0.629315402 1
chr17 44927653 44947381 + NGFR -1.332460534 1.374728621 7.90E-06 0.005264291 0.50693152 0.192570949 0.18376594 1
chr10 90684810 90741127 - ACTA2 -1.105976433 3.095741633 1.37E-05 0.008599514 -0.222359022 1.858920898 0.438756766 1
chr17 37132416 37144424 - HAP1 -1.066912668 3.592623019 4.55E-08 9.79E-05 -0.161700289 2.625497341 0.461794637 1
chr6 36752214 36763095 + CDKN1A -1.057734202 6.267310189 4.82E-11 3.63E-07 -0.223180959 4.816216738 0.168299898 1
chr13 102179717 102209423 - CCDC168 -1.053282934 2.162082792 2.72E-05 0.013229621 -0.209998463 0.475209698 0.549919805 1
chr17 44022821 44038773 + HOXB-AS3 -1.005391316 4.756720225 1.91E-08 6.78E-05 0.042223115 3.946689375 0.830960127 1
chr8 96007375 96030791 - TP53INP1 -0.953642714 4.772480412 3.71E-06 0.002941424 -0.667379855 3.660971884 0.00079237 0.068202657
chr7 27191551 27195437 + HOXA-AS5 -0.939639625 4.244340846 6.60E-07 0.000903949 -0.119891338 3.975213846 0.545692795 1
chr19 6482009 6486939 + TNFSF9 -0.933731443 3.200416601 1.96E-05 0.010529801 -0.078380556 2.891999944 0.741192048 1
chr1 148088382 148088964 - HIST2H2BC -0.930196359 3.492540973 1.67E-05 0.009698014 0.004143119 2.324376129 1 1
chr19 45620248 45623772 - SERTAD1 -0.929249497 3.920717993 3.71E-07 0.000579414 0.155732397 2.115802626 0.507112545 1
chr10 76831291 76838746 + ZNF503-AS2 -0.866424503 5.188134577 8.12E-07 0.000940965 0.109578851 4.681740106 0.574711018 1
chr8 95961628 95976658 - CCNE2 -0.851407024 5.626129819 3.21E-08 8.06E-05 -0.048945243 5.214461233 0.755163054 1
chr8 23049048 23077485 - TNFRSF10D -0.822805488 4.338144698 3.51E-05 0.015566412 -0.341632678 3.75881083 0.08547648 1
chr22 36531059 36533389 + H1F0 -0.800324133 8.077945126 1.55E-06 0.001554275 0.159659919 7.689811987 0.297182829 1
chr6 27968455 27968942 - HIST1H2AM -0.771660988 3.412599467 0.000100577 0.035232192 0.138836619 3.234626437 0.587823783 1
chr1 191044791 191048030 + RGS2 -0.762081879 3.844464673 5.35E-05 0.021789455 0.379712207 3.020658809 0.071932119 0.985012275
chr7 27146507 27162072 + HOXA-AS3 -0.751555564 5.448153081 1.85E-07 0.000347451 0.070078895 4.956775892 0.66782584 1
chr1 148122633 148124856 - HIST2H2BE -0.728039139 5.26217119 0.000112056 0.038361325 0.325029909 4.892244097 0.16483912 1
chr16 88515917 88530006 + TUBB3 -0.721007063 4.339014951 0.000133044 0.042639142 0.003316151 3.627694282 1 1
chr12 52680143 52683387 + HOXC9 -0.70981464 5.430457659 8.06E-07 0.000940965 0.136377683 5.130894665 0.385238708 1
chr13 65774966 66702469 - PCDH9 -0.696276647 5.3036176 5.09E-05 0.021789455 0.24375815 5.405859014 0.128919633 1
chr17 44023617 44026102 - HOXB5 -0.678066117 5.10411087 2.63E-06 0.002358182 0.300926316 4.764859655 0.063056047 0.961349424
chrX 53128266 53134453 + TSPYL2 -0.669300692 5.535778165 1.49E-05 0.0089777 0.13423463 5.898150297 0.390823806 1
chr6 94006458 94186021 - EPHA7 -0.652555553 4.928555035 0.000157854 0.047555016 -0.210801747 5.219287865 0.177437382 1
chr6 41148684 41178124 + NFYA -0.623657463 6.120510265 6.80E-05 0.026952827 -0.0571224 6.22124452 0.704533703 1
chr6 43651855 43696238 + POLH -0.617921211 6.266450682 9.12E-05 0.033509095 -0.098701118 5.626965954 0.524597131 1
chr1 144149818 144153985 + TXNIP -0.615854233 5.317906683 0.000121555 0.04067075 0.953629933 5.490576351 2.01E-09 1.08E-06
chr11 65021808 65030515 + MALAT1 -0.610835914 9.999367932 0.000143965 0.044974258 0.154358336 9.887225409 0.339596544 1
chr10 63331018 63526713 + ARID5B -0.58896163 6.049687687 0.000146301 0.044974258 0.092820129 5.315387819 0.565461753 1
chr17 40580466 40585251 + HEXIM1 -0.587442969 7.204683941 5.35E-05 0.021789455 0.115721479 6.369671754 0.463157231 1
chr17 3512935 3518722 - TAX1BP3 -0.584012474 5.029029003 7.69E-05 0.029076327 -0.146654285 4.761383642 0.377025665 1
chr5 172674331 172689112 - STC2 0.566974935 6.913223998 3.49E-05 0.015566412 0.264153378 6.563617654 0.087735981 1
chr17 3710365 3743086 - CAMKK1 0.58037408 4.798503337 9.97E-05 0.035232192 -0.217165798 5.038283113 0.180580406 1
chr3 137538688 137953935 - STAG1 0.592628644 6.42773176 0.000124202 0.04067075 1.160542278 6.749867354 1.33E-13 2.87E-10
chr5 137829079 137832903 + EGR1 0.623573154 7.178224997 7.25E-06 0.005216845 -0.769177542 2.635577886 6.52E-05 0.009180417
chr8 134536272 134653365 - ST3GAL1 0.665784759 4.16233909 3.29E-05 0.015497782 -0.133845916 4.422849107 0.417695867 1
chrX 107862382 107866263 - IRS4 0.726757038 9.525407099 1.30E-06 0.001396489 0.039983274 9.70013011 0.800981158 1
chr8 126511744 126519826 + TRIB1 0.731163548 5.124976165 1.77E-05 0.009895423 0.112639189 5.209839811 0.470004025 1
chr20 36482652 36497432 - LOC388796 0.734979802 6.117374784 2.05E-05 0.010651409 0.159391522 5.242480908 0.309527315 1
chr8 128817496 128822862 + MYC 0.868857148 6.888740089 2.25E-08 6.78E-05 -0.089924204 7.127191259 0.565343548 1
chr11 124010894 124051409 - SIAE 1.014433973 6.919696157 3.05E-06 0.002551014 0.162075929 5.982727425 0.560600802 1
chr8 67568044 67593313 + C8orf46 1.219609841 0.796674988 7.72E-05 0.029076327 0.84639459 -1.614571388 0.147179916 1
chr19 18228905 18246319 - KIAA1683 1.243388536 1.989556024 2.66E-06 0.002358182 -0.381367368 -0.999944872 0.435832629 1
chr7 141342147 141453016 + MGAM 1.302158211 1.092436362 2.30E-05 0.011556936 -0.15048453 -1.43575098 0.793222467 1
chr14 19881069 19881410 - RPPH1 1.370968788 5.799066017 2.23E-08 6.78E-05 -0.127201192 4.822174662 0.569473772 1
chr9 138227916 138236776 - LHX3 1.389571111 1.139565454 8.04E-06 0.005264291 -0.147057004 -0.334166382 0.812908108 1
chr1 109057078 109086890 + FNDC7 1.430697071 1.487779142 3.85E-07 0.000579414 -0.084310221 -1.158715598 0.907554233 1
chr6 31647854 31650077 + LTA 1.565977491 0.70410787 7.27E-06 0.005216845 -1.237924802 -3.533576071 0.365768361 1
FC CPM p-val FDR FC CPM p-val FDR
RAD21 Cleavage CTCF depleted
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chr. start end strand Gene Name
chr20 44235782 44313741 - CDH22 0.287052228 2.139319467 0.25870855 1 -2.104646401 -0.040501259 1.45E-07 5.32E-05
chr17 43239731 43254146 - OSBPL7 0.019973674 2.620075753 0.851724191 1 -1.916062813 0.965818529 8.26E-09 4.01E-06
chr2 70742723 70848883 - ADD2 0.10696415 5.717907945 0.539120212 1 -1.867310472 5.283533892 3.72E-30 2.81E-26
chr11 63864265 63881582 + CCDC88B -0.115969195 1.573594497 0.944206359 1 -1.711427495 0.862346784 7.78E-07 0.000229766
chr1 16256850 16272714 - FAM131C 0.438309366 2.067954813 0.066870812 1 -1.661430088 1.562561838 3.25E-08 1.40E-05
chr19 51059357 51068895 + FOXA3 0.010408809 0.290351106 0.843946989 1 -1.633309178 -0.54407043 0.000329562 0.033769972
chr16 18902756 18982763 + TMC7 0.015303495 3.588202402 0.934655531 1 -1.556498489 2.782003459 1.56E-12 1.56E-09
chr2 29057667 29128600 + FAM179A 0.548611012 0.759603845 0.057779221 1 -1.545373503 -0.476365303 0.000362358 0.036632217
chr19 45664965 45774205 + SPTBN4 0.097851786 2.430478667 0.593834884 1 -1.485107849 1.266450549 1.19E-06 0.000325765
chr12 56305817 56313252 - B4GALNT1 -0.092936186 3.895398765 0.866674831 1 -1.458843301 3.458807614 2.44E-12 2.30E-09
chr12 54361596 54364661 + METTL7B -0.392425761 2.599378846 0.225696823 1 -1.420280169 2.259017043 2.52E-07 8.64E-05
chr12 56406289 56408406 + LOC100130776 0.073189581 3.02736681 0.742070506 1 -1.385444511 2.376124893 3.48E-08 1.46E-05
chrX 76968517 77037721 - MAGT1 -0.16086069 6.984624242 0.334732982 1 -1.361929317 7.226839394 3.89E-18 1.47E-14
chr22 18835993 18841786 - RIMBP3 0.013446728 2.508685216 0.656708468 1 -1.349317634 1.77857075 2.41E-06 0.000625215
chr1 27591738 27594904 + GPR3 0.546440381 1.825786873 0.043537373 1 -1.342543649 0.236843125 0.00020317 0.023010172
chr4 15080586 15212278 + CC2D2A -0.1007299 3.376078661 0.559661652 1 -1.298050902 3.343647967 4.64E-10 3.18E-07
chr22 34107059 34120207 + HMOX1 -0.456991024 4.268754105 0.030993495 0.894213246 -1.292483511 3.841521043 1.66E-10 1.19E-07
chr15 71996861 72007642 - LOC100287616 0.320017855 2.145175987 0.133387357 1 -1.249295464 2.320733319 4.95E-06 0.001064447
chr11 118544649 118559936 + NLRX1 -0.042872259 4.627369647 0.80075582 1 -1.232813517 3.993944453 5.74E-13 9.60E-10
chr11 298106 299410 + IFITM2 -0.104907496 2.742277429 0.707574723 1 -1.205662748 2.457818021 1.12E-06 0.000312481
chr12 55678883 55686564 - ZBTB39 -0.024469128 5.516374041 0.79653164 1 -1.20474427 4.853465067 1.69E-13 3.17E-10
chr12 56404342 56422211 - AGAP2 -0.113638894 3.788678709 0.902685942 1 -1.181078406 3.272281681 4.17E-07 0.00013359
chr7 37926687 37958067 + EPDR1 -0.001154875 3.857316371 0.873572466 1 -1.152130503 3.377704801 2.41E-08 1.07E-05
chr10 123706592 123724733 - NSMCE4A 0.158712677 5.946472665 0.350812881 1 -1.14295931 5.282412063 1.05E-12 1.42E-09
chr19 11392271 11406980 - CCDC151 0.021069757 1.285355455 0.915521235 1 -1.13286405 0.897933739 0.000315339 0.032533895
chr1 152168600 152185778 - DENND4B 0.194384223 6.515528444 0.251920232 1 -1.126007147 5.930148611 1.18E-12 1.42E-09
chr20 61589809 61600949 - EEF1A2 -0.019051731 7.083428838 0.963167024 1 -1.12507215 5.986368939 1.32E-12 1.42E-09
chr11 125638023 125644087 - SRPR -0.092455657 7.027447611 0.480514641 1 -1.118771497 6.285435775 1.23E-12 1.42E-09
chr9 129968164 130006483 - CIZ1 -0.026122642 7.952762208 0.770980864 1 -1.108636487 7.382652073 1.14E-12 1.42E-09
chr16 29789980 29818086 - SEZ6L2 0.040319609 3.971662593 0.939845807 1 -1.10370632 3.572079999 6.14E-08 2.37E-05
chr16 66153810 66230589 + CTCF 0.175387153 6.938425397 0.318715866 1 -1.090678587 6.50276881 3.77E-12 3.34E-09
chr19 40679958 40696400 - DMKN -0.101954575 6.309359926 0.453433863 1 -1.073689118 5.939081595 1.25E-11 1.04E-08
chr17 35770430 35774471 - GJD3 0.181528972 2.228673511 0.326657924 1 -1.067431989 1.790465425 0.000156713 0.019191649
chr7 73848419 73905777 - GTF2IRD2 0.12850774 3.205586377 0.599100052 1 -1.064871324 1.981721786 3.28E-05 0.005149687
chr22 34952200 34965946 - APOL2 -0.382766009 3.524574622 0.047664823 1 -1.044895361 3.085940175 5.81E-07 0.000178587
chr1 149235924 149247478 - FAM63A -0.253291733 4.589517175 0.136140462 1 -1.022211305 3.982886476 1.56E-09 9.04E-07
chr5 35653745 35850470 + SPEF2 0.118545814 2.540699334 0.609592228 1 -1.014157365 1.799499414 0.00011072 0.014502337
chr11 61323672 61341105 - FADS1 -0.017071153 6.362064775 0.909747275 1 -1.014149879 6.114814041 1.23E-10 9.26E-08
chr14 93663870 93665710 - IFI27L2 -0.1049038 2.197466761 0.762487186 1 -1.012954763 1.881072312 0.000332442 0.033834989
chr2 74578151 74583951 - LBX2 0.004335649 2.681038448 0.938774727 1 -0.993172387 2.102129426 9.57E-05 0.012867486
chr16 54070581 54098087 + MMP2 -0.310890855 1.973875964 0.334797105 1 -0.988756022 2.546439083 0.00020002 0.02299927
chr11 780474 788269 - SLC25A22 0.248224584 5.416236545 0.098588604 1 -0.981132989 5.211525474 1.03E-09 6.48E-07
chr7 904062 960815 - ADAP1 0.139392639 3.677413001 0.371184575 1 -0.975255104 3.168220761 2.67E-06 0.000660551
chr7 36859035 37455420 - ELMO1 -0.348196835 2.44034968 0.194032123 1 -0.971635344 2.15463096 0.000106886 0.014248018
chr14 75406357 75658553 - BCYRN1 -0.422665217 5.549284904 0.007357548 0.518114086 -0.966071589 5.074474828 1.38E-09 8.32E-07
chr4 39734918 39836267 + N4BP2 0.029824131 5.635937267 0.58674151 1 -0.96478601 5.086306546 1.89E-09 1.05E-06
chr6 100075590 100087780 + LOC100130890 -0.080190581 3.050672191 0.729349379 1 -0.954419658 2.545286266 8.02E-05 0.01098033
chr1 23627642 23683337 - ASAP3 -0.170350422 3.620009276 0.644742927 1 -0.942397163 3.266910921 4.85E-05 0.0071622
chr5 101597590 101660152 - SLCO4C1 -0.281167311 2.675858828 0.306789008 1 -0.931335053 2.19847122 0.000197538 0.022888557
chr2 68364806 68400687 - CNRIP1 0.068265327 3.995133804 0.767333065 1 -0.927559892 3.584428053 5.24E-06 0.001095454
chr11 61276696 61312565 + C11orf9 -0.191822478 3.672574115 0.409885445 1 -0.912407923 2.797719842 2.08E-05 0.003482653
chr2 241156676 241166822 + RNPEPL1 0.061558633 4.301421716 0.68841807 1 -0.904571671 4.324625123 5.66E-08 2.24E-05
chr19 46528651 46551671 - TGFB1 -0.113606109 5.960018035 0.326556818 1 -0.90154991 5.331776429 1.78E-08 8.29E-06
chr5 179961111 180009230 - FLT4 -0.116266138 5.893422227 0.605097621 1 -0.901186097 5.311181508 1.82E-08 8.29E-06
chr18 50139168 50162402 + C18orf54 0.025159156 4.458142095 0.847162179 1 -0.888778766 4.093066341 1.04E-07 3.92E-05
chr3 27732889 27738789 - EOMES -0.040469904 3.122600739 0.856314147 1 -0.877197748 2.435237048 0.000390965 0.038744071
chr19 18560494 18564147 + C19orf60 0.044615866 4.128275182 0.946756918 1 -0.864935663 4.015185656 1.31E-05 0.002325127
chr10 69712422 69762690 - PBLD -0.027481038 3.757081795 0.780614866 1 -0.858657034 2.851203368 5.20E-05 0.007608371
chr12 129840099 129889772 - STX2 -0.056365427 5.008409195 0.819755266 1 -0.838449802 4.965578852 1.88E-07 6.75E-05
chr3 101694152 101778975 + TMEM45A -0.020724893 3.198927561 0.868790958 1 -0.835119739 2.888905475 0.00045206 0.043649863
chr12 3594754 3732627 - EFCAB4B 0.228682187 2.581056792 0.242180891 1 -0.829464319 2.751035146 0.000515474 0.047929523
chr4 12978444 13095087 - RAB28 0.181150315 4.526748741 0.216936806 1 -0.823844733 4.074245014 8.50E-07 0.000246107
chrX 151746526 151749957 - CETN2 -0.062714149 5.025510307 0.81958119 1 -0.809344763 4.69704168 6.50E-07 0.000195738
chr16 88542639 88561969 + DEF8 0.010574611 6.361494058 0.925900097 1 -0.805061229 5.549160997 3.83E-07 0.000125323
chr10 69773280 69837057 - RUFY2 0.085606948 5.464483745 0.532665825 1 -0.803779781 4.944250343 5.45E-07 0.000171051
chr7 26298039 26380474 + SNX10 -0.012967191 4.354362744 0.731597728 1 -0.797499461 3.961247722 5.55E-05 0.008038554
chr5 1062167 1091925 + NKD2 0.106285206 3.629962866 0.587753447 1 -0.794691215 3.30106433 0.000121448 0.015503137
chr5 137829079 137832903 + EGR1 0.623573154 7.178224997 7.25E-06 0.005216845 -0.769177542 2.635577886 6.52E-05 0.009180417
chr4 17097113 17122955 - QDPR 0.070836721 4.697354029 0.646494237 1 -0.764651725 4.507843327 3.40E-06 0.000799354
chr3 173831128 173911702 - NCEH1 -0.245142335 4.028861196 0.255908649 1 -0.762222556 3.574508592 0.000148773 0.018520341
chr1 150271605 150276135 - S100A11 -0.164888224 4.75459977 0.39135624 1 -0.760221271 4.901961884 2.72E-06 0.000660551
chr16 65868913 65880904 + PLEKHG4 0.248763011 5.309491918 0.062463674 1 -0.757929664 4.139847361 5.68E-06 0.001157096
chr6 127801243 127882193 - C6orf174 -0.063797574 6.181349741 0.688556521 1 -0.749958969 5.616275496 2.02E-06 0.000532733
FC CPM p-val FDR FC CPM p-val FDR




chr9 130504622 130523020 + PKN3 -0.050145543 6.104787723 0.78594556 1 -0.744689036 5.631911081 2.69E-06 0.000660551
chr6 127801243 127822228 - KIAA0408 -0.045990323 5.414041402 0.69316684 1 -0.73929192 4.9320291 4.11E-06 0.00091094
chr15 41597097 41611110 + MAP1A -0.414412036 4.773985267 0.033382953 0.922655828 -0.731680604 5.545881269 3.48E-06 0.000805979
chr10 115428924 115480654 + CASP7 -0.251623972 4.371058179 0.15445097 1 -0.726067334 4.35788515 1.01E-05 0.001860686
chr3 16273571 16281500 - DPH3 -0.099268373 5.909386544 0.655303463 1 -0.724737218 5.508463663 4.71E-06 0.001027375
chrX 128501932 128554211 + OCRL 0.018153527 5.898316979 0.854443216 1 -0.72152472 6.217581592 3.74E-06 0.00085448
chr17 24424653 24531533 - MYO18A 0.069604245 5.248247823 0.559145927 1 -0.71691285 4.931792546 8.63E-06 0.001631656
chr16 19777793 19803652 - GPRC5B -0.326034933 3.826073177 0.103903133 1 -0.712786833 3.795946559 0.000365975 0.036751225
chr7 47281276 47588267 - TNS3 -0.142722062 3.223244983 0.574054579 1 -0.708623298 3.464902687 0.000483508 0.045798684
chr6 26646550 26655143 + HMGN4 0.131473179 5.595611497 0.259570653 1 -0.705375218 5.451325597 8.67E-06 0.001631656
chr11 117212900 117253411 - FXYD6 -0.261395254 4.190136959 0.265171854 1 -0.697457581 3.847359942 0.00051292 0.047929523
chr3 47819402 47866690 + DHX30 0.149240647 7.981281775 0.528415504 1 -0.693024955 7.764988378 7.58E-06 0.001482345
chr19 11170968 11234168 - DOCK6 0.182845683 5.177773801 0.242309016 1 -0.689407874 4.592228507 2.07E-05 0.003482653
chr19 54160377 54161948 + FTL -0.268331279 8.560057468 0.123367601 1 -0.683759845 8.175721272 9.69E-06 0.001802449
chr2 121271336 121466699 + GLI2 0.056780575 4.685124862 0.558434637 1 -0.679605688 4.637123913 3.09E-05 0.004893743
chr12 51577237 51629917 - KRT8 -0.040923052 3.500015693 0.905681424 1 -0.678351493 4.707159529 0.000443595 0.043108874
chr1 149298774 149307597 + MLLT11 -0.329158908 4.759894898 0.062359053 1 -0.67467216 4.463364608 3.80E-05 0.005841918
chr15 38973919 38983465 + VPS18 -0.263498895 5.011571031 0.101192209 1 -0.668680271 4.609134071 3.94E-05 0.005999338
chr9 103277428 103289296 - C9orf125 0.013927128 4.507866974 0.754991629 1 -0.668155657 4.535141187 4.84E-05 0.0071622
chr14 64523259 64599123 + FNTB -0.181547066 4.663800152 0.185960919 1 -0.662597897 4.314203818 6.40E-05 0.00909512
chr21 37045058 37284415 - HLCS 0.169569654 5.286538739 0.275566206 1 -0.654792451 5.286179749 4.06E-05 0.006109363
chr1 152564659 152590404 + ATP8B2 -0.038064937 6.785081278 0.983161448 1 -0.623381054 6.847038194 6.06E-05 0.008688732
chr15 61268780 61347026 + RAB8B -0.121496759 4.939662237 0.559328432 1 -0.620010877 4.226287745 0.000175739 0.021009163
chr1 40278841 40310908 + CAP1 -0.203911175 7.826450298 0.179839122 1 -0.613025455 7.29464485 7.45E-05 0.010395458
chr1 167603817 167632404 + BLZF1 -0.140111404 5.007835446 0.399790981 1 -0.61287194 4.359459667 0.000175047 0.021009163
chr2 74216035 74228547 - BOLA3 0.027445642 5.891300044 0.98640676 1 -0.607408867 5.345072197 0.000153288 0.018926041
chr3 49032911 49035930 + NDUFAF3 -0.106066931 6.152654659 0.460567832 1 -0.602518115 6.614675645 0.000113683 0.014762147
chr22 37590193 37598204 - CBX6 0.149506273 7.678307356 0.485150977 1 -0.600886751 7.051827726 0.000110084 0.014502337
chr11 44073674 44223556 + EXT2 -0.182271369 5.998134574 0.285211538 1 -0.599991528 5.709041255 0.000148354 0.018520341
chr7 148759386 148788986 - ZNF777 0.297961145 5.563103396 0.107119837 1 -0.598688223 4.896989269 0.000202185 0.023010172
chr1 170017383 170033479 + METTL13 0.131212672 5.575550804 0.472744273 1 -0.592348784 5.47886018 0.000194404 0.022700056
chr1 199755654 199756343 + RPS10P7 -0.136863287 4.749446947 0.529930401 1 -0.589034604 4.542592278 0.000304512 0.031853233
chr20 32896183 32924322 - GGT7 -0.221444106 5.489040162 0.204606667 1 -0.585046962 4.803846689 0.00029501 0.031293872
chr14 59020913 59041834 + JKAMP -0.04686861 5.568725806 0.868682986 1 -0.582543127 5.061122844 0.000265982 0.028823649
chr5 61744329 61960172 + IPO11 0.052014029 6.635933029 0.676655688 1 -0.581247299 6.299007702 0.000190595 0.022605738
chr5 133765654 133775497 - CDKN2AIPNL 0.050623445 5.551046787 0.829911247 1 -0.578981051 5.297820246 0.000278774 0.029781331
chr19 6445329 6453330 - TUBB4A -0.209114217 5.162882945 0.198649909 1 -0.578410548 5.221897683 0.000302894 0.031853233
chr5 76047623 76067351 + F2R 0.067895148 4.512794413 0.425663441 1 -0.577662925 5.008410346 0.000311933 0.032404421
chr6 133132199 133161440 - C6orf192 0.067163856 5.051658819 0.53739283 1 -0.563594393 5.222083502 0.000414305 0.040523839
chr18 42007985 42100953 + C18orf25 0.012040549 6.150258783 0.986750513 1 -0.551402828 5.465046779 0.000486476 0.045798684
chr1 160733587 160766043 + UHMK1 0.042917194 7.779650008 0.752065846 1 -0.544396575 7.420805847 0.000409159 0.040282105
chr20 18516555 18692560 + DTD1 -0.087277202 5.03747259 0.603345681 1 0.551489312 5.55614381 0.000465384 0.044367579
chr14 67125775 67136770 - PIGH -0.008477136 5.198221455 0.927156569 1 0.558964053 5.07013721 0.000458689 0.044007866
chr6 21701950 21706828 + SOX4 -0.035772443 6.6543047 0.624384941 1 0.582829753 7.489964656 0.000167502 0.020347484
chr6 139735089 139737478 - CITED2 -0.140856125 4.996716338 0.400843343 1 0.590765324 5.245035182 0.000217964 0.024141147
chr12 122311492 122322640 - CDK2AP1 0.048942456 6.901220668 0.826706852 1 0.595064922 7.1990635 0.000121024 0.015503137
chr6 121798443 121812572 + GJA1 -0.073876341 5.230736287 0.999014478 1 0.620716419 6.015474938 7.92E-05 0.0109455
chr12 64816983 64850074 - TMBIM4 0.051793189 4.847661229 0.633362774 1 0.662089274 5.13400203 3.54E-05 0.005496704
chr4 55907144 55934023 + SRD5A3 0.152221627 5.059577753 0.255691014 1 0.667355181 5.692712442 2.38E-05 0.003891701
chr12 43188324 43593978 - NELL2 -0.047611549 4.706471495 0.925965029 1 0.674605387 4.949613237 2.80E-05 0.004534574
chr16 53510278 53520580 - CRNDE 0.270169019 4.413640914 0.077445282 1 0.675480734 4.767376093 2.84E-05 0.004556489
chr16 65195435 65205296 + CMTM3 -0.078579979 4.396795818 0.69874618 1 0.682390542 5.053811757 1.98E-05 0.003393812
chr1 52380633 52584946 + ZFYVE9 0.101968888 5.156004581 0.35388244 1 0.69913071 5.59500728 1.04E-05 0.001888798
chr8 144878090 144887902 - FAM83H 0.17192707 4.387782648 0.313603017 1 0.700428961 4.16270336 0.000371558 0.03706471
chr14 35077308 35348183 - RALGAPA1 -0.013372653 6.377334451 0.967388355 1 0.700905212 7.080850863 6.35E-06 0.001274489
chr6 126319553 126343082 + HINT3 0.121662408 5.941462815 0.349463433 1 0.701232894 6.024689673 8.15E-06 0.001573073
chr10 73703682 73705803 + DDIT4 0.146999442 5.418488527 0.160458614 1 0.702633559 5.702617867 0.000193019 0.022700056
chr3 195336624 195339095 + HES1 -0.195725839 4.49662823 0.205992814 1 0.716077175 4.545480332 1.20E-05 0.002145415
chr5 121426788 121441954 - LOX -0.099263625 4.64577154 0.686132282 1 0.723749475 5.616187488 5.05E-06 0.001072186
chr5 130627600 130758281 + CDC42SE2 0.053231563 5.385869669 0.687409398 1 0.725324026 5.256225328 5.65E-06 0.001157096
chr1 210805298 210860742 + ATF3 0.717191547 6.685314539 0.001271559 0.18289697 0.72748061 4.232722277 0.000215515 0.024046714
chr2 190319630 190336169 - OSGEPL1 0.143515276 3.474197973 0.356289238 1 0.729906524 4.113717186 0.000206492 0.023211817
chr17 71892284 71895536 + SPHK1 0.185693805 3.846901191 0.296949341 1 0.733505427 3.662703876 0.000222856 0.024502791
chr3 198146669 198153861 - NCBP2 0.149463722 5.808439727 0.372105964 1 0.737562698 6.297139049 2.54E-06 0.000648191
chr14 49161641 49171698 - DNAAF2 0.271940938 4.476029584 0.063718267 1 0.744248597 5.00255538 3.86E-06 0.000867737
chr19 47509316 47521054 + TMEM145 0.261758204 3.422392336 0.226719949 1 0.75259587 3.274754546 0.000246287 0.026882785
chr2 217245072 217268517 - IGFBP5 -0.099413094 3.766774211 0.817277777 1 0.816979613 5.559132955 2.67E-07 8.92E-05
chr16 391858 402488 + DECR2 0.221888791 3.186913264 0.225199437 1 0.855142751 3.555603288 2.31E-05 0.00381994
chr11 75157425 75190229 + DGAT2 -0.102752135 2.564964104 0.754238298 1 0.874941775 2.611773383 0.000269717 0.029019654
chr11 106049947 106394381 - GUCY1A2 0.65494924 -0.24515094 0.018396439 0.735715694 0.882716151 4.293321974 7.27E-06 0.001441471
chr8 19215360 19298009 + SH2D4A 0.130539753 2.188196686 0.501914762 1 0.898244757 3.004849989 0.000142862 0.018083448
chr1 144149818 144153985 + TXNIP -0.615854233 5.317906683 0.000121555 0.04067075 0.953629933 5.490576351 2.01E-09 1.08E-06
chr4 970784 988317 + IDUA 0.004587952 1.952145038 0.939385261 1 0.954863284 2.565381927 8.67E-05 0.011767874
chr5 76408287 76418786 - ZBED3 0.328578444 3.22962119 0.116112157 1 0.96846413 3.55262833 1.96E-06 0.00052728
chr22 40816882 40851298 + LOC100132273 -0.164131608 2.436510347 0.451226759 1 1.021200782 3.010992793 1.50E-05 0.002593385
chr16 2829574 2832753 - PRSS30P 0.158293396 1.781977314 0.560757252 1 1.040641275 2.833219499 1.40E-05 0.002445271
chr12 81276406 81397147 + C12orf26 0.323932677 2.814695557 0.10943509 1 1.055127028 3.649622185 2.14E-07 7.48E-05
chr18 53448531 53487506 + LOC100505549 0.141507683 1.980934367 0.623541358 1 1.116770385 2.770852913 3.37E-06 0.000799354
chr3 137538688 137953935 - STAG1 0.592628644 6.42773176 0.000124202 0.04067075 1.160542278 6.749867354 1.33E-13 2.87E-10
95
chr17 6858779 6861567 + C17orf49 0.126880876 4.463302612 0.489014468 1 1.318307948 4.934123173 5.81E-16 1.75E-12
chr19 45045802 45132373 - FCGBP -0.270644414 2.040338183 0.285024971 1 1.461022958 2.695268206 2.68E-09 1.34E-06
chr12 119123476 119135014 + LOC100506649 -0.028581398 1.936031421 0.991248638 1 1.494337232 2.876909718 7.12E-10 4.66E-07
chr11 111249989 111255391 - FDXACB1 0.330430642 3.066709528 0.102570831 1 1.51015353 4.316248054 4.14E-14 1.04E-10
chr15 39032927 39036009 + CHAC1 0.37398851 2.99227481 0.047083288 1 1.585617077 2.471695255 5.24E-08 2.13E-05
chr7 141050606 141084499 - FLJ40852 -0.062937753 0.691413102 0.902507157 1 1.685541742 0.971100482 9.75E-07 0.00027719
chr4 146759989 146800637 + MMAA 0.120184832 1.19175043 0.629015322 1 1.791246419 2.525937822 8.44E-11 6.69E-08
chr16 29782504 29786875 + LOC440356 0.37567817 -0.177403112 0.265962513 1 2.113020711 0.970916243 2.67E-09 1.34E-06
chr6 132000134 132110243 + ENPP3 0.298202083 0.296262085 0.208687767 1 3.860050305 2.324064363 1.03E-28 5.17E-25
chrX 151833641 151892681 + ZNF185 0.338869437 1.405751976 0.121427222 1 4.023726175 5.031710915 1.29E-72 1.94E-68
96
chr. start end strand Gene Name
chr7 142053693 142055088 + MTRNR2L6 -3.001885189 3.596146636 3.17E-11 3.63E-07 -0.260664767 -0.240044182 0.629315402 1
chr17 44927653 44947381 + NGFR -1.332460534 1.374728621 7.90E-06 0.005264291 0.50693152 0.192570949 0.18376594 1
chr10 90684810 90741127 - ACTA2 -1.105976433 3.095741633 1.37E-05 0.008599514 -0.222359022 1.858920898 0.438756766 1
chr17 37132416 37144424 - HAP1 -1.066912668 3.592623019 4.55E-08 9.79E-05 -0.161700289 2.625497341 0.461794637 1
chr6 36752214 36763095 + CDKN1A -1.057734202 6.267310189 4.82E-11 3.63E-07 -0.223180959 4.816216738 0.168299898 1
chr19 18357967 18360986 + GDF15 -1.054100385 1.60491729 0.000952804 0.157715221 -0.449648611 -0.707031304 0.357929089 1
chr13 102179717 102209423 - CCDC168 -1.053282934 2.162082792 2.72E-05 0.013229621 -0.209998463 0.475209698 0.549919805 1
chr11 64968504 64968604 + MIR612 -1.007751009 0.482153697 0.001106845 0.171095159 0.258615979 0.300421964 0.493977567 1
chr17 44022821 44038773 + HOXB-AS3 -1.005391316 4.756720225 1.91E-08 6.78E-05 0.042223115 3.946689375 0.830960127 1
chr6 11291516 11490567 - NEDD9 -0.978087774 0.829756181 0.001066992 0.16917999 -0.30400911 0.564428127 0.401067497 1
chr8 96007375 96030791 - TP53INP1 -0.953642714 4.772480412 3.71E-06 0.002941424 -0.667379855 3.660971884 0.00079237 0.068202657
chr7 27191551 27195437 + HOXA-AS5 -0.939639625 4.244340846 6.60E-07 0.000903949 -0.119891338 3.975213846 0.545692795 1
chr19 6482009 6486939 + TNFSF9 -0.933731443 3.200416601 1.96E-05 0.010529801 -0.078380556 2.891999944 0.741192048 1
chr1 148088382 148088964 - HIST2H2BC -0.930196359 3.492540973 1.67E-05 0.009698014 0.004143119 2.324376129 1 1
chr19 45620248 45623772 - SERTAD1 -0.929249497 3.920717993 3.71E-07 0.000579414 0.155732397 2.115802626 0.507112545 1
chr6 26342418 26343195 - HIST1H1D -0.927140345 0.916444653 0.001311351 0.18289697 0.376958919 2.14114365 0.224068144 1
chr19 4473543 4486208 - PLIN5 -0.926208741 0.99437813 0.001416334 0.189560422 0.027952879 -0.183465739 0.941607475 1
chr9 106583104 106730348 - ABCA1 -0.876016156 3.52464251 0.0005514 0.118300818 0.583360251 3.307197502 0.011313355 0.426032668
chr10 76831291 76838746 + ZNF503-AS2 -0.866424503 5.188134577 8.12E-07 0.000940965 0.109578851 4.681740106 0.574711018 1
chr8 95961628 95976658 - CCNE2 -0.851407024 5.626129819 3.21E-08 8.06E-05 -0.048945243 5.214461233 0.755163054 1
chr9 19398924 19442500 + ACER2 -0.84921886 3.28412685 0.000179877 0.053127155 0.057131788 2.573644382 0.819866354 1
chr8 23049048 23077485 - TNFRSF10D -0.822805488 4.338144698 3.51E-05 0.015566412 -0.341632678 3.75881083 0.08547648 1
chr17 30594198 30618874 + SLFN5 -0.817744305 2.738685214 0.000467227 0.106633837 -0.417200858 2.421517094 0.086066571 1
chr22 36531059 36533389 + H1F0 -0.800324133 8.077945126 1.55E-06 0.001554275 0.159659919 7.689811987 0.297182829 1
chr6 27968455 27968942 - HIST1H2AM -0.771660988 3.412599467 0.000100577 0.035232192 0.138836619 3.234626437 0.587823783 1
chr5 57785566 57791723 - PLK2 -0.769056206 3.769568071 0.000972475 0.159221711 -0.098506337 2.472782805 0.695631419 1
chr1 191044791 191048030 + RGS2 -0.762081879 3.844464673 5.35E-05 0.021789455 0.379712207 3.020658809 0.071932119 0.985012275
chr6 26231673 26232111 - HIST1H2BC -0.756517247 3.557840475 0.000790516 0.136868249 0.216994658 3.382161045 0.434452952 1
chr3 168936125 169026051 + SERPINI1 -0.752725743 3.947070414 0.000329119 0.082625371 0.026854303 2.998816236 0.928246406 1
chr7 27146507 27162072 + HOXA-AS3 -0.751555564 5.448153081 1.85E-07 0.000347451 0.070078895 4.956775892 0.66782584 1
chr1 148122633 148124856 - HIST2H2BE -0.728039139 5.26217119 0.000112056 0.038361325 0.325029909 4.892244097 0.16483912 1
chr16 88515917 88530006 + TUBB3 -0.721007063 4.339014951 0.000133044 0.042639142 0.003316151 3.627694282 1 1
chr12 52680143 52683387 + HOXC9 -0.70981464 5.430457659 8.06E-07 0.000940965 0.136377683 5.130894665 0.385238708 1
chr7 64088167 64104559 - ERV3-1 -0.704771337 3.646883724 0.000423597 0.09969744 -0.184264113 3.431764946 0.359854662 1
chr9 98831779 98841746 - CTSL2 -0.700219138 4.669374314 0.000632118 0.126102227 0.169433535 4.153275707 0.387611146 1
chr17 70370213 70380751 - FDXR -0.700126301 4.238070595 0.000557615 0.118300818 -0.345780429 3.35993722 0.097824619 1
chr13 65774966 66702469 - PCDH9 -0.696276647 5.3036176 5.09E-05 0.021789455 0.24375815 5.405859014 0.128919633 1
chr17 44023617 44026102 - HOXB5 -0.678066117 5.10411087 2.63E-06 0.002358182 0.300926316 4.764859655 0.063056047 0.961349424
chrX 53128266 53134453 + TSPYL2 -0.669300692 5.535778165 1.49E-05 0.0089777 0.13423463 5.898150297 0.390823806 1
chr6 94006458 94186021 - EPHA7 -0.652555553 4.928555035 0.000157854 0.047555016 -0.210801747 5.219287865 0.177437382 1
chr16 30011135 30015038 - YPEL3 -0.646197016 3.807047026 0.001294092 0.18289697 -0.243468091 2.946030854 0.250174583 1
chr6 41148684 41178124 + NFYA -0.623657463 6.120510265 6.80E-05 0.026952827 -0.0571224 6.22124452 0.704533703 1
chr12 6441664 6450104 - VAMP1 -0.621902088 3.675515031 0.000735753 0.133525928 0.111557116 3.959192273 0.579717313 1
chr6 43651855 43696238 + POLH -0.617921211 6.266450682 9.12E-05 0.033509095 -0.098701118 5.626965954 0.524597131 1
chr1 144149818 144153985 + TXNIP -0.615854233 5.317906683 0.000121555 0.04067075 0.953629933 5.490576351 2.01E-09 1.08E-06
chr11 65021808 65030515 + MALAT1 -0.610835914 9.999367932 0.000143965 0.044974258 0.154358336 9.887225409 0.339596544 1
chr4 78297380 78310237 + CCNG2 -0.606402376 4.480197338 0.000284277 0.073828773 0.194039752 4.815114655 0.235443823 1
chr4 6627802 6675089 + MAN2B2 -0.604794546 4.233238672 0.001341913 0.185442474 -0.179787525 3.907368016 0.376368336 1
chr3 180217706 180272350 - ZMAT3 -0.600908384 5.535934954 0.000239171 0.066715519 -0.218803881 5.453358917 0.165120436 1
chr4 30331127 30757521 + PCDH7 -0.599322969 5.037224437 0.000691478 0.131156512 0.08618576 5.324976876 0.593999774 1
chr17 44007867 44010742 - HOXB4 -0.594515854 4.818449417 0.000275245 0.07339844 -0.002657855 4.153162418 0.989436697 1
chr10 63331018 63526713 + ARID5B -0.58896163 6.049687687 0.000146301 0.044974258 0.092820129 5.315387819 0.565461753 1
chr17 40580466 40585251 + HEXIM1 -0.587442969 7.204683941 5.35E-05 0.021789455 0.115721479 6.369671754 0.463157231 1
chr17 3512935 3518722 - TAX1BP3 -0.584012474 5.029029003 7.69E-05 0.029076327 -0.146654285 4.761383642 0.377025665 1
chr12 67488237 67525479 + MDM2 -0.57485266 8.615474247 0.000419666 0.09969744 -0.003775538 7.962493061 0.971245761 1
chr12 7174233 7202797 + CLSTN3 -0.5738985 4.816141079 0.000755141 0.134825171 -0.244113188 4.905445138 0.129471449 1
chr9 73488101 73573620 - TMEM2 -0.567509143 5.097182815 0.000656595 0.12844541 -0.073562437 5.429299751 0.639127156 1
chr20 34953640 35013660 - SAMHD1 -0.565337929 5.868479236 0.000411097 0.09969744 -0.123901045 6.032346859 0.417399738 1
chr11 64635916 64640283 + TM7SF2 -0.562614058 5.122134783 0.000705283 0.131156512 -0.23619539 4.569705399 0.143643734 1
chr7 64072264 64088849 - ZNF117 -0.557314826 4.835671666 0.000697153 0.131156512 -0.090398376 4.553054227 0.570354634 1
chr14 22664343 22722689 - SLC7A8 -0.554288335 4.427814275 0.000918181 0.153672883 0.164323599 4.469832459 0.313945121 1
chr17 34279637 34331549 + LASP1 -0.539820267 5.220619164 0.001411535 0.189560422 -0.00580424 4.941934522 0.989920704 1
chr7 27159862 27162821 - HOXA7 -0.535880797 4.34754186 0.001422049 0.189560422 -0.014521075 4.138872777 0.960450973 1
chr21 45318920 45470906 + ADARB1 -0.534961678 5.174295442 0.000444616 0.103034714 -0.162251044 5.558483522 0.302868196 1
chr8 22933592 22982645 - TNFRSF10B -0.524315062 6.420891016 0.000998824 0.160545397 0.098737617 6.169029038 0.53597467 1
chr20 32755808 32764898 + TP53INP2 -0.515654426 4.838656089 0.000778174 0.13629816 -0.284662605 4.367534783 0.084818484 1
chr15 61232591 61236794 - RPS27L -0.513862768 5.488526829 0.001309032 0.18289697 0.032052703 4.981028732 0.87434548 1
chr1 78243223 78255583 + DNAJB4 -0.512665727 5.054246595 0.001385369 0.189560422 -0.149214144 4.126238978 0.370610189 1
chr7 27176734 27186405 - HOXA10 -0.498943851 7.22680972 0.000690644 0.131156512 0.325538297 6.7275917 0.034679073 0.783753711
chr7 27187300 27191360 - HOXA11 -0.476878097 5.509762322 0.000909087 0.153672883 0.063054014 5.263723218 0.701998159 1
chr5 138637339 138646772 + SNHG4 0.48845291 3.840019291 0.00123211 0.181953727 -0.042044967 4.699780105 0.796580421 1
chr8 124579307 124622674 - FBXO32 0.508449601 6.002761749 0.001113146 0.171095159 0.098691705 5.280608856 0.52855877 1
chr17 17045033 17050371 - PLD6 0.526901281 4.517062554 0.001303065 0.18289697 0.030844383 4.823887058 0.834079896 1
chr6 31815703 31838434 + MSH5 0.528453899 4.119106129 0.000636246 0.126102227 -0.019110516 4.522567333 0.912324178 1
chr6 31815703 31840603 + MSH5-SAPCD1 0.537313857 4.307322224 0.00051717 0.114560753 -0.035453935 4.809662364 0.831413339 1
chr5 172127697 172130809 - DUSP1 0.538453092 6.013870861 0.001180952 0.179683655 0.07512377 4.345476789 0.656135368 1
FC CPM p-val FDR FC CPM p-val FDR




chr1 96959762 97053193 + PTBP2 0.540711924 6.073547118 0.000760814 0.134825171 0.221118111 6.024816145 0.160611699 1
chr7 148590194 148613018 + ZNF783 0.556365923 5.333199372 0.000629247 0.126102227 0.012374602 5.396288559 0.924133146 1
chr13 109204184 109236915 - IRS2 0.560224613 5.056153134 0.000277748 0.07339844 0.055441272 4.75967174 0.714592094 1
chr5 172674331 172689112 - STC2 0.566974935 6.913223998 3.49E-05 0.015566412 0.264153378 6.563617654 0.087735981 1
chr6 31910671 31915520 + C6orf48 0.57095497 5.861490194 0.000581374 0.121628314 0.393971611 5.314542136 0.01307859 0.463535999
chr16 4247187 4263002 - TFAP4 0.573792799 4.717927843 0.000226483 0.064368141 0.25928592 5.138233993 0.10326271 1
chr17 3710365 3743086 - CAMKK1 0.58037408 4.798503337 9.97E-05 0.035232192 -0.217165798 5.038283113 0.180580406 1
chr11 5210634 5212434 - HBD 0.587599692 7.294474252 0.000635853 0.126102227 -2.356581317 -6.858657874 1 1
chr3 137538688 137953935 - STAG1 0.592628644 6.42773176 0.000124202 0.04067075 1.160542278 6.749867354 1.33E-13 2.87E-10
chr14 20738077 20744899 - LOC283624 0.607579811 6.917018994 0.000400639 0.098931456 -0.072061431 6.658168752 0.636769289 1
chr5 137829079 137832903 + EGR1 0.623573154 7.178224997 7.25E-06 0.005216845 -0.769177542 2.635577886 6.52E-05 0.009180417
chr10 103882776 103900080 + PPRC1 0.633940095 7.363800575 0.000269151 0.07339844 0.023365222 7.11360633 0.874963947 1
chr5 1306286 1348162 - TERT 0.644131951 2.702413962 0.001521087 0.199236002 0.287989649 3.769062159 0.144844198 1
chr8 134536272 134653365 - ST3GAL1 0.665784759 4.16233909 3.29E-05 0.015497782 -0.133845916 4.422849107 0.417695867 1
chr22 49354155 49363962 - CPT1B 0.678157427 3.794755046 0.000303155 0.077396944 0.300172269 3.742108609 0.132772917 1
chr1 210805298 210860742 + ATF3 0.717191547 6.685314539 0.001271559 0.18289697 0.72748061 4.232722277 0.000215515 0.024046714
chrX 107862382 107866263 - IRS4 0.726757038 9.525407099 1.30E-06 0.001396489 0.039983274 9.70013011 0.800981158 1
chr8 126511744 126519826 + TRIB1 0.731163548 5.124976165 1.77E-05 0.009895423 0.112639189 5.209839811 0.470004025 1
chr20 36482652 36497432 - LOC388796 0.734979802 6.117374784 2.05E-05 0.010651409 0.159391522 5.242480908 0.309527315 1
chr19 54883753 54886059 + C19orf76 0.748252522 2.091867921 0.00121 0.181953727 0.062127374 2.477033759 0.82336646 1
chr8 143689411 143692835 - ARC 0.77543248 3.653537603 0.000916325 0.153672883 -0.261552352 1.34107119 0.344012888 1
chr8 128817496 128822862 + MYC 0.868857148 6.888740089 2.25E-08 6.78E-05 -0.089924204 7.127191259 0.565343548 1
chr9 103162519 103187108 - BAAT 0.878094618 1.923570513 0.001001877 0.160545397 0.317121388 0.308152641 0.372596866 1
chr22 17385346 17387761 + DGCR9 0.896566077 0.947758911 0.001227755 0.181953727 0.084493257 0.230420688 0.859113873 1
chr12 55708567 55730816 - MYO1A 0.918855821 1.093090385 0.001301038 0.18289697 0.607345853 -0.61243799 0.174062402 1
chr1 67545634 67635171 + IL12RB2 0.932724361 2.508061497 0.000475505 0.10690335 -0.173482045 1.337553823 0.541586572 1
chrX 154880439 154893676 + IL9R 0.955426399 1.530204359 0.000187434 0.054294477 0.156800617 0.623084223 0.687190459 1
chr12 48784067 48791362 + GPD1 0.962102991 0.880647776 0.001460901 0.193031208 -0.228082403 -0.534627466 0.663314739 1
chr1 111818126 111822657 + C1orf162 0.969985911 1.553366224 0.001092581 0.171095159 0.403559102 -0.388283202 0.369548098 1
chr11 124010894 124051409 - SIAE 1.014433973 6.919696157 3.05E-06 0.002551014 0.162075929 5.982727425 0.560600802 1
chr17 15432701 15463743 - CDRT1 1.058407239 0.664787324 0.000735173 0.133525928 -0.377954265 0.028995773 0.358821901 1
chr8 67568044 67593313 + C8orf46 1.219609841 0.796674988 7.72E-05 0.029076327 0.84639459 -1.614571388 0.147179916 1
chr19 18228905 18246319 - KIAA1683 1.243388536 1.989556024 2.66E-06 0.002358182 -0.381367368 -0.999944872 0.435832629 1
chr7 141342147 141453016 + MGAM 1.302158211 1.092436362 2.30E-05 0.011556936 -0.15048453 -1.43575098 0.793222467 1
chr14 19881069 19881410 - RPPH1 1.370968788 5.799066017 2.23E-08 6.78E-05 -0.127201192 4.822174662 0.569473772 1
chr7 102899466 103417199 - RELN 1.375288522 -1.594085678 0.000543635 0.118300818 0.375665911 2.235245499 0.170443843 1
chr9 138227916 138236776 - LHX3 1.389571111 1.139565454 8.04E-06 0.005264291 -0.147057004 -0.334166382 0.812908108 1
chr1 109057078 109086890 + FNDC7 1.430697071 1.487779142 3.85E-07 0.000579414 -0.084310221 -1.158715598 0.907554233 1




chr. start end strand Gene Name FC CPM p-val FDR
chr20 44235782 44313741 - CDH22 0.287052228 2.139319467 0.25870855 1 -2.104646401 -0.040501259 1.45E-07 5.32E-05
chr17 43239731 43254146 - OSBPL7 0.019973674 2.620075753 0.851724191 1 -1.916062813 0.965818529 8.26E-09 4.01E-06
chr2 70742723 70848883 - ADD2 0.10696415 5.717907945 0.539120212 1 -1.867310472 5.283533892 3.72E-30 2.81E-26
chr11 36546138 36557886 + RAG1 -0.271278741 0.51495031 0.386203247 1 -1.712938404 -0.803554828 0.00054653 0.050197486
chr11 63864265 63881582 + CCDC88B -0.115969195 1.573594497 0.944206359 1 -1.711427495 0.862346784 7.78E-07 0.000229766
chr1 16256850 16272714 - FAM131C 0.438309366 2.067954813 0.066870812 1 -1.661430088 1.562561838 3.25E-08 1.40E-05
chr19 51059357 51068895 + FOXA3 0.010408809 0.290351106 0.843946989 1 -1.633309178 -0.54407043 0.000329562 0.033769972
chr16 18902756 18982763 + TMC7 0.015303495 3.588202402 0.934655531 1 -1.556498489 2.782003459 1.56E-12 1.56E-09
chr2 29057667 29128600 + FAM179A 0.548611012 0.759603845 0.057779221 1 -1.545373503 -0.476365303 0.000362358 0.036632217
chr19 45664965 45774205 + SPTBN4 0.097851786 2.430478667 0.593834884 1 -1.485107849 1.266450549 1.19E-06 0.000325765
chr12 56305817 56313252 - B4GALNT1 -0.092936186 3.895398765 0.866674831 1 -1.458843301 3.458807614 2.44E-12 2.30E-09
chr12 54361596 54364661 + METTL7B -0.392425761 2.599378846 0.225696823 1 -1.420280169 2.259017043 2.52E-07 8.64E-05
chr12 56406289 56408406 + LOC100130776 0.073189581 3.02736681 0.742070506 1 -1.385444511 2.376124893 3.48E-08 1.46E-05
chrX 76968517 77037721 - MAGT1 -0.16086069 6.984624242 0.334732982 1 -1.361929317 7.226839394 3.89E-18 1.47E-14
chr22 18835993 18841786 - RIMBP3 0.013446728 2.508685216 0.656708468 1 -1.349317634 1.77857075 2.41E-06 0.000625215
chr1 27591738 27594904 + GPR3 0.546440381 1.825786873 0.043537373 1 -1.342543649 0.236843125 0.00020317 0.023010172
chr11 1972981 1975641 - H19 -0.64539011 1.779503802 0.031753703 0.900764654 -1.335869398 -0.275212609 0.001280392 0.097406825
chr11 120036237 120362179 + GRIK4 0.101574995 0.284767511 0.752895378 1 -1.314253197 -0.297967902 0.001562879 0.114072882
chr4 15080586 15212278 + CC2D2A -0.1007299 3.376078661 0.559661652 1 -1.298050902 3.343647967 4.64E-10 3.18E-07
chr22 34107059 34120207 + HMOX1 -0.456991024 4.268754105 0.030993495 0.894213246 -1.292483511 3.841521043 1.66E-10 1.19E-07
chr17 7939942 7962959 - ALOXE3 0.314552807 0.819358695 0.24725781 1 -1.28313453 0.299433303 0.000597835 0.053923245
chr15 71996861 72007642 - LOC100287616 0.320017855 2.145175987 0.133387357 1 -1.249295464 2.320733319 4.95E-06 0.001064447
chr19 54669277 54681300 + FLT3LG 0.406162719 0.479026791 0.189529971 1 -1.235551979 0.301659176 0.000933018 0.077220069
chr11 118544649 118559936 + NLRX1 -0.042872259 4.627369647 0.80075582 1 -1.232813517 3.993944453 5.74E-13 9.60E-10
chr11 298106 299410 + IFITM2 -0.104907496 2.742277429 0.707574723 1 -1.205662748 2.457818021 1.12E-06 0.000312481
chr12 55678883 55686564 - ZBTB39 -0.024469128 5.516374041 0.79653164 1 -1.20474427 4.853465067 1.69E-13 3.17E-10
chr12 56404342 56422211 - AGAP2 -0.113638894 3.788678709 0.902685942 1 -1.181078406 3.272281681 4.17E-07 0.00013359
chr7 37926687 37958067 + EPDR1 -0.001154875 3.857316371 0.873572466 1 -1.152130503 3.377704801 2.41E-08 1.07E-05
chr8 72917911 73131101 + LOC100132891 -0.253696154 0.586872728 0.458448931 1 -1.150167678 0.455080526 0.001275519 0.097406825
chr10 123706592 123724733 - NSMCE4A 0.158712677 5.946472665 0.350812881 1 -1.14295931 5.282412063 1.05E-12 1.42E-09
chr19 11392271 11406980 - CCDC151 0.021069757 1.285355455 0.915521235 1 -1.13286405 0.897933739 0.000315339 0.032533895
chr12 47975175 47978748 + PRPH -0.137180479 0.515779324 0.681830478 1 -1.129164293 1.012426276 0.000601912 0.053967823
chr1 152168600 152185778 - DENND4B 0.194384223 6.515528444 0.251920232 1 -1.126007147 5.930148611 1.18E-12 1.42E-09
chr20 61589809 61600949 - EEF1A2 -0.019051731 7.083428838 0.963167024 1 -1.12507215 5.986368939 1.32E-12 1.42E-09
chr11 125638023 125644087 - SRPR -0.092455657 7.027447611 0.480514641 1 -1.118771497 6.285435775 1.23E-12 1.42E-09
chr6 24652310 24754362 - KIAA0319 0.20125513 0.641123962 0.397614298 1 -1.11589709 0.738940526 0.001131586 0.089241217
chr9 129968164 130006483 - CIZ1 -0.026122642 7.952762208 0.770980864 1 -1.108636487 7.382652073 1.14E-12 1.42E-09
chr16 29789980 29818086 - SEZ6L2 0.040319609 3.971662593 0.939845807 1 -1.10370632 3.572079999 6.14E-08 2.37E-05
chr16 66153810 66230589 + CTCF 0.175387153 6.938425397 0.318715866 1 -1.090678587 6.50276881 3.77E-12 3.34E-09
chr19 40679958 40696400 - DMKN -0.101954575 6.309359926 0.453433863 1 -1.073689118 5.939081595 1.25E-11 1.04E-08
chr17 35770430 35774471 - GJD3 0.181528972 2.228673511 0.326657924 1 -1.067431989 1.790465425 0.000156713 0.019191649
chr7 73848419 73905777 - GTF2IRD2 0.12850774 3.205586377 0.599100052 1 -1.064871324 1.981721786 3.28E-05 0.005149687
chr9 33431151 33437631 - AQP3 -0.166672206 1.893433873 0.72716338 1 -1.049364032 1.154868748 0.000562471 0.051348499
chr22 34952200 34965946 - APOL2 -0.382766009 3.524574622 0.047664823 1 -1.044895361 3.085940175 5.81E-07 0.000178587
chr1 149235924 149247478 - FAM63A -0.253291733 4.589517175 0.136140462 1 -1.022211305 3.982886476 1.56E-09 9.04E-07
chr5 35653745 35850470 + SPEF2 0.118545814 2.540699334 0.609592228 1 -1.014157365 1.799499414 0.00011072 0.014502337
chr11 61323672 61341105 - FADS1 -0.017071153 6.362064775 0.909747275 1 -1.014149879 6.114814041 1.23E-10 9.26E-08
chr14 93663870 93665710 - IFI27L2 -0.1049038 2.197466761 0.762487186 1 -1.012954763 1.881072312 0.000332442 0.033834989
chr16 65981212 65984922 - TPPP3 -0.279130327 1.235359919 0.486205619 1 -1.003693425 0.729235201 0.003344541 0.197564032
chr2 74578151 74583951 - LBX2 0.004335649 2.681038448 0.938774727 1 -0.993172387 2.102129426 9.57E-05 0.012867486
chr16 54070581 54098087 + MMP2 -0.310890855 1.973875964 0.334797105 1 -0.988756022 2.546439083 0.00020002 0.02299927
chr11 780474 788269 - SLC25A22 0.248224584 5.416236545 0.098588604 1 -0.981132989 5.211525474 1.03E-09 6.48E-07
chr7 904062 960815 - ADAP1 0.139392639 3.677413001 0.371184575 1 -0.975255104 3.168220761 2.67E-06 0.000660551
chr7 36859035 37455420 - ELMO1 -0.348196835 2.44034968 0.194032123 1 -0.971635344 2.15463096 0.000106886 0.014248018
chr14 75406357 75658553 - BCYRN1 -0.422665217 5.549284904 0.007357548 0.518114086 -0.966071589 5.074474828 1.38E-09 8.32E-07
chr4 39734918 39836267 + N4BP2 0.029824131 5.635937267 0.58674151 1 -0.96478601 5.086306546 1.89E-09 1.05E-06
chr6 100075590 100087780 + LOC100130890 -0.080190581 3.050672191 0.729349379 1 -0.954419658 2.545286266 8.02E-05 0.01098033
chr5 36070875 36102780 - UGT3A2 -0.120136549 0.978983845 0.932046369 1 -0.947937879 1.518895024 0.00248556 0.157193719
chr1 23627642 23683337 - ASAP3 -0.170350422 3.620009276 0.644742927 1 -0.942397163 3.266910921 4.85E-05 0.0071622
chr5 101597590 101660152 - SLCO4C1 -0.281167311 2.675858828 0.306789008 1 -0.931335053 2.19847122 0.000197538 0.022888557
chr2 68364806 68400687 - CNRIP1 0.068265327 3.995133804 0.767333065 1 -0.927559892 3.584428053 5.24E-06 0.001095454
chr11 61276696 61312565 + C11orf9 -0.191822478 3.672574115 0.409885445 1 -0.912407923 2.797719842 2.08E-05 0.003482653
chr19 1456016 1464188 - ADAMTSL5 -0.013970058 1.482726474 0.957348381 1 -0.912088965 1.03137257 0.003188076 0.193637079
chr8 144888297 144900495 + LOC100128338 0.255270099 1.846169271 0.313570921 1 -0.907447474 1.741423343 0.001464065 0.10863652
chr11 46255803 46299548 + CREB3L1 -0.723622461 1.367238301 0.030693462 0.894213246 -0.90585451 1.585294202 0.003319127 0.197564032
chr2 241156676 241166822 + RNPEPL1 0.061558633 4.301421716 0.68841807 1 -0.904571671 4.324625123 5.66E-08 2.24E-05
chr19 46528651 46551671 - TGFB1 -0.113606109 5.960018035 0.326556818 1 -0.90154991 5.331776429 1.78E-08 8.29E-06
chr5 179961111 180009230 - FLT4 -0.116266138 5.893422227 0.605097621 1 -0.901186097 5.311181508 1.82E-08 8.29E-06
chr18 50139168 50162402 + C18orf54 0.025159156 4.458142095 0.847162179 1 -0.888778766 4.093066341 1.04E-07 3.92E-05
chr11 128274669 128281336 - C11orf45 0.017828748 1.906710203 0.815118525 1 -0.883000791 1.592873725 0.002081459 0.137513233
FC CPM p-val FDR
RAD21 Cleavage CTCF depleted
99
chr3 27732889 27738789 - EOMES -0.040469904 3.122600739 0.856314147 1 -0.877197748 2.435237048 0.000390965 0.038744071
chr19 18560494 18564147 + C19orf60 0.044615866 4.128275182 0.946756918 1 -0.864935663 4.015185656 1.31E-05 0.002325127
chr10 69712422 69762690 - PBLD -0.027481038 3.757081795 0.780614866 1 -0.858657034 2.851203368 5.20E-05 0.007608371
chr14 105012175 105017545 + CRIP2 -0.216302571 3.013280865 0.434943628 1 -0.852568378 1.661211136 0.001425934 0.106859937
chr14 36055352 36059181 - NKX2-1 -0.1055063 1.478679256 0.851184332 1 -0.851176086 2.001168637 0.002196732 0.143244071
chr7 72294837 72323594 - GTF2IRD2P1 0.180262082 2.590518314 0.456113591 1 -0.83997347 1.263276761 0.002811866 0.174300993
chr12 129840099 129889772 - STX2 -0.056365427 5.008409195 0.819755266 1 -0.838449802 4.965578852 1.88E-07 6.75E-05
chr3 101694152 101778975 + TMEM45A -0.020724893 3.198927561 0.868790958 1 -0.835119739 2.888905475 0.00045206 0.043649863
chr12 3594754 3732627 - EFCAB4B 0.228682187 2.581056792 0.242180891 1 -0.829464319 2.751035146 0.000515474 0.047929523
chr4 12978444 13095087 - RAB28 0.181150315 4.526748741 0.216936806 1 -0.823844733 4.074245014 8.50E-07 0.000246107
chr17 40827050 40866065 - ARHGAP27 0.033376942 3.476751977 0.733008742 1 -0.823474988 2.791538121 0.000608883 0.054269816
chrX 151746526 151749957 - CETN2 -0.062714149 5.025510307 0.81958119 1 -0.809344763 4.69704168 6.50E-07 0.000195738
chr16 88542639 88561969 + DEF8 0.010574611 6.361494058 0.925900097 1 -0.805061229 5.549160997 3.83E-07 0.000125323
chr11 92851286 92916194 - C11orf75 0.115710218 2.725791562 0.598636406 1 -0.804088061 2.700229191 0.000818249 0.070030039
chr10 69773280 69837057 - RUFY2 0.085606948 5.464483745 0.532665825 1 -0.803779781 4.944250343 5.45E-07 0.000171051
chr1 221460783 221604167 - SUSD4 -0.129271266 2.226280228 0.862607076 1 -0.803691437 2.186036767 0.003333038 0.197564032
chr7 26298039 26380474 + SNX10 -0.012967191 4.354362744 0.731597728 1 -0.797499461 3.961247722 5.55E-05 0.008038554
chr5 1062167 1091925 + NKD2 0.106285206 3.629962866 0.587753447 1 -0.794691215 3.30106433 0.000121448 0.015503137
chr20 36867761 36985081 + PPP1R16B -0.309616735 2.958684812 0.241568204 1 -0.787663859 2.463048972 0.001218603 0.094563381
chr19 18901009 18913041 - HOMER3 0.047081943 3.01488798 0.765961429 1 -0.78270594 2.501049089 0.001415321 0.106594874
chr5 137829079 137832903 + EGR1 0.623573154 7.178224997 7.25E-06 0.005216845 -0.769177542 2.635577886 6.52E-05 0.009180417
chr4 17097113 17122955 - QDPR 0.070836721 4.697354029 0.646494237 1 -0.764651725 4.507843327 3.40E-06 0.000799354
chr3 173831128 173911702 - NCEH1 -0.245142335 4.028861196 0.255908649 1 -0.762222556 3.574508592 0.000148773 0.018520341
chr9 111442888 111753577 + PALM2 0.202542569 0.964918886 0.418309353 1 -0.760488681 3.134601465 0.001088345 0.087060057
chr1 150271605 150276135 - S100A11 -0.164888224 4.75459977 0.39135624 1 -0.760221271 4.901961884 2.72E-06 0.000660551
chr20 62266270 62344050 + MYT1 0.098822143 2.399057409 0.586127148 1 -0.759742365 2.179864935 0.002730774 0.169973772
chr16 65868913 65880904 + PLEKHG4 0.248763011 5.309491918 0.062463674 1 -0.757929664 4.139847361 5.68E-06 0.001157096
chr6 127801243 127882193 - C6orf174 -0.063797574 6.181349741 0.688556521 1 -0.749958969 5.616275496 2.02E-06 0.000532733
chr9 130504622 130523020 + PKN3 -0.050145543 6.104787723 0.78594556 1 -0.744689036 5.631911081 2.69E-06 0.000660551
chr6 127801243 127822228 - KIAA0408 -0.045990323 5.414041402 0.69316684 1 -0.73929192 4.9320291 4.11E-06 0.00091094
chr15 41597097 41611110 + MAP1A -0.414412036 4.773985267 0.033382953 0.922655828 -0.731680604 5.545881269 3.48E-06 0.000805979
chr10 115428924 115480654 + CASP7 -0.251623972 4.371058179 0.15445097 1 -0.726067334 4.35788515 1.01E-05 0.001860686
chr3 16273571 16281500 - DPH3 -0.099268373 5.909386544 0.655303463 1 -0.724737218 5.508463663 4.71E-06 0.001027375
chrX 128501932 128554211 + OCRL 0.018153527 5.898316979 0.854443216 1 -0.72152472 6.217581592 3.74E-06 0.00085448
chr17 24424653 24531533 - MYO18A 0.069604245 5.248247823 0.559145927 1 -0.71691285 4.931792546 8.63E-06 0.001631656
chr16 19777793 19803652 - GPRC5B -0.326034933 3.826073177 0.103903133 1 -0.712786833 3.795946559 0.000365975 0.036751225
chr7 47281276 47588267 - TNS3 -0.142722062 3.223244983 0.574054579 1 -0.708623298 3.464902687 0.000483508 0.045798684
chr6 26646550 26655143 + HMGN4 0.131473179 5.595611497 0.259570653 1 -0.705375218 5.451325597 8.67E-06 0.001631656
chr11 117212900 117253411 - FXYD6 -0.261395254 4.190136959 0.265171854 1 -0.697457581 3.847359942 0.00051292 0.047929523
chr3 47819402 47866690 + DHX30 0.149240647 7.981281775 0.528415504 1 -0.693024955 7.764988378 7.58E-06 0.001482345
chr19 11170968 11234168 - DOCK6 0.182845683 5.177773801 0.242309016 1 -0.689407874 4.592228507 2.07E-05 0.003482653
chr19 54160377 54161948 + FTL -0.268331279 8.560057468 0.123367601 1 -0.683759845 8.175721272 9.69E-06 0.001802449
chr2 121271336 121466699 + GLI2 0.056780575 4.685124862 0.558434637 1 -0.679605688 4.637123913 3.09E-05 0.004893743
chr12 51577237 51629917 - KRT8 -0.040923052 3.500015693 0.905681424 1 -0.678351493 4.707159529 0.000443595 0.043108874
chr3 69107057 69145464 - C3orf64 -0.072228832 4.320298598 0.706144538 1 -0.675477737 4.229632535 0.000546444 0.050197486
chr1 149298774 149307597 + MLLT11 -0.329158908 4.759894898 0.062359053 1 -0.67467216 4.463364608 3.80E-05 0.005841918
chr15 38973919 38983465 + VPS18 -0.263498895 5.011571031 0.101192209 1 -0.668680271 4.609134071 3.94E-05 0.005999338
chr9 103277428 103289296 - C9orf125 0.013927128 4.507866974 0.754991629 1 -0.668155657 4.535141187 4.84E-05 0.0071622
chr8 96007375 96030791 - TP53INP1 -0.953642714 4.772480412 3.71E-06 0.002941424 -0.667379855 3.660971884 0.00079237 0.068202657
chr14 64523259 64599123 + FNTB -0.181547066 4.663800152 0.185960919 1 -0.662597897 4.314203818 6.40E-05 0.00909512
chr21 37045058 37284415 - HLCS 0.169569654 5.286538739 0.275566206 1 -0.654792451 5.286179749 4.06E-05 0.006109363
chr3 11806918 11863352 - TAMM41 0.355953124 3.835527525 0.116785596 1 -0.653724109 4.168690789 0.000865102 0.072799038
chr1 92712905 92725021 - GFI1 0.225857924 3.867467541 0.196350427 1 -0.648454922 3.05481278 0.001822283 0.124632147
chrX 19288096 19443300 - MAP3K15 -0.038253786 2.683156043 0.922966722 1 -0.647838807 3.725368097 0.001256559 0.0965691
chr10 81575637 81577338 + LOC642361 0.13448254 4.432826368 0.587152833 1 -0.646143806 4.017115057 0.001069625 0.086159146
chr8 142207901 142275082 + DENND3 0.221541981 3.603909976 0.220119274 1 -0.632131016 3.665335962 0.001741264 0.122572229
chr1 39861689 39877935 - HEYL -0.035069357 3.690628932 0.820987827 1 -0.630357846 3.076773127 0.002447451 0.155948556
chr11 64838864 64846476 + CDC42EP2 0.33620249 4.057103945 0.105310011 1 -0.625171703 3.677648568 0.001967449 0.132302149
chr1 152564659 152590404 + ATP8B2 -0.038064937 6.785081278 0.983161448 1 -0.623381054 6.847038194 6.06E-05 0.008688732
chr15 61268780 61347026 + RAB8B -0.121496759 4.939662237 0.559328432 1 -0.620010877 4.226287745 0.000175739 0.021009163
chr20 3091272 3097207 - ProSAPiP1 -0.183162187 4.465481714 0.418193936 1 -0.616007911 4.16111092 0.001773797 0.124273043
chr1 40278841 40310908 + CAP1 -0.203911175 7.826450298 0.179839122 1 -0.613025455 7.29464485 7.45E-05 0.010395458
chr1 167603817 167632404 + BLZF1 -0.140111404 5.007835446 0.399790981 1 -0.61287194 4.359459667 0.000175047 0.021009163
chr12 97430881 97434135 - LOC100128191 -0.061596828 4.314661496 0.705986793 1 -0.610029311 4.143539648 0.002064628 0.137002147
chr2 74216035 74228547 - BOLA3 0.027445642 5.891300044 0.98640676 1 -0.607408867 5.345072197 0.000153288 0.018926041
chr3 49032911 49035930 + NDUFAF3 -0.106066931 6.152654659 0.460567832 1 -0.602518115 6.614675645 0.000113683 0.014762147
chr22 37590193 37598204 - CBX6 0.149506273 7.678307356 0.485150977 1 -0.600886751 7.051827726 0.000110084 0.014502337
chr9 98711177 98712558 + LOC441454 -0.164699646 4.17607307 0.226816612 1 -0.600244539 4.822192249 0.001741383 0.122572229
chr11 44073674 44223556 + EXT2 -0.182271369 5.998134574 0.285211538 1 -0.599991528 5.709041255 0.000148354 0.018520341
chr7 148759386 148788986 - ZNF777 0.297961145 5.563103396 0.107119837 1 -0.598688223 4.896989269 0.000202185 0.023010172
chr3 87069812 87122947 - VGLL3 -0.194753535 3.531474577 0.563197667 1 -0.594028128 4.091791446 0.002453682 0.155948556
chr1 170017383 170033479 + METTL13 0.131212672 5.575550804 0.472744273 1 -0.592348784 5.47886018 0.000194404 0.022700056
chr1 199755654 199756343 + RPS10P7 -0.136863287 4.749446947 0.529930401 1 -0.589034604 4.542592278 0.000304512 0.031853233
chr20 32896183 32924322 - GGT7 -0.221444106 5.489040162 0.204606667 1 -0.585046962 4.803846689 0.00029501 0.031293872
chr14 59020913 59041834 + JKAMP -0.04686861 5.568725806 0.868682986 1 -0.582543127 5.061122844 0.000265982 0.028823649
100
chr5 61744329 61960172 + IPO11 0.052014029 6.635933029 0.676655688 1 -0.581247299 6.299007702 0.000190595 0.022605738
chr5 133765654 133775497 - CDKN2AIPNL 0.050623445 5.551046787 0.829911247 1 -0.578981051 5.297820246 0.000278774 0.029781331
chr19 6445329 6453330 - TUBB4A -0.209114217 5.162882945 0.198649909 1 -0.578410548 5.221897683 0.000302894 0.031853233
chr5 76047623 76067351 + F2R 0.067895148 4.512794413 0.425663441 1 -0.577662925 5.008410346 0.000311933 0.032404421
chr6 133132199 133161440 - C6orf192 0.067163856 5.051658819 0.53739283 1 -0.563594393 5.222083502 0.000414305 0.040523839
chr18 42007985 42100953 + C18orf25 0.012040549 6.150258783 0.986750513 1 -0.551402828 5.465046779 0.000486476 0.045798684
chr1 160733587 160766043 + UHMK1 0.042917194 7.779650008 0.752065846 1 -0.544396575 7.420805847 0.000409159 0.040282105
chr13 102249399 102291889 + BIVM 0.042349377 5.05733952 0.645851627 1 -0.543052902 5.232811108 0.000659286 0.058075029
chr15 89275158 89276778 - HDDC3 0.199669606 4.664078362 0.191424046 1 -0.541381488 4.344558579 0.00102217 0.083226743
chr1 31965304 32002235 - BAI2 -0.049467113 4.947647652 0.966537146 1 -0.529790562 4.675270996 0.001221425 0.094563381
chr3 49133550 49145603 - LAMB2 -0.258695577 5.775805904 0.173383174 1 -0.528104839 5.674819248 0.000787511 0.068202657
chr1 153557263 153567533 + RUSC1 -0.076300393 5.996689453 0.575480304 1 -0.527135635 5.703716858 0.000846366 0.072027192
chr2 235066424 235070432 - ARL4C -0.179457711 4.451038538 0.307871046 1 -0.524192195 4.717454994 0.001205396 0.094563381
chr6 44374440 44389041 - AARS2 -0.092889727 6.311338257 0.545222585 1 -0.519326973 6.158207928 0.00087848 0.073514166
chr1 183353840 183392853 - TRMT1L 0.072704068 5.51577735 0.675703823 1 -0.518246406 5.270362308 0.001123624 0.089079704
chr6 31234281 31239971 + TCF19 -0.247611003 5.435127213 0.133939526 1 -0.516562078 5.60876095 0.001092369 0.087060057
chr9 76787692 76833130 - C9orf41 0.037973307 5.649063165 0.634115085 1 -0.514609773 5.776823185 0.000999895 0.081855522
chr1 149290070 149298749 - CDC42SE1 -0.009351616 6.819919408 0.941246981 1 -0.508536756 6.616226201 0.001068107 0.086159146
chr15 70320575 70350682 - PARP6 0.302681672 5.832271534 0.073393439 1 -0.506379155 5.071434998 0.001567622 0.114072882
chr6 44329815 44333261 - SLC35B2 0.087121766 5.236863848 0.562061318 1 -0.50472792 4.973504618 0.001806053 0.124632147
chr11 107881367 107969584 - EXPH5 0.149199972 4.912119238 0.367641375 1 -0.502296966 5.045117292 0.001647706 0.118187563
chr19 877036 923803 + ARID3A -0.060973956 5.196045061 0.818369149 1 -0.500687843 4.545979161 0.002237962 0.145303532
chr12 121915827 121946665 - VPS37B 0.024200076 5.62802167 0.806455218 1 -0.500592149 4.834082068 0.00198657 0.132490569
chr11 124115038 124122312 + NRGN -0.396323932 4.429504549 0.006339498 0.475083894 -0.497817177 4.854690554 0.002115922 0.139179589
chr9 70840298 70904914 + FXN 0.281131819 5.449211928 0.123032378 1 -0.496676159 5.667752922 0.001624708 0.117095615
chr15 50386772 50608539 - MYO5A -0.019604784 5.747544742 0.889124652 1 -0.494849322 5.892310393 0.001575602 0.1141024
chr10 88844932 88941202 + FAM35A 0.153387936 5.116073212 0.310106234 1 -0.494216814 5.475753491 0.001715301 0.121875389
chr2 74279197 74295932 + MTHFD2 0.221898968 7.793341149 0.071015628 1 -0.493053652 7.258558521 0.001407059 0.106505155
chr10 46317646 46359151 + FAM35B 0.119766389 4.181670887 0.401573076 1 -0.491646173 4.435267952 0.002673891 0.167123756
chr17 74360653 74433067 - TIMP2 -0.392327272 4.692033386 0.016733482 0.704068253 -0.490091006 4.590101931 0.00266477 0.167123756
chr6 24603175 24645414 + ALDH5A1 0.028404726 5.452837143 0.687426328 1 -0.487763099 5.82148897 0.001818578 0.124632147
chr10 70418482 70446745 + KIAA1279 -0.172345112 6.134691317 0.246962094 1 -0.485440529 5.756888965 0.001966805 0.132302149
chr7 134114703 134306020 + CALD1 -0.206169689 6.039663333 0.353253122 1 -0.48526617 6.388224332 0.001828567 0.124632147
chr1 221955917 222030343 + CAPN2 0.072848233 7.162639742 0.538524888 1 -0.479788515 7.112965393 0.001987842 0.132490569
chr20 55366902 55368285 - MTRNR2L3 -0.268087749 7.076241476 0.111640607 1 -0.47921999 6.633140977 0.001944865 0.131961725
chr13 49384842 49408626 - SPRYD7 0.098754612 5.215144314 0.589554921 1 -0.478925659 4.951338036 0.002844988 0.175631401
chr7 94374884 94763663 + PPP1R9A 0.054406651 4.879465988 0.555462694 1 -0.47480886 4.507388815 0.003316593 0.197564032
chr9 122403016 122516586 - MEGF9 -0.364785307 5.248872895 0.033687637 0.927243547 -0.471810491 4.983736695 0.003208058 0.194068194
chr3 57236804 57282538 + APPL1 -0.052135321 6.695944194 0.910126982 1 -0.458135279 6.908159315 0.003045108 0.185702255
chr2 181553356 181636395 + UBE2E3 0.197881987 6.066858652 0.23334446 1 0.456485376 6.424559191 0.003326592 0.197564032
chr5 141360417 141372804 - GNPDA1 0.094639 5.605410565 0.506185362 1 0.465461947 6.168455433 0.002871717 0.176557835
chr9 129249773 129253532 - RPL12 -0.042206312 10.06099287 0.835797041 1 0.475656787 9.886860411 0.001820841 0.124632147
chr12 22492784 22588719 - KIAA0528 0.080297313 5.756316225 0.483471483 1 0.47726554 6.38367627 0.002301578 0.148156683
chr3 106568246 106778447 + ALCAM -0.086922905 6.11490157 0.808288717 1 0.477926945 6.639045265 0.002143606 0.140387533
chr14 51025604 51267194 + FRMD6 -0.246351206 4.781400629 0.197294529 1 0.488726909 4.807988813 0.002494145 0.157193719
chr16 67435009 67676586 + TMCO7 0.17644935 4.685317083 0.295717592 1 0.49204087 4.80840619 0.002296309 0.148156683
chr15 39853923 39907345 + MAPKBP1 -0.066131911 4.735438056 0.621703222 1 0.509005376 5.068083999 0.001447033 0.107904248
chr3 184836104 184884998 + KLHL24 -0.327380961 5.11189353 0.100883734 1 0.512756066 4.572265087 0.00171027 0.121875389
chr2 70376611 70382724 - FAM136A 0.019182542 6.889785206 0.942535983 1 0.513347464 7.110273539 0.000864136 0.072799038
chr1 1260520 1274355 - DVL1 0.127556725 5.78074189 0.366344321 1 0.514150483 6.140020576 0.000948817 0.078098515
chr3 123585712 123611651 + FAM162A -0.096075426 6.060183361 0.501056754 1 0.530574091 6.200288825 0.000670728 0.058739406
chr7 89678935 89704928 + STEAP2 0.024421807 4.468027106 0.597729765 1 0.533250312 5.148328467 0.000888136 0.073911532
chr12 47682321 47698896 - PRKAG1 0.024197731 5.151274822 0.810306272 1 0.541790332 5.548373974 0.000612684 0.054287404
chr12 75776626 75796930 - CSRP2 -0.39292072 4.973587798 0.013958896 0.651625917 0.544942371 5.317467389 0.000572271 0.051928427
chr20 18516555 18692560 + DTD1 -0.087277202 5.03747259 0.603345681 1 0.551489312 5.55614381 0.000465384 0.044367579
chr14 67125775 67136770 - PIGH -0.008477136 5.198221455 0.927156569 1 0.558964053 5.07013721 0.000458689 0.044007866
chr6 21701950 21706828 + SOX4 -0.035772443 6.6543047 0.624384941 1 0.582829753 7.489964656 0.000167502 0.020347484
chr6 139735089 139737478 - CITED2 -0.140856125 4.996716338 0.400843343 1 0.590765324 5.245035182 0.000217964 0.024141147
chr12 122311492 122322640 - CDK2AP1 0.048942456 6.901220668 0.826706852 1 0.595064922 7.1990635 0.000121024 0.015503137
chr6 121798443 121812572 + GJA1 -0.073876341 5.230736287 0.999014478 1 0.620716419 6.015474938 7.92E-05 0.0109455
chr22 43655706 43784473 - PHF21B 0.460160203 4.173163639 0.01788585 0.728147444 0.629965031 3.922494698 0.001530372 0.112448724
chr12 64816983 64850074 - TMBIM4 0.051793189 4.847661229 0.633362774 1 0.662089274 5.13400203 3.54E-05 0.005496704
chr4 55907144 55934023 + SRD5A3 0.152221627 5.059577753 0.255691014 1 0.667355181 5.692712442 2.38E-05 0.003891701
chr12 43188324 43593978 - NELL2 -0.047611549 4.706471495 0.925965029 1 0.674605387 4.949613237 2.80E-05 0.004534574
chr16 53510278 53520580 - CRNDE 0.270169019 4.413640914 0.077445282 1 0.675480734 4.767376093 2.84E-05 0.004556489
chr16 65195435 65205296 + CMTM3 -0.078579979 4.396795818 0.69874618 1 0.682390542 5.053811757 1.98E-05 0.003393812
chr1 31425178 31485321 - NKAIN1 0.449039757 2.142460573 0.06954819 1 0.692444599 2.860479776 0.003330448 0.197564032
chr1 52380633 52584946 + ZFYVE9 0.101968888 5.156004581 0.35388244 1 0.69913071 5.59500728 1.04E-05 0.001888798
chr8 144878090 144887902 - FAM83H 0.17192707 4.387782648 0.313603017 1 0.700428961 4.16270336 0.000371558 0.03706471
chr14 35077308 35348183 - RALGAPA1 -0.013372653 6.377334451 0.967388355 1 0.700905212 7.080850863 6.35E-06 0.001274489
chr6 126319553 126343082 + HINT3 0.121662408 5.941462815 0.349463433 1 0.701232894 6.024689673 8.15E-06 0.001573073
chr10 73703682 73705803 + DDIT4 0.146999442 5.418488527 0.160458614 1 0.702633559 5.702617867 0.000193019 0.022700056
chr3 195336624 195339095 + HES1 -0.195725839 4.49662823 0.205992814 1 0.716077175 4.545480332 1.20E-05 0.002145415
chr16 65751391 65755578 + FBXL8 0.071531317 1.855440469 0.702633522 1 0.717243478 2.89764521 0.00233701 0.149797339
chr5 121426788 121441954 - LOX -0.099263625 4.64577154 0.686132282 1 0.723749475 5.616187488 5.05E-06 0.001072186
101
chr5 130627600 130758281 + CDC42SE2 0.053231563 5.385869669 0.687409398 1 0.725324026 5.256225328 5.65E-06 0.001157096
chr1 210805298 210860742 + ATF3 0.717191547 6.685314539 0.001271559 0.18289697 0.72748061 4.232722277 0.000215515 0.024046714
chr2 190319630 190336169 - OSGEPL1 0.143515276 3.474197973 0.356289238 1 0.729906524 4.113717186 0.000206492 0.023211817
chr17 71892284 71895536 + SPHK1 0.185693805 3.846901191 0.296949341 1 0.733505427 3.662703876 0.000222856 0.024502791
chr3 198146669 198153861 - NCBP2 0.149463722 5.808439727 0.372105964 1 0.737562698 6.297139049 2.54E-06 0.000648191
chr14 49161641 49171698 - DNAAF2 0.271940938 4.476029584 0.063718267 1 0.744248597 5.00255538 3.86E-06 0.000867737
chr19 47509316 47521054 + TMEM145 0.261758204 3.422392336 0.226719949 1 0.75259587 3.274754546 0.000246287 0.026882785
chr8 23755378 23768265 - STC1 -0.650918459 1.552717657 0.011853193 0.611454283 0.764475469 3.616197879 0.000791979 0.068202657
chr8 48812028 48813279 - CEBPD -0.108217658 1.461553379 0.694624572 1 0.815054479 2.029396379 0.002996914 0.18350615
chr2 217245072 217268517 - IGFBP5 -0.099413094 3.766774211 0.817277777 1 0.816979613 5.559132955 2.67E-07 8.92E-05
chr22 40852444 40856827 - CYP2D6 0.111652052 1.844852932 0.815606266 1 0.828496087 2.529383758 0.001819234 0.124632147
chr16 391858 402488 + DECR2 0.221888791 3.186913264 0.225199437 1 0.855142751 3.555603288 2.31E-05 0.00381994
chr11 75157425 75190229 + DGAT2 -0.102752135 2.564964104 0.754238298 1 0.874941775 2.611773383 0.000269717 0.029019654
chr11 106049947 106394381 - GUCY1A2 0.65494924 -0.24515094 0.018396439 0.735715694 0.882716151 4.293321974 7.27E-06 0.001441471
chr8 19215360 19298009 + SH2D4A 0.130539753 2.188196686 0.501914762 1 0.898244757 3.004849989 0.000142862 0.018083448
chr1 144149818 144153985 + TXNIP -0.615854233 5.317906683 0.000121555 0.04067075 0.953629933 5.490576351 2.01E-09 1.08E-06
chr4 970784 988317 + IDUA 0.004587952 1.952145038 0.939385261 1 0.954863284 2.565381927 8.67E-05 0.011767874
chr5 76408287 76418786 - ZBED3 0.328578444 3.22962119 0.116112157 1 0.96846413 3.55262833 1.96E-06 0.00052728
chr22 40816882 40851298 + LOC100132273 -0.164131608 2.436510347 0.451226759 1 1.021200782 3.010992793 1.50E-05 0.002593385
chr16 2829574 2832753 - PRSS30P 0.158293396 1.781977314 0.560757252 1 1.040641275 2.833219499 1.40E-05 0.002445271
chr18 586997 640293 + CLUL1 -0.609370206 0.553024514 0.032767755 0.91743623 1.053489023 0.999676771 0.001486706 0.10977574
chr12 81276406 81397147 + C12orf26 0.323932677 2.814695557 0.10943509 1 1.055127028 3.649622185 2.14E-07 7.48E-05
chr10 32775046 32903498 + CCDC7 -0.110614281 0.524758663 0.856046252 1 1.110347879 0.781125178 0.001224182 0.094563381
chr18 53448531 53487506 + LOC100505549 0.141507683 1.980934367 0.623541358 1 1.116770385 2.770852913 3.37E-06 0.000799354
chr3 137538688 137953935 - STAG1 0.592628644 6.42773176 0.000124202 0.04067075 1.160542278 6.749867354 1.33E-13 2.87E-10
chr17 6858779 6861567 + C17orf49 0.126880876 4.463302612 0.489014468 1 1.318307948 4.934123173 5.81E-16 1.75E-12
chr19 45045802 45132373 - FCGBP -0.270644414 2.040338183 0.285024971 1 1.461022958 2.695268206 2.68E-09 1.34E-06
chr12 119123476 119135014 + LOC100506649 -0.028581398 1.936031421 0.991248638 1 1.494337232 2.876909718 7.12E-10 4.66E-07
chr11 111249989 111255391 - FDXACB1 0.330430642 3.066709528 0.102570831 1 1.51015353 4.316248054 4.14E-14 1.04E-10
chr15 39032927 39036009 + CHAC1 0.37398851 2.99227481 0.047083288 1 1.585617077 2.471695255 5.24E-08 2.13E-05
chr7 141050606 141084499 - FLJ40852 -0.062937753 0.691413102 0.902507157 1 1.685541742 0.971100482 9.75E-07 0.00027719
chr4 146759989 146800637 + MMAA 0.120184832 1.19175043 0.629015322 1 1.791246419 2.525937822 8.44E-11 6.69E-08
chr16 29782504 29786875 + LOC440356 0.37567817 -0.177403112 0.265962513 1 2.113020711 0.970916243 2.67E-09 1.34E-06
chr6 132000134 132110243 + ENPP3 0.298202083 0.296262085 0.208687767 1 3.860050305 2.324064363 1.03E-28 5.17E-25




Nr. Forward Reverse Genomic Position
328 CAGAGGGAGTCACACTAACG GTGCAGGTGTGGAGAATG chr11:1,493,349-1,493,623
331 AGGTGGCACTGTTGCATAG CCTGCCAAAGGAGAGCTTTATC chr11:1,630,677-1,630,849
332 CAACACGCAGGAGAAAGG AAGCGCAGATGAGCAGTC chr11:1,671,708-1,671,998
333 GTCTTCCGGTGTAAATGGTC AGCTGCCATGCTAACTTG chr11:1,931,466-1,931,618
204 TTCAGCCGGTTCAAGGGACG CTAGGGAGGAGGACAGAGGCAAGAG chr11:2,014,891-2,015,077
200 GAGCTCAACAATTAGCCCTTGATC AGCCTGGGAGAAAGCACATCT chr11:2,121,433-2,121,703
185 GCTGCTGTTTCCGCCATTCATTTC GCTGATACCAACCACCAATCCATGAG chr11:59,140,122-59,140,236
338 AGGCATGGCACCAAGACAC GTCTCCCTCTGCCAAGTTAGC chr11:3,069,776-3,069,983
102
Supplementary table 6:
qPCR primers for transcript analysis
Target gene Forward Reverse Genomic Position
&7&) CAGCCATTCCACATCATCTACG CACCATGTCCCACCTACAAATC chr16:66,157,405-66,157,639
SMC3 TTGACCAGGCTCTGGATG CTCCCAAACCAGTAGGTAG chr10:112,352,709-112,354,079
RAD21 GTGATGGAGGCCAGCAGAAC ACCTGCTGAGGAGGCATCAC chr8:117,932,176-117,933,456
H19 CTTTACAACCACTGCACTACCTGAC GATGGTGTCTTTGATGTTGGGCTGA chr11:1,973,551-1,973,726
HOXBAS3 AACCCAGCGATATCCGCACCAG AGGGAATGAGTCCGGGAGCAAG chr17:44,036,386-44,038,655
HOXA-AS3 ATTCCACCCACGCACCTATTC TGGCTAATTTCCTGCGTCCTC chr7:27,157,720-27,158,542
CDH22 TCTTGGTCTGCGTTCTCATCC CCGCCTTCGTCGTTGTATTTG chr20:44,237,015-44,240,018
ENPP3 TATCATCCCTCACCGACCTAC GAGACAGGCTGCACTTTATCC chr6:132,103,174-132,109,737
MMAA GCTGTTGCTGACATGGTTGAC ATCCTTCGAGCTGGCACAATC chr4:146,791,684-146,794,681
NAD  ACTGGCTACTGCGTACATCC  AGATGCGCCTATCTCTTTCC chrX:118,889,962-118,891,355
SNAPIN  GCTGCATACGTGAGGCTTAC  TGGGTGGACAGAGGTCATTC chr1:151,900,673-151,900,856
TMC7 GCCTTTGCAGTTCCTTTC CGCTCAGTCTAGTTAGTTCC chr16:18,975,489-18,980,678
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The cohesin complex is crucial for chromosome segregation during mitosis and has recently 
also been implicated in transcriptional regulation and chromatin architecture. The NIPBL 
SURWHLQLVUHTXLUHGIRUWKHORDGLQJRIFRKHVLQRQWRFKURPDWLQEXWKRZDQGZKHUHFRKHVLQLV
loaded in vertebrate cells is unclear. Heterozygous mutations of NIPBL were found in 50% 
of the cases of Cornelia de Lange Syndrome (CdLS), a human developmental syndrome 
with a complex phenotype. However, no defects in the mitotic function of cohesin have been 
observed so far and the links between NIPBL mutations and the observed developmental 
defects are unclear.
We show that NIPBL binds in somatic cells independently from cohesin to chromatin and 
almost exclusively to the promoters of active genes. NIPBL or cohesin knockdown reduce 
transcription of these genes differently, suggesting a cohesin-independent role of NIPBL for 
transcription. Motif analysis and comparison to published data show that NIPBL co-localizes 
ZLWKDVSHFL¿FVHWRIRWKHUWUDQVFULSWLRQIDFWRUV ,QFHOOVGHULYHGIURP&G/6SDWLHQWV1,3%/
binding levels are reduced and several of the NIPBL-bound genes have previously been 
observed to be mis-expressed in CdLS. 
In summary, our observations indicate that NIPBL mutations might cause developmental 
GHIHFWVLQGLIIHUHQWZD\V)LUVWGHIHFWVRI1,3%/PLJKWOHDGWRFRKHVLQORDGLQJGHIHFWVDQG
WKHUHE\DOWHUJHQHH[SUHVVLRQDQGVHFRQG1,3%/GH¿FLHQF\PLJKWDIIHFWJHQHVGLUHFWO\YLDLWV
role at the respective promoters.
 
Author summary
The multi-protein complex cohesin is crucial for chromosome segregation during cell divisions 
but has recently also been implicated in transcriptional regulation and chromatin architecture. 
&RKHVLQ¶VELQGLQJ WRFKURPDWLQGHSHQGVRQ1,3%/D IDFWRU WKDWZDV IRXQG WREHPXWDWHG
in 50% of the cases of the human multisystem developmental disorder Cornelia de Lange 
Syndrome (CdLS). To understand the molecular mechanism of cohesin, we need to know 
when and where the complex is loaded onto DNA. Therefore we compared the genomic 
binding sites of NIPBL and cohesin in different cell lines. To our surprise, NIPBL does not 
bind to the same sites in the genome as cohesin but instead resides at active promoters 
and the activity of these genes depends on NIPBL. These observations point to a dual role 
for NIPBL in cohesin-loading but also as potential transcription co-factor. This has important 
implications for the research on Cornelia de Lange Syndrome, since NIPBL mutations might 
GLUHFWO\ LQÀXHQFHH[SUHVVLRQRI GHYHORSPHQWDOO\ LPSRUWDQW JHQHV&RQVLVWHQWZLWK WKLVZH






between daughter cells. This process crucially depends on the cohesin complex, consisting of 
the core subunits SMC3, SMC1A, RAD21, SA1/STAG1 or SA2/STAG2 and several transiently 
associated regulatory proteins (reviewed in Peters, Tedeschi et al., 2008). Cohesin tethers 
both sister chromatid together from S-phase on, allowing for their proper segregation in 
PLWRVLV)XUWKHUPRUHFRKHVLQ LV LPSRUWDQW IRU'1$GDPDJHUHSDLU IRU UHYLHZVHH6MRJUHQ







et al., 2010). How exactly cohesin associates with DNA is not understood since none of the 
subunits binds directly to DNA. Rather, cohesin is hypothesized to bind to DNA by embracing 
WKH'1$VWUDQGVZLWKD³SURWHLQULQJ´IRUPHGE\WKHFRUHVXEXQLWV+DHULQJ/RZHHWDO
+DHULQJ)DUFDVHWDO
&RKHVLQ¶V ELQGLQJ WR FKURPDWLQ LV WLJKWO\ UHJXODWHG WKURXJKRXW WKH FHOO F\FOH 7R HQDEOH
chromosome segregation it is removed from chromosomes during mitosis. A prophase 
SDWKZD\GHSHQGLQJRQ:$3/DQGVSHFL¿FSKRVSKRU\ODWLRQRIFRKHVLQVXEXQLWVGLVVRFLDWHV
cohesin from chromosome arms. The remaining cohesin is removed by proteolytic cleavage 
of the RAD21 subunit at anaphase onset (reviewed in Peters, Tedeschi et al., 2008). Cohesin 
re-associates with chromatin at the G1-S-phase transition in yeast but in vertebrates already 
earlier during G1 phase. 
7KHFKURPRVRPDOORFDOL]DWLRQRIFRKHVLQLVGHWHUPLQHGE\VHYHUDOIDFWRUV)LUVWWKHFRKHVLQ
loading factors NIPBL (also known as IDN3 or Delangin or Nipped-B, in D. melanogaster; 
Scc2, in S. cerevisiae)DQG0$8DOVR.,$$6FFLQS. cerevisiae) which are crucial for 
the re-loading of cohesin in G1-phase after its complete dissociation from chromatin during 
mitosis (reviewed in Peters, Tedeschi et al., 2008). In yeast, it has been shown that cohesin 
DVVRFLDWHV¿UVWZLWK6FFELQGLQJVLWHVDQGWKHQUHORFDOL]HVWRGLIIHUHQWSRVLWLRQV/HQJURQQH
.DWRXHWDO+X,WRKHWDO,QD. melanogaster cohesin colocalizes with NIPBL to 
actively transcribed genes (Misulovin, Schwartz et al., 2008) and in mouse ES cells a subset 
of cohesin binding sites was described to colocalize with NIPBL and the mediator complex 
(Kagey, Newman et al.). Second, factors co-localizing with cohesin on chromatin such as 
&7&):HQGW<RVKLGDHWDODQG(VWURJHQUHFHSWRU6FKPLGW6FKZDOLHHWDO
determine where cohesin is positioned.
Mutations in NIPBL and cohesin subunits, have been linked to the “Cohesinopathy” Cornelia 
de Lange syndrome (CdLS, OMIM #122470, #300590 and #610759). This dominant, 
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genetically heterogeneous developmental disorder has a high degree of variability in its clinical 
presentation with multiple organ systems affected. It is estimated to occur in 1:60.000 to 
1:45.000 live births. Characteristic features include craniofacial anomalies, growth retardation, 
intellectual disability, upper limb defects, hirsutism, and involvement of the gastrointestinal and 
other visceral organ systems (Liu and Krantz, 2009). Clinically, CdLS phenotypes can range 
from very mildly affected (no structural abnormalities, minor intellectual disability) to severely 
affected (upper limb defects, severe intellectual disability). Heterozygous mutations of NIPBL, 
ranging from nonsense and frame shift mutations to truncation mutations, have been found in 
50% of CdLS patients and mutations of the cohesin subunits SMC1A and SMC3 were found 
in another 5% (reviewed in Liu and Baynam, 2010). 
Observations in patients and mouse models show that in cells with heterozygous NIPBL 
mutations the NIPBL transcript levels are only reduced by ~30% due to an increased expression 
IURPWKHLQWDFWDOOHOH.DZDXFKL&DORIHWDO/LX=KDQJHWDO$FOLQLFDOSKHQRW\SH
is observed with a modest 15% reduction in expression (Borck, Zarhrate et al., 2006). This 
indicates that NIPBL expression levels are tightly regulated and are critical for cells. Defects in 
cohesin-dependent chromosome cohesion were not observed at this level of NIPBL reduction 
LQ&G/6SDWLHQWVRUDQ\PRGHOV\VWHPV&DVWURQRYR*HUYDVLQLHWDO.DZDXFKL&DORI
et al., 2009). However, a reduction of cohesin binding sites was observed in cells derived from 
CdLS patients, which was most obvious in close proximity to genes (Liu, Zhang et al., 2009). 
This suggested that the clinical features of CdLS are the collective outcomes of changes in 
the expression level of multiple genes during development. NIPBL has already been linked 
to gene regulation. In Drosophila, NIPBL was found to facilitate the activation of the cut and 
8OWUDELWKRUD[ genes by remote enhancers. In the case of the cut gene, NIPBL facilitates its 
long-range activation while cohesin has an inhibitory effect on cut expression (Rollins, Korom 
HWDO)XUWKHUKXPDQ1,3%/ZDVDOUHDG\VKRZQWRELQGKLVWRQHGHDFHW\ODVHV+'$&
3) (Jahnke, Xu et al., 2008) and heterochromatin protein 1 (HP1) (Lechner, Schultz et al., 
2005). These observations implied a “dual role” for NIPBL, in loading cohesin and in gene 
regulation. It is not known, whether these two functions are independent of each other, or if 
NIPBL mediates gene regulation via loading of cohesin onto DNA. 
In this study we have aimed to determine when and where NIPBL binds to chromatin to 
GHWHUPLQHZKHUHFRKHVLQLVLQLWLDOO\ORDGHG)XUWKHUPRUHZHZDQWHGWRHOXFLGDWHZKHWKHUWKH
position of NIPBL binding in the genome accounts for the altered gene expression patterns 
observed in CdLS patients carrying NIPBL mutations (Liu, Zhang et al., 2009). 
Results
Consecutive loading of NIPBL, CTCF and cohesin 
To gain insight into the cohesin loading mechanism it is crucial to understand when cohesin 




VSHFL¿F IRU &7&) 1,3%/ DQG WKH FRKHVLQ VXEXQLWV 5$' DQG 6$67$* ,W ZDV WKHQ
determined at which stage the signals of these proteins appeared on chromatin during the exit 
from mitosis (Figure 1). 
Figure 1: Chromatin association of NIPBL, cohesin and CTCF during exit from mitosis.
(A)7RDGGUHVVWKHDVVRFLDWLRQRIFRKHVLQ&7&)DQG1,3%/ZLWKFKURPDWLQGXULQJHQGRIPLWRVLV+H/DFHOOVZHUH¿[HG
ZLWK3)$DQGVWDLQHGZLWKDQWLERGLHVDJDLQVW&7&)&7&)WKHFRKHVLQVXEXQLW5$'DQG1,3%/1,3%/
Image stacks were taken with a confocal microscope and a Z-projection generated with Image J. Different states of 
mitosis are shown, from top to bottom: metaphase, late anaphase, telophase, complete cytokinesis and metaphase. 
(B) One image slice (100 μm) of the telophase images in (A) is shown to highlight the lack of cohesin signal on 
FKURPDWLQZKLOH1,3%/DQG&7&)DUHDOUHDG\SUHVHQW
These results were also correlated with the reassembly of the nuclear envelope in HeLa cells 
H[SUHVVLQJ/DPLQ%(*)36LPLODUWRFRKHVLQZHIRXQGWKHVLJQDOVRI1,3%/DQG&7&)WREH
(largely) excluded from metaphase chromosomes. However to our surprise NIPBL and also 
&7&)VLJQDOVDSSHDURQFKURPDWLQDWDQHDUOLHUVWDJHRIPLWRWLFH[LW WKDQFRKHVLQ Figure 
1) and before the nuclear envelope is reassembled as shown by comparison to Lamin B 
signals (Figure S17KHUHIRUH1,3%/DQG&7&)DUHDOUHDG\SUHVHQWRQFKURPDWLQEHIRUH
the cohesin complex is loaded and the productive interactions that determine the chromatin 
localization of cohesin might occur on chromatin.
10 Pm
DAPI NIPBL CTCF RAD21A.
B.
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NIPBL localizes in somatic cells independently of cohesin
7RDQDO\]H WKHJHQRPLF ORFDOL]DWLRQ RI1,3%/ELQGLQJ VLWHV UHODWLYH WR FRKHVLQ DQG&7&)
we selected the NIPBL antibody (referred as NIPBL#1) that performs best in human cells 
(Figure S2DQGSHUIRUPHG&K,3VHTXHQFLQJIRU1,3%/FRKHVLQDQG&7&)XVLQJ+%FHOOV




LQ+% FHOOV E\&K,3VHTXHQFLQJ RI51$3RO ,,&K,3 IRU1,3%/60&&7&)DQG51$
Polymerase II (RNA Pol II) was performed as described in Wendt, Yoshida et al., 2008, but for 
60&$&K,3D6'6IUHHSURWRFROZDVXVHGWRPD[LPL]HWKH&K,3HI¿FLHQF\6FKPLGW:LOVRQ





and the conclusions for CdLS are discussed in detail in a later section.
6XUSULVLQJO\LQ+%FHOOVWKH1,3%/ELQGLQJVLWHVGRQRWRYHUODSZLWKFRKHVLQRU&7&)ELQGLQJ
sites (Figure 2A). Heatmaps centred on NIPBL (Figure 2B RU&7&)RU FRKHVLQELQGLQJ
sites (Figures 2C,DVKRZQRRYHUODSRIFRKHVLQRU&7&)VLJQDOVZLWK1,3%/VLJQDOV$V
H[SHFWHG WKHUHZDVD KLJK FRUUHODWLRQ EHWZHHQ FRKHVLQ DQG&7&)VLJQDOV7KHDEVHQFH
RIRYHUODSSLQJ1,3%/DQGFRKHVLQVLWHVZDVFRQ¿UPHGE\T3&5DQDO\VLVRIVHYHUDO1,3%/
and cohesin binding sites in SMC3 and NIPBL ChIP experiments, where we observed only 
background levels of NIPBL binding on cohesin sites and vice versa (Figure 2E). The missing 
colocalization between NIPBL and cohesin is in contrast with observations in mouse embryonic 
stem cells (mouse ES) that report colocalization of cohesin with NIPBL (Kagey, Newman et al., 
2010). To address this, we compared our NIPBL antibody with the one used for this study using 
the ChIP protocol described (Kagey, Newman et al., 2010) to exclude that different results are 
due to the use of different antibodies or protocols. Both antibodies perform in mouse ES cells 
HTXDOO\ZHOORQWKUHH1,3%/ELQGLQJVLWHVDWSURPRWHUVLGHQWL¿HGLQWKHVWXG\E\.DJH\HWDO
(Nanog, Lefty, Oct4) (Kagey, Newman et al., 2010). We observed that several NIPBL binding 
VLWHV LGHQWL¿HGLQKXPDQFHOOVDUHFRQVHUYHGLQPRXVH(6FHOOV7LDP$QNKG6SDQG
DOVRIRXQGWKDWRXUDQWLERG\GHWHFWVWKHVHVLWHVPRUHHI¿FLHQWO\Figure S7). A very notable 
difference between the antibodies is also observed when carrying out immunoprecipitation 
experiments from HeLa cells (Figure S2B:HDUHWKHUHIRUHFRQ¿GHQWWKDWZHGRQRWPLVV
any binding events compared to the other NIPBL antibody and the differences in the NIPBL 
binding patterns with respect to overlap with cohesin and enhancers might be explained by 
variations of the chromatin structure between stem cells and somatic cells. Cohesin may need 
to localize only transiently at NIPBL binding sites during loading and later re-localize to more 
permanent positions as suggested by studies in yeast (Lengronne, Katou et al., 2004). 
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Figure 2: Binding of NIPBL, cohesin and CTCF in the human genome.
(A)*HQRPLFELQGLQJRI1,3%/&7&)DQGWKHFRKHVLQVXEXQLWV60&DQG60&$LQWKHEUHDVWHQGRWKHOLDOFHOOOLQH
+%DWDVHOHFWHGUHJLRQRIFKURPRVRPHDVGHWHUPLQHGE\&K,3VHTXHQFLQJ7KH51$3RO,,ELQGLQJSUR¿OHWKH
FRQWURO&K,3DQG WKH51$VHTXHQFLQJGDWD IURP WKHVHFHOOVDUHDOVRVKRZQ (B-D) Heatmaps showing the ChIP 
VLJQDO LQWHQVLW\RI WKH LQGLFDWHG&K,3VHTXHQFLQJH[SHULPHQWV LQDZLQGRZRIESDURXQGDOO1,3%/SHDNV
(B)DVZHOODVWKHWRS&7&)(C) and SMC3 (D) peaks. Number of binding sites is indicated on the y-axis. 
&RKHVLQ60&60&$DQG&7&)ELQGLQJGRHVQRWFRUUHODWHZLWK1,3%/ELQGLQJHYHQWV51$3RO,,VLJQDOVDUH




background level (red horizontal line). Only the DUSP10 site is higher than the background in the SMC3 ChIP, very 
OLNHO\GXHWRD&7&)FRKHVLQVLWHFORVHWRWKH1,3%/VLWH$OOH[SHULPHQWVZHUHDWOHDVWSHUIRUPHGWKUHHWLPHVDQG
one representative example is shown.
ScaleChr19: 100 kb
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To test this we generated a HEK293T cell line expressing a doxycycline-inducible ATP-
K\GURO\VLVGH¿FLHQWPXWDQWRIFRKHVLQ¶V60&VXEXQLW60&(4IXVHGWRD&WHUPLQDO
(*)3WDJ Figures S5A,B). This mutant was suggested to represent a transition state of 
cohesin which can be loaded onto DNA but does not relocalize from the loading site (Hu, 
,WRKHWDO,PPXQRSUHFLSLWDWLRQZLWKDQWL(*)3DQWLERGLHVVKRZHGWKDW60&(4
(*)3LVLQFRUSRUDWHGLQWRWKHFRKHVLQFRPSOH[Figure S5C). Chromatin immunoprecipitation 
ZLWKDQWL(*3)DQWL60&DQGDQWL1,3%/DQWLERGLHVDQGT3&5DQDO\VLVVKRZHGWKDW1,3%/
ELQGLQJ DW WKH WHVWHG VLWHV LV FRQVHUYHG LQ+(.7 FHOOV+RZHYHU60&(4(*)3
localizes to known cohesin binding sites, not to NIPBL sites (Figure S5D). Assuming the same 
JHQHUDOSURSHUWLHVRI60&PXWDQWVEHWZHHQ\HDVWDQGKXPDQFRKHVLQWKLV¿QGLQJLQGLFDWHV
that cohesin is very likely not initially loaded at NIPBL sites. We have also considered that 
NIPBL might localize on repetitive regions since cohesin was found on centromeric repeats 
DQG$OX HOHPHQWV 7DQDND &RVPD HW DO :DL]HQHJJHU +DXI HW DO  +DNLPL
%RFKDUHWDODQGKDYHDQDO\]HGWKHHQULFKPHQWRIVHTXHQFLQJUHDGVPDSSLQJXQLTXHO\
WR WKHUHSHDWVHTXHQFHVTable S8). NIPBL is indeed highly enriched at rRNA repeats (13 
fold), in particular at the large subunit (LSU, 15 fold enriched) and small subunit (SSU, 14 fold 
enriched) repeat families. RRNA repeats are pseudogenes of unknown function distributed all 
RYHUWKHKXPDQJHQRPH-XUND.DSLWRQRYHWDO:LWK1,3%/&K,3DQGT3&5SULPHUV
VSHFL¿FIRU/68DQG668UHSHDWVZHFRQ¿UPHGIRXURI¿YH/68UHSHDWUHJLRQVDQGRQHRI
three SSU regions (Figure S5E). In total we observed NIPBL only at 20 out of 467 known 
LSU/SSU regions (Hg19 assembly of the human genome), a small subset which is unlikely 
to be of importance for cohesin loading also since it does not match with the repeat classes 
described for cohesin.
NIPBL binds to active promoters, together with a distinct set of 
transcription factors 
1,3%/ELQGLQJVLWHVDUHGLVWULEXWHGRYHUWKHHQWLUHJHQRPHUHSHWLWLYHVHTXHQFHVZHUHRPLWWHG
during the mapping of the reads to the genome) and correlate with gene density (Figure S6). 
7KHELQGLQJRI1,3%/LVYHU\VSHFL¿FRI1,3%/VLWHVLQ+%FHOOVORFDOL]HLQ
the promoter area (+/- 1000 bp from transcription start sites) (Figure 3A) while only ~10% of 
WKHFRKHVLQDQG&7&)VLWHVORFDOL]HWRSURPRWHUV$ERXWRI1,3%/ERXQGSURPRWHUVDUH
CpG island promoters (Table S4$QDO\VLVRI51$VHTXHQFLQJGDWDIURP+%FHOOVUHYHDOHG
that >98% of these NIPBL-bound genes are actively transcribed (Figure 3A and Table S3), 
indicating a preferential binding of NIPBL to active promoters. Comparison with RNA Pol II 
binding sites showed that NIPBL preferentially binds 100 – 200 nucleotides upstream of RNA 
Pol II (Figure 3B). This correlation is also visible as bimodal distribution of the RNA Pol II 
signal (Figure 2B). 
To analyse the properties of NIPBL-binding sites further, we used the NIPBL-binding sites 
REVHUYHGLQWKHFRQWURO/&/¶V1VLQFHDODUJHQXPEHURIGDWDIRUKLVWRQHPRGL¿FDWLRQVDQG
transcription factors is available for lymphoblastoid cells like GM12878 from earlier publications 




H3K27ac, H3K9ac) (Figure 3C). However, the H3K4me1 mark, characteristic for enhancers 
does not show an enrichment (Figure 3C). NIPBL itself resides apparently in nucleosome-free 
areas.
7KHPLVVLQJHQKDQFHUVSHFL¿FKLVWRQHPDUN LV LQ FRQWUDVWZLWKREVHUYDWLRQV LQPRXVH(6
cells showing a colocalization of NIPBL with enhancers and cohesin (Kagey, Newman et al., 
2010). Therefore we also compared the NIPBL binding with the enhancer marker p300 and 
the cohesin subunit RAD21 (Figure S8B) and observed again no correlation, indicating a 
difference between mouse ES cells and human somatic cells. 
0RWLIDQDO\VLVRI1,3%/ELQGLQJVLWHVLQ+%FHOOVDQG/&/¶VXVLQJ0(0(%DLOH\DQG(ONDQ
UHYHDOVWKDWWKHPRWLIVIRUWKHWUDQVFULSWLRQIDFWRU1)<$VXEXQLWRIWKH1)<FRPSOH[
are present at 80% of NIPBL sites and for SP1 at 50% of the sites (Figure 3D1)<ELQGV
the CCAAT box which correlates well with the presence of CpG islands at promoters, also a 
FRQQHFWLRQEHWZHHQ1)<DQG63KDVRIWHQEHHQUHSRUWHGZLWKSUHVHQFHRIERWKPRWLIVDW
WKHVDPHSURPRWHU7RWHVWZKHWKHUWKHSUHVHQFHRIWKH1)<$PRWLILVFRUUHODWHGWRWKH&S*
island promoter or a genuine property of the NIPBL-bound promoters we analyzed NIPBL-
bound CpG island promoters versus randomly selected CpG island promoters and observed 
DVWDWLVWLFDOVLJQL¿FDQWSUHIHUHQFH)LVKHUWHVWSRI1)<$IRU1,3%/ERXQG&S*LVODQG
SURPRWHUV&K,3ZLWK DQWL1)<%DQWLERGLHV IURP+H/D FHOOV FRQ¿UPVELQGLQJ RI WKH1)<
complex to NIPBL binding sites determined above (Figure S8A). To investigate whether other 
WUDQVFULSWLRQIDFWRUVFRORFDOL]HVSHFL¿FDOO\ZLWK1,3%/ZHFRPSDUHGWKH1,3%/VLWHVLQ/&/¶V
ZLWKDYDLODEOH&K,3VHTXHQFLQJGDWDIRUWUDQVFULSWLRQIDFWRUVIRU*0FHOOVFROOHFWHGE\
ENCODE (Consortium, 2011). 
6SHFL¿FDOO\ZHDQDO\]HGLQWRWDOELQGLQJSUR¿OHVDQGJHQHUDWHGKHDWPDSVFRYHULQJ
500 bp around NIPBL binding sites conserved in lymphoblastoid cells. By visual inspection 
RIWKHPDSVZHLGHQWL¿HG¿YHWUDQVFULSWLRQIDFWRUVSUHVHQWRQ1,3%/VLWHV1)<$1)<%DQG
63ZKLFKLVFRQVLVWHQWZLWKWKHSUHVHQFHRIWKHPRWLIDVZHOODV3%;&)26DQG,5)
(Figure 3E). The heatmaps displaying the signals of the other transcription factors on NIPBL 








- +5 kbp (See also Table S2). (B) Bubble plot representation of NIPBL binding around RNA Pol II peaks in HB2 cells. 
The x-axis denotes the position of NIPBL respective to the closest RNA Pol II peak and the y-axis the strength of 
the RNA Pol II peak. Bubble size indicates the strength of the NIPBL peak. NIPBL binds 100 - 250 bp around RNA 
Pol II peaks, preferentially upstream, which is consistent with binding to active promoters. (C) NIPBL binding in the 
FRQWURO/&/¶V1ZDVFRPSDUHGZLWKORFDOL]DWLRQRIKLVWRQHPRGL¿FDWLRQVDQG&7&)LQWKHO\PSKREODVWRLGFHOOOLQH
GM12878 (Ernst, Kheradpour et al., 2011). The plot is centred on the NIPBL peaks and the y-axis displays the signal 
LQWHQVLW\RIWKHUHVSHFWLYHKLVWRQHPRGL¿FDWLRQDQG&7&)LQ*0FHOOV(D) Consensus motif derived de-novo 
from NIPBL binding sites in HB2 cells. The region ±50 bp around the peak maximum was used to determine motifs 
with MEME (Bailey and Elkan, 1994). These motifs are nearly identical to the respective motifs of the transcription 
IDFWRUV1)<$DQG63LQGLFDWLQJWKDWRQHRUPRUHWUDQVFULSWLRQIDFWRUVPLJKWFRORFDOL]HZLWK1,3%/
(E)&RPSDULVRQRI1,3%/VLWHV LQ/&/¶V 1ZLWK&K,3VHTXHQFLQJGDWDRIYDULRXV WUDQVFULSWLRQ IDFWRUV UHYHDOHG
a subset of transcription factors colocalizing with NIPBL. The heatmaps reveal a strong correlation of PBX3, SP1, 
&)26,5)DQG1)<$%ZLWK1,3%/VLWHV(F)+HDWPDSVVKRZLQJWKHFRUUHODWLRQRIWKHIDFWRUVLQ(WR1)<%VLWHV
at GpG island promoters (sites ranked according to strength with the strongest signals at the bottom). The strongest 
FRUUHODWLRQZLWKWKHRWKHUIDFWRUVLVYLVLEOHIRUWKHVWURQJHVW1)<%SHDNV1XPEHURIELQGLQJVLWHVLVLQGLFDWHGRQWKH
y-axis.







































































































Motif 1 - NFYA
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NIPBL is important for gene activity
NIPBL-bound genes in HB2 cells were analyzed using IPA (Ingenuity® Systems, www.
ingenuity.com) and found to be linked to very different cellular functions, such as cell cycle 
FRQWUROJHQHH[SUHVVLRQFHOOGHDWK51$SRVWWUDQVODWLRQDOPRGL¿FDWLRQDQGFRQWURORIFHOOXODU
growth and proliferation (Table S5). Remarkably, 100 of the 912 NIPBL-bound genes (11%) 
might be transcription factors since they appear on the list of 1391 potential transcription 
IDFWRUVLGHQWL¿HGE\9DTXHUL]DVHWDO9DTXHUL]DV.XPPHUIHOGHWDO([DPSOHV
are SP1, SP2, SP3, BBX and STAT3, all are important transcription factors for development 
and NIPBL binding at their promoters could be important for their appropriate expression. 
To address whether NIPBL is important for the active transcription of the associated genes 
we selected functionally different genes with conserved NIPBL binding in the promoter, but 
no cohesin binding site close to the gene, and asked whether their transcription changes in 
HB2 cells after knockdown of NIPBL, MAU2 or SMC3. To avoid problems in cell division due 
to impaired sister chromatid cohesion we synchronized cells in G2 phase during the siRNA 
treatment (Figure S3B). 
Figure 4: NIPBL is important to maintain gene activity.
Transcript levels of genes with NIPBL-bound promoters and no cohesin sites close to the gene (GLCCI1, BBX, 
763$1$576DQG=1)DQGWKHFRKHVLQUHJXODWHG0<&JHQHZHUHDQDO\]HGE\573&5T3&5DIWHU51$L
depletion of NIPBL, MAU2 or SMC3 in HB2 cells. The cells were synchronized in G2 phase and the transcript 
levels are normalized against the housekeeping gene NAD. Transcripts of NIPBL and MAU2 were also analyzed to 
exclude that NIPBL affects transcription of MAU2 and vice versa. Standard deviation from three biological replicates 
LVLQGLFDWHG3YDOXHVZHUHGHWHUPLQHGXVLQJ6WXGHQWVWHVWVLJQL¿FDQWO\GLIIHUHQW3YDOXHQRWVLJQL¿FDQWO\


































































































The following genes were tested: GLCCI1, DJOXFRFRUWLFRLG LQGXFLEOH WUDQVFULSWTSPAN31, 
HQFRGLQJ D WUDQVPHPEUDQH SURWHLQ LQYROYHG LQ VLJQDO WUDQVGXFWLRQ DQG JURZWKUHJXODWLRQ
BBX, encoding a HMG-BOX transcription factor; ZNF695, DQ XQFKDUDFWHUL]HG ]LQF¿QJHU
protein and ARTS-1/ERAP1, an endoplasmic reticulum aminopeptidase. Transcript levels 
ZHUHDQDO\VHGE\573&5DQGT3&5DQGQRUPDOL]HGDJDLQVWWKHKRXVHNHHSLQJJHQHNAD. 
'HSOHWLRQRI1,3%/DQGDOVRRI0$8OHDGVWRDVWDWLVWLFDOO\VLJQL¿FDQWt-test, P-values <0,05) 
decrease of gene expression levels of the candidate genes (Figure 4), indicating that NIPBL 
and MAU2 dosage are important for maintaining expression levels. The depletion of SMC3 
GLGQRWVLJQL¿FDQWO\ UHGXFH WKHH[SUHVVLRQRI WKHVH WUDQVFULSWVDOWKRXJK WKHH[SUHVVLRQRI
the known cohesin-regulated MYC gene (Rhodes, Bentley et al., 2010) was reduced. This 
indicates that the changes in expression as a result of NIPBL depletion are not the indirect 
UHVXOWRIUHGXFHGFRKHVLQELQGLQJDQGFRKHVLQ¶VUROHIRUWUDQVFULSWLRQ
Insights into Cornelia de Lange Syndrome (CdLS)
Mutations in the NIPBLJHQHKDYHEHHQLGHQWL¿HGLQDSSUR[LPDWHO\RI&G/6SDWLHQWV2XU
discovery that NIPBL binds to active promoters prompted us to identify NIPBL binding sites in 
O\PSKREODVWRLGFHOOV/&/¶VGHULYHGIURPEORRGVDPSOHVRIVHYHUHO\DIIHFWHG&G/6SDWLHQWV
with NIPBL truncation mutations and normal controls (Figures 5A,B).
We detected 1612 NIPBL sites in the control (N5) and 2061/2009 sites in the patient-derived 
lines (PT1/PT9) with 1295 sites overlapping between N5/PT1 and 1273 sites between N5/
PT9. In summary 80% of the sites in the control N5 are also found in PT1 and PT9 (Figure 
5C). The majority (74%) of these conserved sites were also observed in HB2 cells, indicating 




such as immune response. Although expected from patient-derived cell lines with NIPBL 
KDSORLQVXI¿FLHQF\ZHGLGQRWREVHUYHVLJQL¿FDQWGLIIHUHQFHVLQSHDNQXPEHURUSHDNLQWHQVLW\
EHWZHHQFRQWUROVDQGSDWLHQWGHULYHG/&/¶V7KLVLVH[SODLQHGE\WKHUDWKHUVPDOOGLIIHUHQFHV
of NIPBL protein levels between CdLS patients and controls (Liu, Zhang et al., 2009) due to 
LQFUHDVHGWUDQVFULSWLRQIURPWKHLQWDFWDOOHOH7KH&K,3VHTXHQFLQJPHWKRGLVQRWTXDQWLWDWLYH
DQG WKHUHIRUH VPDOO FKDQJHV RI1,3%/ OHYHOVPLJKW QRW EH UHÀHFWHG E\ SHDN LQWHQVLW\7R
DGGUHVV WKLV ZH SHUIRUPHG1,3%/&K,3T3&5 IURP IRXU FRQWURO FHOO OLQHV DQG IRXU &G/6
patient cell lines with primers for seven NIPBL binding sites and one cohesin binding site 
(negative control). QPCR revealed a reduction of the NIPBL signal between the control and 
patient-derived cell lines (Figures 5D and S9), but also variations among individual control 
and patient-derived cell lines. In general, strong NIPBL binding sites (OSBP, GPR108) seem 
to be more reduced than weaker binding sites. The position of NIPBL at promoters could be 
important for the emergence of the developmental defects seen in CdLS cases. Therefore we 
compared NIPBL binding sites with a list of genes found to be differentially expressed between 
/&/¶VIURP&G/6SDWLHQWVDQGFRQWUROV/LX=KDQJHWDO
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Figure 5: Position of NIPBL sites is conserved but the occupancy is reduced in CdLS.
(A)1,3%/&K,3VHTXHQFLQJGDWDRIDUHJLRQRIFKURPRVRPHVKRZLQJWKDW1,3%/VLWHVDUHFRQVHUYHGEHWZHHQ
CdLS patient cells and the control. (B) CdLS patient and control cell lines used in this study. The cell lines highlighted 
ZHUH XVHG IRU &K,3VHTXHQFLQJ 7KH WDEOHV ZHUH GHULYHG IURP /LX =KDQJ HW DO  1XFOHRWLGH QXPEHULQJ
UHIHUVWRWKH1,3%/%LVRIRUPF'1$VHTXHQFHZLWK*HQH%DQNDFFHVVLRQQXPEHU10BDQGVWDUWLQJDWWKH
position of the translation initiation codon. (C) Venn diagrams indicating the number of NIPBL binding sites observed 
LQWKHGLIIHUHQW/&/¶VDQGDOVRWKHVLWHVFRQVLVWHQWO\FDOOHGLQDOOWKUHHOLQHV7KHPDMRULW\RIELQGLQJVLWHVLVFRQVHUYHG
DOWKRXJKHDFKFHOO OLQHGLVSOD\VFHOOOLQHVSHFL¿FVLWHV (D)1,3%/ELQGLQJ LV UHGXFHG LQ/&/¶VGHULYHG IURP&G/6
patients. NIPBL ChIP was performed for four patient-derived cell lines and four age and gender-matched controls 
DQGT3&5DQDO\VLVZDVSHUIRUPHGIRUVHYHQ1,3%/ELQGLQJVLWHVDQGRQHFRKHVLQVLWH7KHHQULFKPHQWFRPSDUHG
WRFRQWURO,J*&K,3ZDVFDOFXODWHG7KHGDWDIRUWKHLQGLYLGXDOFHOOOLQHVDUHGLVSOD\HGLQ)LJ6+HUHZHSUHVHQW
the average relative enrichment for all control and patient-derived lines, p-values derived with a Student test are 
indicated above the respective columns. (E)0RGHO LOOXVWUDWLQJ WKHGXDO UROHRI1,3%/1,3%/FDQ LQÀXHQFHJHQH
DFWLYLW\E\DFWLQJDV³FRKHVLQORDGHU´IRUWKHFRKHVLQFRPSOH[HVSURPRWLQJWRJHWKHUZLWK&7&)FKURPDWLQLQVXODWLRQ





































ID Gender Age(yr) Genotype*
PT1 M 6.9 c.6407insA / Frameshift
PT9 F 7 c.742_743delCT / Frameshift
PT16 F 9 c.4606C>T / Nonsense
PT2 M 0 c.2449_2450insG / Frameshift
Normal controls

































between controls and CdLS patients (Liu, Zhang et al., 2009) with our list of 1671 genes 
QHLJKERXULQJD1,3%/VLWHNE LQWKHSDWLHQWGHULYHG/&/¶V37DQGIRXQGWKDW
(10%) of these genes are differentially expressed (Table S7DVWDWLVWLFDOVLJQL¿FDQWQXPEHU
ZKHQFRPSDUHGWRDUDQGRPOLVWRIJHQHV)LVKHUWHVWS
Discussion
In its classical function, NIPBL promotes the chromatin association of the cohesin complex, but 
is dispensable for maintenance of the chromatin association of cohesin. Rules that regulate 
the place and time of cohesin loading and targeting to its various functions (sister chromatid 
cohesion, transcriptional regulation, mediating long-range chromatin interactions and DNA 
GDPDJHUHSDLUDUHRQO\SDUWO\XQGHUVWRRG)DFWRUVLQWHUDFWLQJZLWKFKURPDWLQERXQGFRKHVLQ
VXFKDVWKHFKURPDWLQLQVXODWRU&7&)3DUHOKR+DGMXUHWDO5XELR5HLVVHWDO
Wendt, Yoshida et al., 2008) and to a smaller extend estrogen receptor alpha (ERa) (Schmidt, 
Schwalie et al., 2010) determine the localization of cohesin, but not its general chromatin 
binding (Wendt, Yoshida et al., 2008). They might either direct NIPBL-dependent cohesin 
ORDGLQJWRWKHLUELQGLQJVLWHVRUFDSWXUHFRKHVLQFRPSOH[HVWKDWVOLGHDORQJWKH'1$¿EUH
)LUVWZHKDYHDGGUHVVHGZKHQFRKHVLQ&7&)DQG1,3%/DVVRFLDWHZLWKFKURPDWLQ6RIDU
only very weak and probably transient interactions have been reported between cohesin and 
NIPBL in the non-chromatin-bound pool of nuclear proteins (Watrin, Schleiffer et al., 2006). If 
WKHVHWUDQVLHQWLQWHUDFWLRQVDUHVXI¿FLHQWIRU1,3%/DQG&7&)WRELQGFRKHVLQDQGUHFUXLWLW
onto chromatin, we would expect the proteins to appear on chromatin at the same time after 
PLWRVLV$QDO\VLVRIFHOOVH[LWLQJPLWRVLVE\LPPXQRÀXRUHVFHQFHVWDLQLQJVKRZHGWKDW1,3%/
&7&) DQG FRKHVLQ DUH ODUJHO\ H[FOXGHG IURP PHWDSKDVH FKURPRVRPHV DV VHHQ EHIRUH
:HQGW<RVKLGDHWDO7KHVLJQDOVRI1,3%/DQG&7&)UHDSSHDURQ'1$EHIRUHWKH
nuclear envelope reassembles but cohesin overlaps with chromatin only during or after the 





enriched in G1 phase and observed about 1100 NIPBL sites, mostly at active CpG-island 
SURPRWHUVEXWZLWKRXWDQ\RYHUODSZLWKFRKHVLQRU&7&)VLWHV0LVVLQJFRORFDOL]DWLRQEHWZHHQ
NIPBL and cohesin was observed before. In yeast, non-overlapping foci were observed 
for Scc2 (NIPBL ortholog in S. cerevisiae) and Scc1 (RAD21 ortholog in S. cerevisiae) by 
LPPXQRÀXRUHVFHQVH PLFURVFRS\ RQ VSUHDG FKURPDWLQ &LRVN 6KLUD\DPD HW DO 
)XUWKHUD&K,3PLFURDUUD\VWXG\LQEXGGLQJDQG¿VVLRQ\HDVWREVHUYHGDWUDQVLHQWRYHUODS
EHWZHHQFRKHVLQDQG6FFLQ*SKDVHFHOOVDQGDVXEVHTXHQWUHORFDOL]DWLRQRIFRKHVLQWR
more permanent positions between convergently transcribed genes (Lengronne, Katou et al., 
$QRWKHUVWXG\LQ\HDVWFRQ¿UPHGWKLVSURSHUW\RIFRKHVLQ+X,WRKHWDOZKLOH
a third study observed that colocalization of Scc2 with cohesin persists also after cohesin 
121
loading (Kogut, Wang et al., 2009). In D. melanogaster the NIPBL ortholog, Nipped-b, was 
found to colocalize with cohesin and often overlap with RNA polymerase II, decorating entire 
active transcriptional units (Misulovin, Schwartz et al., 2008). Remarkably, cohesin does not 
FRORFDOL]HZLWK&7&)LQWKHIUXLWÀ\$VWXG\LQPRXVHHPEU\RQLFVWHPFHOOVUHSRUWHGWKDW1,3%/
occupies enhancers and core promoter regions of transcriptionally active genes which are 
also bound by cohesin and by Mediator, a huge transcriptional co-activator complex (Kagey, 
Newman et al., 2010) (for review see Malik and Roeder, 2010). Although we observe a similar 
localization of NIPBL we did not detect cohesin at NIPBL sites, even with relaxed parameters 
for peak calling and different ChIP protocols. Possible explanations for the difference might 
be a different occupancy of chromatin by cohesin and NIPBL in embryonic stem cells than in 
differentiated cells. This is actually supported by the same study demonstrating that the binding 
of cohesin and mediator is very different between mouse ES cells and mouse embryonic 
¿EUREODVWV.DJH\1HZPDQHWDO7KH1,3%/DQWLERGLHVXVHGLQRXUVWXG\UHFRJQL]HG
more NIPBL forms in HeLa cells than antibodies used by Kagey et al. (Kagey, Newman et al., 
2010) (Figure S2B). In mouse ES cells our antibody performs similarly and better than the 
commercial NIPBL antibody (Figure S7). It is therefore unlikely that we missed NIPBL binding 
events due to the performance of the antibody.
Could the NIPBL-binding sites be cohesin loading sites, despite the lack of colocalization? 
Promoters are open chromatin regions which would allow NIPBL direct access to the DNA 
strand to load cohesin. In yeast it was found that the cohesin-loading site at the centromere 
affects cohesin-loading up to 50 kb away (Hu, Itoh et al., 2011). The same study suggested that 
FRKHVLQFRQWDLQLQJ$73K\GURO\VLVGH¿FLHQW60&RU60&PXWDQWVUHSUHVHQWVDWUDQVLWLRQ
state in cohesin loading that does not permit cohesin to relocalize from its loading sites (Hu, 
Itoh et al., 2011). The Walker B/DA box motif of SMC3 is highly conserved between yeast 
and human. Therefore we expressed the respective human SMC3 mutant (SMC3E1155Q) in 
HEK293T cells and observed binding to classical cohesin but not NIPBL sites. Thus cohesin 
might be loaded to its binding sites very rapidly and a very transient interaction with NIPBL 
during loading may not be captured by ChIP.
We have also considered repetitive DNA elements as potential loading sites for mammalian 
FRKHVLQVLQFHLWKDVEHHQIRXQGEHIRUHRQFHQWURPHULFUHSHDWV/RVDGD<RNRFKLHWDO
Waizenegger, Hauf et al., 2000), Alu repeats (Hakimi et al. 2002) and D4Z4 repeats (Zeng, de 
Greef et al., 2009 ) and NIPBL was found to associate with D4Z4 repeats (Zeng, de Greef et 
DO:HWKHUHIRUHDQDO\VHGRXU1,3%/&K,3VHTXHQFLQJGDWDIRUELQGLQJWRUHSHWLWLYH
regions and found enrichment at several LSU and SSU rRNA repeat regions, but not at the 
repeats previously described for cohesin. 
The striking localization of NIPBL to promoter of active genes suggested that NIPBL may 
have a direct role for the transcription of the associated genes. We observe that the transcript 
levels of several NIPBL-bound genes decrease after RNAi depletion of NIPBL and MAU2. 
An effect on the transcripts by impaired cohesin loading cannot be entirely excluded but we 
observe that depletion of SMC3 does not have the same effect on the transcripts. Therefore we 
hypothesize that NIPBL could have a role as transcription factor, independent from its function 
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IRUFRKHVLQ$GLIIHUHQWLDOHIIHFWRI1,3%/DQGFRKHVLQKDVDOUHDG\EHHQREVHUYHGLQWKHÀ\
1LSSHGE IDFLOLWDWHV DFWLYDWLRQ RI WKH FXW JHQH EXW VWURPDOLQ6FF WKH À\ RUWKRORJV RI WKH
6$6$FRKHVLQVXEXQLWLQKLELWVLWVDFWLYDWLRQ$UHFHQWVWXG\LQ]HEUD¿VKXVLQJPRUSKROLQR
knockdown observed a reduced transcription of several genes, including the transcription 
factors sox17, foxa2 and sox32, after NIPBL knockdown but not in smc3 and rad21 morphants 
(Muto, Calof et al., 2011).
We also found that a large number of NIPBL-bound genes are transcription factors, 100 of 
912 NIPBL-bound genes in HB2 cells localize at promoters of transcription factors. A number 
of them are very important during development and can also be found on the list of genes 
differentially expressed in CdLS, for example STAT3 and YBX1 (Table S8). Studies using 
mouse models show that the absence of these factors (STAT3, YBX1) leads to severe 
GHYHORSPHQWDOGHIHFWVDQGHPEU\RQLFOHWKDOLW\7DNHGD1RJXFKLHWDO/X%RRNVHWDO
/X%RRNVHWDO1,3%/GH¿FLHQF\FRXOGWKHUHIRUHLQWHUIHUHZLWKWKHSURSHUWLPLQJ
and expression of transcription factors during development.
The observation that NIPBL might be important for gene expression lead us to ask whether 
1,3%/KDSORLQVXI¿FLHQF\LQ&G/6FDQEHOLQNHGWRWUDQVFULSWLRQDOFKDQJHVREVHUYHGLQWKHVH
SDWLHQWV :H KDYH GHWHUPLQHG 1,3%/ VLWHV LQ XQV\QFKURQL]HG /&/¶V GHULYHG IURP &G/6
SDWLHQWVZLWK1,3%/KDSORLQVXI¿FLHQF\DQGQRUPDO FRQWUROV7KHVHELQGLQJ VLWHVDUHDJDLQ
PRVWO\ORFDWHGDW&S*LVODQGSURPRWHUVQRWRYHUODSSLQJFRKHVLQRU&7&)7KHVLWHVDUHLQ
part conserved between different tissues, 85% of NIPBL sites conserved between different 
/&/¶VDUHDOVRIRXQGLQ+%FHOOVLQGLFDWLQJWKDWWKHUHDUHFRQVWLWXWLYHDQGFHOOW\SHVSHFL¿F
VLWHV7KHSRVLWLRQVRIWKH1,3%/ELQGLQJVLWHVDUHFRQVHUYHGEHWZHHQWKH/&/¶VIURPSDWLHQWV
and controls, but the actual levels of NIPBL binding are reduced in patients with a hypomorphic 
NIPBL truncation. To link NIPBL sites to differential gene expression we compared NIPBL-
ERXQGJHQHVLGHQWL¿HGLQDSDWLHQWFHOOOLQH37ZLWKFDQGLGDWH&G/6WDUJHWJHQHVLGHQWL¿HG
E\/LXHWDO/LX=KDQJHWDODQGREVHUYHGWKDWDVLJQL¿FDQWSHUFHQWDJH)LVFKHU
test P<0,001) of these genes have a NIPBL binding site. When we asked whether NIPBL 
RNAi affects gene expression (Figure 4) a subset of these genes was tested and found to be 
sensitive to NIPBL knockdown. This leads us to the conclusion that a part of the differentially 
expressed genes in CdLS could be direct targets of NIPBL, and the observed CdLS phenotype 
could be a cumulative effect of small changes in the transcriptional program of a larger number 
of genes.
&RPSDULVRQRI1,3%/VLWHV LQ/&/¶VZLWKSXEOLVKHGELQGLQJSUR¿OHVRI WUDQVFULSWLRQ IDFWRUV
in the lymphoblastoid cell line GM12878 revealed that NIPBL colocalizes with several 
WUDQVFULSWLRQ IDFWRUV 63 1)< 3%; F)26 ,5) 3E[ EHORQJV WR WKH 3E[ IDPLO\ RI
TALE (three amino acid loop extension)-class of homeodomain transcription factors which 
are implicated in developmental and transcriptional gene regulation in numerous cell types. 
3E[GH¿FLHQWPLFHGLHDIWHUELUWKGXHWRQHXURQDOPDOIXQFWLRQV5KHH$UDWDHWDO7KH
factor is important for facial development in mice (Di Giacomo, Koss et al., 2006) together with 
Pbx1 and Pbx2 and a human Pbx3 mutation was linked to heart defects (Arrington, Dowse 
HWDO,5)LQWHUIHURQUHJXODWRU\IDFWRULVDQ,5)IDPLO\WUDQVFULSWLRQIDFWRUZKLFK
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translocates from the cytoplasm to the nucleus upon activation, where it acts together with 
CBP/p300 to activate transcription of interferons alpha and beta, as well as other interferon-
LQGXFHGJHQHVIRUUHYLHZVHH<RQH\DPD6XKDUDHWDO&)26LVSDUWRI WKH$3
DFWLYDWRUSURWHLQWUDQVFULSWLRQIDFWRUFRPSOH[ZKLFKDOVRFRQWDLQVWKH-81$7)DQG0$)
proteins. The complex regulates genes involved in cell proliferation, differentiation, apoptosis, 
angiogenesis and tumour invasion and can have oncogenic but also anti-oncogenic properties 
depending on cell type or differentiation state (Eferl and Wagner, 2003). How these factors 
functionally interact with NIPBL remains to be investigated. 
In summary, we show in this study when and where NIPBL binds to the human genome and 
GLVFRYHUHGWKDW1,3%/SUHIHUHQWLDOO\ORFDOL]HVWRDFWLYHSURPRWHUVWRJHWKHUZLWKDVSHFL¿FVHW
of other transcription factors. NIPBL is important for the activity of the bound genes, suggesting 
WKDW1,3%/LQÀXHQFHVWUDQVFULSWLRQLQWZRZD\VGLUHFWO\GXHWRLWVELQGLQJWRWKHSURPRWHUVDQG
indirectly by loading of cohesin complexes which then regulate genes by chromatin insulation 
and chromosomal long-range interactions (Figure 5E). The possibility that NIPBL directly 
DIIHFWVH[SUHVVLRQVXJJHVWV WKDW1,3%/GH¿FLHQF\DOVRGLUHFWO\ FRQWULEXWHV WR WKHFRPSOH[




If different antibodies for the same protein were used the antibodies were numbered to clearly 
identify them in the different experiments.
NIPBL#1 - polyclonal rabbit anti-NIPBL antibody raised against residues 2598-2825 of the X. 
laevis6FF%SXUL¿HGXVLQJWKHHSLWRSHXVHGIRULPPXQL]DWLRQ0
NIPBL#2 - polyclonal rabbit anti-NIPBL antibody raised against residues 787-1164 of X. 
laevis 6FF% SXUL¿HG XVLQJ WKH HSLWRSH XVHG IRU LPPXQL]DWLRQ 0 *HQHUDWLRQ DQG
characterisation of the NIPBL #1 and NIPBL #2 antibodies have been published already 





NIPPBL#5 - polyclonal rabbit anti-NIPBL antibody raised against a region between amino acid 
residues 550 and 600 of human NIPBL (Bethyl Laboratories A301-778A)
NIPPBL#6 - polyclonal rabbit anti-NIPBL antibody raised against a region between amino acid 




SMC1A#1 - polyclonal rabbit anti-SMC3 antibodies (Bethyl Laboratories A300-055A)
SMC3 - polyclonal rabbit anti-SMC3 antibodies obtained from Jan-Michael Peters, described 
for immunoprecipitation and ChIP in (Sumara, Vorlaufer et al., 2000) and (Wendt, Yoshida et 
al., 2008).
MAU2 - polyclonal rabbit anti-MAU2(Scc4), described in (Watrin, Schleiffer et al., 2006).
RNA Pol II - polyclonal rabbit antibody (N-20) (Santa Cruz sc-899)
Tubulin - mouse anti-tubulin (Sigma) 
Control IgG - rabbit whole serum 
Rad21 - polyclonal rabbit anti-RAD21 (Jan-Michael Peters), described in (Waizenegger, Hauf 
et al., 2000)
Cell culture
HeLa cells were cultured in DMEM supplemented with 0.2mM L-glutamine, 100 units/ml 
SHQLFLOOLQPJPOVWUHSWRP\FLQDQG)&6
HB2 cells (1-7HB2, a clonal derivative of the human mammary luminal epithelial cell line 
MTSV1-7, (Bartek, Bartkova et al., 1991) were cultured in DMEM supplemented with 
P0 /JOXWDPLQH  XQLWVPO SHQLFLOOLQ  PJPO VWUHSWRP\FLQ  )&6  JPO
hydroxycortisone and 10 μg/ml human insulin.
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Lymphoblastoid cell lines derived from controls and Cornelia de Lange syndrome patients 
(Figure 5BZHUHREWDLQHGIURP,DQ.UDQW]7KH&KLOGUHQ¶V+RVSLWDORI3KLODGHOSKLD3KLODGHOSKLD
Pennsylvania, United States of America) and cultured in RPMI medium supplemented with 
P0/JOXWDPLQHXQLWVSHUPOSHQLFLOOLQPJSHUPOVWUHSWRP\FLQ)&6




The following siRNA oligos purchased form AMBION were used to deplete the respective 
proteins for ChIP-analysis and analysis of transcription
GL2 
sense       CGUACGCGGAAUACUUCGAtt
antisense UCGAAGUAUUCCGCGUACGtt
NIPBL
sense       GCAUCGGUAUCAAGUCCCAtt
antisense UGGGACUUGAUACCGAUGCtt
MAU2
sense       GCAUCGGUAUCAAGUCCCAtt
antisense UGGGACUUGAUACCGAUGCtt
SMC3
sense       AUCGAUAAAGAGGAAGUUUtt
antisense AAACUUCCUCUUUAUCGAUtg
The following hairpin siRNA constructs in the pLKO.1–puro vector were obtained from the TRC 
0LVVLRQKXPDQOLEUDU\6LJPDDQGZHUHXVHGWRGHSOHWH1,3%/GHPRQVWUDWHWKHVSHFL¿FLW\
of the NIPBL antibodies:
&RQWUROFORQH6+&QRQWDUJHWLQJVHTXHQFH
1,3%/FORQH75&1WDUJHWLQJVHTXHQFH*&$*$*$&$*$$*$7*$7*$$
The transfection of the siRNA oligos was performed with Lipofectamine RNAiMAX (Invitrogen) 
DFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV7KHWUDQVIHFWLRQRIWKHKDLUSLQVL51$FRQVWUXFWV
ZDV SHUIRUPHG ZLWK /LSRIHFWDPLQH  ,QYLWURJHQ DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V
instructions. Cells were harvested 48 hours after transfection. 
7RSHUIRUPLVRIRUPVSHFL¿F51$LKDLUSLQVL51$ROLJRVWDUJHWLQJWKHGLIIHUHQW LVRIRUPVZHUH
FORQHG LQ WKH S683(5FKHUU\QHR YHFWRU 7KH VHTXHQFHV DUH DYDLODEOH XSRQ UHTXHVW 7KH




with TX100 and blocking with 3% BSA the slides were stained with the respective antibodies. 
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,PDJHVZHUHWDNHQRQD/HLFD'05%(PLFURVFRSHHTXLSSHGZLWKD+DPDWVX&&'&
camera with a 100X objective. Images were processed with Image J, the colouring, overlay of 








in hypotonic buffer (20mM Hepes-KOH pH 8.0, 5mM KCl, 1.5mM MgCl2, 0.1mM DTT). Nuclei 
were collected by centrifugation and extracted for 30 min on ice with extraction buffer (15mM 
Tris-HCl pH 7.5, 1mM EDTA, 0.4 M NaCl, 10% sucrose, 0,01%TX-100, 1mM DTT and 1 tablet 
Complete (Roche) per 50 ml buffer). Debris were removed by centrifugation (14.000 rpm, 30 
min). 
The nuclear extract was diluted to 50% with IP buffer (20mM Tris-HCl pH 7.5, 100mM NaCl, 
P00J&O 13 P01D) P0'77 DQG LQFXEDWHG IRU  K DW &ZLWK WKH
UHVSHFWLYHDQWLERGLHV$I¿3UHS3URWHLQ$VXSSRUWEHDGV%LR5DGZHUHDGGHGDQGLQFXEDWHG
KDW&7KHEHDGVZHUHZDVKHGWLPHVZLWK,3EXIIHUDQGSURWHLQVZHUHHOXWHGE\ERLOLQJ
with SDS-page loading buffer. Western blots were analyzed with ECL+ reagent and Alliance 
imaging system.
Chromatin immunoprecipitation




inhibitor (Roche)) and chromatin was sonicated (Diagenode Bioruptor) to around 500 bp 
DNA fragments. Debris were removed by centrifugation, the lysate diluted 1:4 with IP dilution 
buffer (20mM Tris-HCl pH 8.0, 0.15 M NaCl, 2mM EDTA, 1% TX-100, protease inhibitors) and 
SUHFOHDUHGZLWK$I¿3UHS3URWHLQ$VXSSRUWEHDGV%LR5DG




buffer II (20mM Tris-HCl pH 8.0, 0.5 M NaCl, 2mM EDTA, 1% TX-100, 0,1% SDS, 1mM 
306)ZDVKLQJEXIIHU,,,P07ULV+&OS+0/L&OP0('7$13
sodium desoxycholate) and TE-buffer (10mM Tris-HCl pH 8.0, 1mM EDTA). The chromatin 
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from the beads were eluted twice (25mM Tris-HCl pH 7.5, 5mM EDTA, 0.5% SDS) for 20 
PLQDW&7KHHOXDWHVZHUH WUHDWHGZLWKSURWHLQDVH.DQG51DVH IRUKDW&DQG
GHFURVVOLQNHGDW &RYHUQLJKW7KHVDPSOHVZHUH IXUWKHUSXUL¿HGE\SKHQROFKORURIRUP
extraction and ethanol-precipitated. The pellet was dissolved in 50Pl TE buffer.
7KLVSURWRFROZDVXVHGWRSHUIRUP&K,3T3&5RU&K,3VHTXHQFLQJIRU&7&)60&1,3%/
DQG51$SRO\PHUDVH,,)RU60&$DPLOGHU&K,3SURWRFROIURP'XQFDQ2GRP¶VJURXSZDV
used (Schmidt, Wilson et al., 2009). 
)RU1,3%/&K,3VHTXHQFLQJ+%FHOOVZHUHV\QFKURQL]HGLQ*SKDVHE\DGRXEOHWK\PLGLQH
block as described (Nativio, Wendt et al., 2009) (Figure S8). All other preparations were 
GRQHIURPXQV\QFKURQL]HGFHOOV)RU1,3%/&K,3WKHFHOOVZHUHV\QFKURQL]HGLQ*SKDVH
by double thymidine block, starting 6 hours after transfection of the NIPBL targeting or control 
siRNA oligos. Details of the thymidine block to obtain HeLa cells in G1 phase have been 





ChIP sequencing and peak detection




generation was performed using the Illumina Cluster Reagents preparation. The libraries for 
1,3%/&7&)60&51$3RO,,DQGWKHUHVSHFWLYHFRQWUROVJHQHUDWHGIURP+%FHOOVZHUH
VHTXHQFHGRQWKH,OOXPLQD*HQRPH$QDO\]HU,,WKH60&$&K,3VDPSOHVIURP+%FHOOV
WKH1,3%/&K,3VDPSOHV IURP/&/VDQG WKH UHVSHFWLYHFRQWUROVZHUHVHTXHQFHGZLWK WKH
,OOXPLQD+L6HTV\VWHP5HDGOHQJWKVRIEDVHVZHUHREWDLQHG,PDJHVZHUHUHFRUGHG
and analyzed by the Illumina Genome Analyzer Pipeline (GAP 1.6.0. and 1.7.0.). The resulting 
VHTXHQFHVZHUHPDSSHGDJDLQVW+XPDQB8&6&KJXVLQJWKH%RZWLH/DQJPHDG7UDSQHOO
et al., 2009) alignment software, with the following parameters: bowtie -m 1 -S -k 1 –n 1. 
8QLTXHUHDGVZHUHVHOHFWHGIRUIXUWKHUDQDO\VLV
3HDN FDOOLQJ IRU WKH &K,3 VHTXHQFLQJ GDWD GHULYHG IURP +% FHOOV ZDV SHUIRUPHG ZLWK
6:(0%/6FKPLGW6FKZDOLHHWDO:LOGHU7K\EHUWHWDOPDQXVFULSWLQSUHSDUDWLRQ
with the respective parameters described in Table S1. 
&RORFDOL]DWLRQ UHDG GHQVLW\ SUR¿OHV ZHUH GRQH E\ H[WHQGLQJ D UHJLRQ DURXQG HDFK SHDN




Complete Ensembl hg18 gene dataset was downloaded on 13.04.2011. The genome was 
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separated into 4 regions: promoter (+/- 1kb from the TSS), upstream (-5000 from the TSS), 
downstream (+5000 from the gene end) and gene body. A region of +/-150 bp was extended 
around each peak and overlapped with the genomic annotation.
Peaks were designated into one category based on the following order of preference: 
promoter -> gene body -> upstream -> downstream.
3HDN FDOOLQJ IRU WKH &K,3 VHTXHQFLQJ GDWD GHULYHG IURP&G/6 SDWLHQWV DQG FRQWUROV ZDV
performed as follows. We switched at this point to a different peak calling algorithm to ensure 
optimal comparability of the data with other datasets generated for lymphoblastoid cells in the 
Shirahige lab. 
6HTXHQFHGUHDGVRIERWK&K,3DQG:&(ZHUHDOLJQHGWRWKHKXPDQJHQRPH8&6&KJ
using Bowtie (Langmead, Trapnell et al., 2009) allowing 3 mismatches. We analysed only 
XQLTXHO\ DOLJQHG UHDGV IRU FDOOLQJ SHDNV (DFK DOLJQHG UHDGZDV H[WHQGHG WR D SUHGLFWHG
fragment length of 150bp. Reads were summed in 10bp bins along the chromosome for ChIP 
and WCE, respectively. The read number of each bin was smoothed with a 500bp width. We 
scanned the genome with a 300bp sliding window, which consisted of 30 bins. One-sided 




this were: 1. the average number of ChIP reads in region / the average number of ChIP reads 
in the genome >3.0 or 2. the maximum read intensity in ChIP bins (less than 30 reads per a 
bin).
Repeat analyses
7R LQYHVWLJDWH WKH UHSHDWHQULFKPHQWSDWWHUQZHXVHGERWKXQLTXHO\ DQGPXOWLSO\DOLJQHG
UHDGV0XOWLSO\DOLJQHGUHDGVZHUHGLYLGHGHTXDOO\DPRQJVWDOO ORFDWLRQV 1WLPHVPDWFKHG
reads were weighted as 1/N reads). The reads which were aligned to reference genome more 
than 10 times were discarded. We applied RPKM measure (reads per kilobase per million 
UHDGVZKLFKZDVXWLOL]HG IRU51$VHTDQDO\VHV 0RUWD]DYL:LOOLDPVHWDOEXWZH
used “per 10 million reads” instead of “per million reads”. We counted the reads which were 
aligned to each repeat class and normalized the counts against the total number of aligned 
reads (whole-genome) and the total length of each repeat class.
RNA sequencing
HB2 cells were enriched in G1 phase by double thymidine block as described (Nativio, Wendt 
HWDO7KH51$ZDV LVRODWHGXVLQJ75,UHDJHQW 6LJPDDFFRUGLQJ WR WKHVXSSOLHU¶V






cDNA using reverse transcriptase and random primers. This is followed by second strand 




SURWRFROV ZZZLOOXPLQDFRP 7KH VDPSOH ZDV VHTXHQFHG IRU ES DQG UDZ GDWD ZDV




reads and the expression value was determined for each gene by taking the RPKM (Mortazavi, 




Motif analysis was performed with the tools MEME and MEME-ChIP (Bailey and Elkan, 1994). 
Residues +/- 50 bp of NIPBL binding site peaks were retrieved and submitted to MEME-ChIP 
using standard parameters.
7RDQDO\VHZKHWKHUWKHSUHVHQFHRIWKH1)<DPRWLIDW1,3%/VLWHVLVGXHWRWKHSUHVHQFH
of CpG islands or is a genuine property of NIPBL binding we selected NIPBL binding sites 





factors generated from GM12878 cells and deposited by the Myers lab (HudsonAlpha Institute 
for Biotechnology) and the Snyder lab (Yale University). When called peaks were available 
they were used, else replicates were pooled and peak calling performed with MACS (Zhang, 
Liu et al., 2008). Peaks were sorted for intensity and for the 10000 ,5000 and 1000 (in case of 
NIPBL) strongest peaks heatmaps were generated centred on NIPBL binding sites conserved 
in the different lymphoblastoid cell lines and also centred on the peaks of the respective 




P300, Pax5, Pbx3, Pml, Pol2, Pol3, Pou2, Pu1, Rad21, Rfx, Runx3, Rxlch, Rxra, Six5, Smc3, 




Bhlh, Brca1, Cfos, Chd2, Ctcf, Ebf1, Gcn5, Irf3, Jund, Max, Mxi1, Nfe2, Nfya, Nfyb, Nrf1, 
P300, Rad21, Rfx, Smc3, Spt, Stat1, Stat3, Tbp, Tr4, Usf2, Whip, Yy1, Znf143, Znf274, Zzz3
Transcript analysis 
HB2 cells were transfected with the respective siRNA oligos using Lipofectamine 2000 and 
were harvested after 48 hours. The RNA was prepared using TRI reagent (Sigma). Remaining 
DNA was removed by DNAse treatment and cDNA synthesis was performed with Superscript 
UHYHUVH7UDQVFULSWDVH,QYLWURJHQXVLQJROLJRG7SULPHUV7KHT3&5DQDO\VLVZDVSHUIRUPHG
as described (Wendt, Yoshida et al., 2008). The transcripts of the housekeeping gene NAD 
were used for normalization of the samples. ''Ct method was used to calculate the fold 
change in gene expression. 
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NIPBL (red). Images from different stages during the exit from mitosis were taken. In (A) the cohesin signal can only 
be observed overlapping with chromatin when a nuclear envelop is visible (white arrows in c and d). In contrast the 























:H ¿UVW FKDUDFWHUL]HG GLIIHUHQW DQWLERGLHV UDLVHG DJDLQVW 1,3%/ D  N'D SURWHLQ WKDW LV GLI¿FXOW WR GHWHFW E\
LPPXQREORWWLQJDQG LPPXQRÀXRUHVFHQVHVWDLQLQJ)RUGHWHFWLRQE\ZHVWHUQEORWWLQJZHXVHG WZR UDWPRQRFORQDO
DQWLERGLHVDJDLQVWWKHWZRPDMRULVRIRUPVRI1,3%/,VRIRUP$13B1,3%/DQG,VRIRUP%13B
NIPBL#4). The isoforms are splice variants of the last exon, residues 1-2683 are identical but isoform A contains 121 
DQGLVRIRUP%XQLTXH&WHUPLQDOUHVLGXHV
(A) :HVWHUQ EORW VKRZLQJ WKDW WKH EDQG UHFRJQL]HG E\ 1,3%/ FDQ EH GHSOHWHG E\ 1,3%/VSHFL¿F VL51$ LQ
unsynchronized HeLa cells while it remains well visible in two control siRNA transfections. 
(B) Immunoprecipitations with the rabbit anti-NIPBL antibodies NIPBL#1 and NIPBL#6 antibodies and anti-SMC3 
antibodies were performed from nuclear extract of G1-phase enriched HeLa cells. Two identical western blots 






from mouse ES cells, precipitates only the lower bands. We concluded that the NIPBL#1 antibody recognizes a wider 
VSHFWUXPRI1,3%/SRVWWUDQVODWLRQDOO\PRGL¿HGIRUPV
,QWHUHVWLQJO\ WKHDQWLERG\DJDLQVW WKHFRKHVLQVXEXQLW60&GLGQRWSUHFLSLWDWHDQ\RI WKH1,3%/LVRIRUPV)LJ



































































Dean/Jett/Fox: %G1 = 29.96; %S = 19.14; %G2 = 40.45.
Event count: 4844












Dean/Jett/Fox: %G1 = 46.3; %S = 29.46; %G2 = 18.32.
Cell cycle distribution:
Event Count: 4619











HB2 cells unsynchronized HB2 cells enriched in G1 phase
Dean/Jett/Fox: %G1 = 10.07; %S = 14.57; %G2 = 71.47.
Event count: 6416












Dean/Jett/Fox: %G1 = 8.086; %S = 31.33; %G2 = 56.38.
Event count: 890












Dean/Jett/Fox: %G1 = 7.398; %S = 22.35; %G2 = 62.29.
Event count: 3774










Dean/Jett/Fox: %G1 = 11.87; %S = 23.22; %G2 = 61.25.
Event count: 188


























(A) Genomic binding of NIPBL in a selected region on chromosome 19 in comparison between HB2 cells and HeLa 
FHOOV%RWKFHOOOLQHVZHUHHQULFKHGLQ*SKDVHIRUWKH&K,3VHTXHQFLQJH[SHULPHQW7KHSRVLWLRQRIWKHSHDNVLV
VLPLODUEHWZHHQ+%DQG+H/DFHOOVDOWKRXJKWKHHQULFKPHQWLQ+H/DZDVPXFKZHDNHU$VFRQWUROVWKHVHTXHQFLQJ
data from the respective input materials are shown. 
(B) Western blot showing the depletion of NIPBL in HeLa cells. Since MAU2 is also destabilized when NIPBL is 
GHSOHWHGLWFDQEHXVHGDVPDUNHUIRU1,3%/GHSOHWLRQ:DWULQ6FKOHLIIHUHWDOZKLFKLVUDWKHUGLI¿FXOWWREORW
7KHEDQGLQGLFDWHGZLWKLVDQXQVSHFL¿FVLJQDORIWKH0$8DQWLERGLHVDQGFDQEHXVHGDVORDGLQJFRQWURO
(C) NIPBL and control ChIP was performed from HeLa cells treated with NIPBL and control siRNA. QPCR analysis 
ZLWKSULPHUVVSHFL¿F IRU VHYHUDO1,3%/ELQGLQJVLWHV LGHQWL¿HG LQ+%FHOOV VKRZV WKDW1,3%/51$LGUDPDWLFDOO\
reduces the NIPBL ChIP signal. The experiment was performed three times and one representative example is 
shown.
(D) HeLa cells were treated with control and NIPBL RNAi and stained with different antibodies against NIPBL (green 
±1,3%/UDEELWSRO\FORQDOUHG1,3%/UDWPRQRFORQDODQGZLWK'$3,WRYLVXDOL]H'1$%RWKDQWLERGLHVVKRZ










































































control region (AMY) were analysed.
Conservation       * *** ***  *** ******** *** * * **     **   **** ****   * 
SMC3 Hs.   1121 SLVALALIFAIQKCDPAPFYLFDEIDQALDAQHRKAVSDMIMELAVHAQFITTTFRPELL 1180 
                            SMC3E1144Q Q       
Smc3 Sc.   1132 TVCAIALILAIQMVDPASFYLFDEIDAALDKQYRTAVATLLKELSKNAQFICTTFRTDML 1191 
                            Smc3E1155Q Q    
BLOT:    


































































































































































































































































The human chromosomes 1-22 are depicted as grey bars and the position of the NIPBL sites determined in HB2 
cells are marked with green stripes. NIPBL binding sites occur in clusters and the graphs for chromosomes 11 and 
19 showing NIPBL binding events together with gene density visualize that regions rich in NIPBL binding events are 
also gene-rich regions. 
5HSHWLWLYH UHJLRQV LQ WKHJHQRPHZHUHRPLWWHG IURP WKHDQDO\VLV WKHUHIRUHJDSVEHWZHHQ1,3%/ELQGLQJHYHQWV



























Distribution of NIPBL binding sites over human chromosomes 1 - 22 and X and
FRUUHODWLRQEHWZHHQGHQVLW\RIJHQHVDQG1,3%/ELQGLQJVLWHVRQFKUDQGFKU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by Kagey et al., 2010
Promoters identified in
HB2 cells 

















(B) In contrast to observations by Kagey et al. that NIPBL localizes to enhancers in mouse ES cells we do not observe 



















































NIPBL (NIPBL#1) and negative control ChIP (IgG) was performed from lymphoblastoid cells derived from CdLS 
SDWLHQWVDQGDJHPDWFKHGFRQWUROVDQGDQDO\]HGE\T3&5ZLWKSULPHUVVSHFL¿FIRUVHYHQ1,3%/ELQGLQJVLWHVRQH
cohesin binding site. The sites analysed are indicated above the graph. The enrichment compared to the control IgG 
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Parameters for peak calling with SWEMBL
CTCF RNA Pol II SMC1A SMC3 NIPBL
#Sequence length 36 36 36 36 36
#Fragment length 150 150 150 150 150
#Background 0.000000 0.000000 0.000000 0.000000 0.000000
#Position Background 0.010000 0.010000 0.010000 0.010000 0.010000
#Long Background 0.050000 0.050000 0.050000 0.050000 0.050000
#Threshold 5.000000 5.000000 5.000000 5.000000 5.000000
#Minimum count above bg 10 10 15 8 10
#Penalty increase 25 25 25 25 25
#Quality cutoff 0.000000 0.000000 0.000000 0.000000 0.000000
#Result cutoff 4.000000 4.000000 8.000000 4.000000 4.000000
#Penalty factor 1.000000 1.000000 1.000000 1.000000 1.000000
A. Peaks identified with SWEMBL in the different datasets
CTCF SMC1A SMC3 RNA Pol II NIPBL
83117989375228449227653skaep fo rebmun latoT
Number of peaks associated with genes* 21743 16501 13657 9148 1016
9829166516seneg htiw detaicossa skaep fo %
Number of peaks associated with Expressed genes 14501 10775 9801 8802 953
% of peaks associated with Expressed  genes 41 37 43 89 84
* as peaks were counted as associated with genes when they matched to one of the following groups:
upstream: -5000 to -1000 bp from transcription start site
promoter: -1000 to +1000 bp around transcription start site
gene body: +1000 bp from transcription start site until end of the coding sequence
downstream: end of the coding sequence + 5000 bp
B. Overlap statistics (%)
Percent overlap in a window of +/- 100 bp:
Total number of sites CTCF SMC1A SMC3 NIPBL SMC1A+SMC3
CTCF 35672 51.4 38.3 0.3 59.3
SMC1A 29448 62.3 39.2 0.2 100.0
SMC3 22573 60.5 51.1 0.4 100.0
NIPBL 1138 9.8 4.3 8.4 10.4
SMC1+SMC3 40465 52.3 72.8 55.8 0.3
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Supplementary table 3:
Position of binding sites relative to genes 
Around each gene four regions were designed:
upstream: -5000 to -1000 bp from transcription start site
promoter: -1000 to +1000 bp around transcription start site
gene body: +1000 bp from transcription start site until end of the coding sequence
downstream: end of the coding sequence + 5000 bp
Binding sites of NIPBL, CTCF, SMC1A, SMC3 and RNA Pol II were sorted in these 
categories. The respective genes were scored for their activity calculating RPKM 
(reads mapping to the genome per kilobase of transcript per million reads sequenced)
Genes with RPKM values >0.6 were scored as expressed.
upstream promoter gene body downstream
Expression no 3 6 1 2yes 24 906 48 26
Total sites: 1138 Sites around genes: 1016
CTCF
upstream promoter gene body downstream
Expression no 415 333 1169 420yes 1589 4405 11861 1551
Total sites: 35668 Sites around genes: 21743
SMC1A
upstream promoter gene body downstream
Expression no 301 227 835 328yes 1200 2761 9545 1304
Total sites: 29441 Sites around genes: 16501
SMC3
upstream promoter gene body downstream
Expression no 214 152 448 221yes 1094 2686 7727 1115
Total sites: 22572 Sites around genes: 13657
RNA Pol II
upstream promoter gene body downstream
Expression no 18 40 7 6
yes 319 7150 1205 403
Total sites: 9879 Sites around genes: 9148
NIPBL
Position around the gene
Position around the gene
Position around the gene
Position around the gene
Position around the gene
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Supplementary table 4:
Classification of promoters and expression status of genes bound by NIPBL1,
cohesin (SMC1A and SMC3), RNA Pol II and CTCF
(1 the identical definition of the NIPBL-gene association as in supplementary table 3)
no yes Total:
no 27 36 63
yes 85 868 953
Total sites: 1138 Sites around genes: 1016
no yes Total:
no 3102 2624 5726
yes 1816 8959 10775
Total sites: 29441 Sites around genes: 16501
no yes Total:
no 2132 1724 3856
yes 1578 8223 9801
Total sites: 22572 Sites around genes: 13657
no yes Total:
no 149 197 346
yes 710 8092 8802
Total sites: 9879 Sites around genes: 9148
no yes Total:
no 3894 3348 7242
yes 2234 12267 14501
Total sites: 35668 Sites around genes: 21743
CTCF
CpG island in promoter
SMC1A
CpG island in promoter
CpG island in promoter
RNA Pol II
NIPBL
CpG island in promoter









Molecular function of genes with NIPBL binding sites in HB2 cells identified by
 IPA analysis (IPA version 9.0, IGENUITY SYSTEMS)
eulav-p seneGyrogetaC
Cell Cycle 105 2,17E-08-3,56E-02
Gene Expression 147 4,83E-08-3,59E-02
Organismal Development 84 1,68E-07-3,64E-02
RNA Post-Transcriptional Modification 30 7,3E-07-1,43E-02
Cell Death 165 1,6E-06-3,66E-02
Cellular Growth and Proliferation 108 3,14E-05-2,9E-02
Infectious Disease 62 3,42E-05-2,9E-02
Embryonic Development 54 6,9E-05-3,46E-02
Cardiovascular System Development and Function 18 6,93E-05-3,35E-02
Cancer 220 7,32E-05-3,74E-02
Developmental Disorder 39 1,09E-04-3,79E-02
Hematological System Development and Function 9 1,3E-04-1,63E-02
Hematopoiesis 13 1,3E-04-2,07E-02
Renal and Urological Disease 33 1,55E-04-3,74E-02
Dermatological Diseases and Conditions 27 1,96E-04-3,79E-02
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Supplementary table 6:
Primers used for ChIP/qPCR and RT-PCR/qPCR
ChIP/qPCR primer
Name forward reverse Position (hg18)
Cohesin binding sites
chr22_11 GGCTCAGGACAGAAGTGACC AGGTCGGCAGAGGCTCC chr22:31255080-31255266
chr22_12 ACATGTGGCCAGCTCAGG GGCGCTATAAGCCAGAGAAC chr22:31522929-31523153
STAT3_3 CCTCCCTTACCGCTGATGTC CTAAGCCTCCAGGCACCTTC chr17:37728538-37728637 
KCNQ1_1 AGGACCCGCATGAGGGATTC CCGCATATCCCTGGTTCAGC chr11:2510878-2511089
KCNQ1_2 AAAGGTGTTTGCAGCCCTTG AACATCGTGCTCTCGGAATC chr11:2510713-2510912
NIPBL binding sites 
OSBP GCTGCTGTTTCCGCCATTCATTTC GCTGATACCAACCACCAATCCATGAG chr11:59140122-59140236
HMGCS1 AATGACGGAGCTGCGAGATAC TTGCTAGGCAACCTGACAGAC chr5:43349567-43349749
DUSP10 TCGGCTTCATTGATCTCCAG AGAGCAGCTTCGGATAAACC chr1:219982022-219982252
STAT3_1 CCTCCCTTACCGCTGATGTC CTAAGCCTCCAGGCACCTTC chr17:37728538-37728637
GPR108 GGAGAGCCGATAACGCTTAAC GCCGGATATCAGATCCATGAC chr19:6688766-6688880
GLCCI1 CACTTACCTCAAGGCTGTCAAC GCGAGCATTTCCATTGGCTTAG chr7:7974693-7974884
MYH9 GCAGACGTATTGGCCTGTGG GCCGCCTCCTGATTGGATTC chr22:35114119-35114326
STAT3_1 CCGGAAACCGCTGAATTAC TAGCTGCTCTCCTCATTGG chr17:37794031-37794204
ARTS1 TAGCGTTGCGAGGGTTAGG GCACTTTGCCACGACAGAG chr5:96169763-96169976
ZNF695 TCTGGCTGCACGCCTGATTG GGTCGAAGTGCCGTGAGGAATG chr1:245238016-245238199
TSPAN31 ATGCGGGTTGATTGGCATGCAG AGGCCAGCCAAACCCAATACTC chr12:56424994-56425106
LMBR1L CTCTCCAGGAGCCAATGAGTTC CGCGCTCACGTTTCAATG chr12:47,790,854-47,790,999
Control
AMY TCTGCTGGGCTCAGTATTCCTC TGTTGCCCAAGCTTCACGTAG chr1:104000510-104000730
Repeats
LSU_2 CAGGTGCAGATGTTGGTGGTAG GAACCGGACTCCCTTTCGATTG chr1:107914874-107915060
LSU_8 GCCGCCACAAGCCAGTTATC AACCTCCCGTGGAGCAGAAG chr1:91625487-91625643
LSU_9 ACTCAGGATTGGCGTCTTCG AGCAGTTGAACACGGGTCAG chr2:229753693-229753871
LSU_10 TGCGGTAACGTGACCGATCC TTTCAAGGGCCAGCGAGAGC chr5:71182503-71182673
LSU_11 GCTCAACAGGGTCTTCTTTCC AGCCAAATGCCTCGTCATC chr8:70764913-70765053
SSU_5 GCTGGATAGCTGGATAGCTGTC GAAGGGCAACTGCTTGGAATG chr15:86163096-86163239
SSU_6 GCCGGACTTATCAAGGCAAAC ACAGGTCTGTGACGCTCATAG chr5:174474329-174474548
SSU_7 GTAGGGCAAGTCTGGTGCCAAC CTGCTCCCGAGATCCAACTACG chr7:80800911-80801011
RT-PCR/qPCR primer
eneGesreverdrawrofemaN
TC27 CATGGTGTCAGAGCACTGAAG GGTGACTATGCAGGATGATGG ARTS1
TC25 AGCGGAGTTTGTATAGGG GTTTGGCTGTCTTCTCTG ZNF695
TC30 AGGCGAACCTCCTCTTTGG GACGCAGAACGCTGATGTG GLCCI1
TC31 TGTCCAGCATCCACATCATC TAGCCAGACATGAGCAAGAG TSPAN31
TC34 GGAATCCTGCTGCATCAC TCGTCCTCCTCTTCTTCC BBX
TC41 AAGCAGTGGCTGGTATGAAG TGAACACAAAGCGCTAGAGG NIPBL
TC48 CACTTGAGCCCAGGAGATTG TGCCTTTCTGCGACCTTG MAU2
TC35 ACTGGCTACTGCGTACATCC AGATGCGCCTATCTCTTTCC NADH
TC143 CCAGCAGCGACTCTGAGGAGGAACAAG GTTTGCTGTGGCCTCCAGCAGAAGGTG MYC
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Supplementary table 7:
Genes with NIPBL binding sites in LCL's (PT1) found to be differentially expressed in 
CdLs patient cells by Liu et al. (2009) with FDR < 0.05
ID Entrez Gene Name Location Type(s)
Symbol )s(epyTnoitacoLemaN eneG zertnE
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 Plasma Membrane transporter
ABHD2 emyznenwonknu2 gniniatnoc niamod esalordyhba
ADSL emyznemsalpotyCesayl etaniccusolyneda
AKAP13 rehtomsalpotyC31 nietorp rohcna )AKRP( esanik A
AMD1 emyznemsalpotyC1 esalyxobraced eninoihtemlysoneda
ANAPC5 emyznesuelcuN5 tinubus xelpmoc gnitomorp esahpana
ANKRD11 rehtosuelcuN11 niamod taeper nirykna
AP3D1 adaptor-related protein complex 3, delta 1 subunit Cytoplasm transporter
ARRB2 rehtomsalpotyC2 ateb ,nitserra
ATP6V1E1 ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 Cytoplasm transporter
ATPIF1 rehtomsalpotyC1 rotcaf yrotibihni esaPTA
BBX rehtosuelcuN)alihposorD( golomoh xos ybbob
BSDC1 rehtonwonknu1 gniniatnoc niamod DSB
BUB3 budding uninhibited by benzimidazoles 3 homolog (yeast) Nucleus other
C16orf46 rehtonwonknu64 emarf gnidaer nepo 61 emosomorhc
C2orf44 rehtonwonknu44 emarf gnidaer nepo 2 emosomorhc
CAT emyznemsalpotyCesalatac
CCDC12 rehtonwonknu21 gniniatnoc niamod lioc-delioc
CCDC130 rehtonwonknu031 gniniatnoc niamod lioc-delioc
CCR7 rotpecer delpuoc nietorp-GenarbmeM amsalP7 rotpecer )fitom C-C( enikomehc
CDKN3 esatahpsohpsuelcuN3 rotibihni esanik tnedneped-nilcyc
CDR2 cerebellar degeneration-related protein 2, 62kDa Cytoplasm other
CETN2 emyznesuelcuN2 ,nietorp dnah-FE ,nirtnec
CHAF1A rehtosuelcuN)051p( A tinubus ,1 rotcaf ylbmessa nitamorhc
CHCHD7 coiled-coil-helix-coiled-coil-helix domain containing 7 Cytoplasm other
COPS3 COP9 constitutive photomorphogenic homolog subunit 3 Cytoplasm other
COPZ1 retropsnartmsalpotyC1 atez tinubus ,xelpmoc nietorp remotaoc
COTL1 rehtomsalpotyC)muiletsoytciD( 1 ekil-nisotcaoc
COX5B emyznemsalpotyCbV tinubus esadixo c emorhcotyc
CREB3L2 cAMP responsive element binding protein 3-like 2 Nucleus other
CS emyznemsalpotyCesahtnys etartic
CYLD rotaluger noitpircsnartsuelcuN)emordnys romut nabrut( sisotamordnilyc
DCTN4 rehtosuelcuN)26p( 4 nitcanyd
DDIT3 rotaluger noitpircsnartsuelcuN3 tpircsnart elbicudni-egamad-AND
DDX11/DDX1DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 Nucleus enzyme
DMXL1 rehtoecapS ralullecartxE1 ekil-xmD
DUSP22 esatahpsohpmsalpotyC22 esatahpsohp yticificeps laud
DYNLRB1 rehtomsalpotyC1 epyt-kcolbdaor ,niahc thgil ,nienyd
EBP emyznemsalpotyC)esaremosi lorets( nietorp gnidnib limapome
EIF1 rotaluger noitalsnartnwonknu1 rotcaf noitaitini noitalsnart citoyrakue
ELMO2 rehtomsalpotyC2 ytilitom llec dna tnemflugne
EMC2 rehtosuelcuN2 tinubus xelpmoc nietorp enarbmem RE
EXOC4 retropsnartmsalpotyC4 tnenopmoc xelpmoc tsycoxe
F11R rehtoenarbmeM amsalProtpecer 11F
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FAM102A family with sequence similarity 102, member A unknown other
FAM111B family with sequence similarity 111, member B unknown other
FASN fatty acid synthase Cytoplasm enzyme
FBXO8 F-box protein 8 Cytoplasm other
FCHO1 FCH domain only 1 Plasma Membrane other
FDFT1 farnesyl-diphosphate farnesyltransferase 1 Cytoplasm enzyme
GART phosphoribosylglycinamide formyltransferase Cytoplasm enzyme
GCSH glycine cleavage system protein H (aminomethyl carrier) Cytoplasm enzyme
GINS2 GINS complex subunit 2 (Psf2 homolog) Nucleus other
GLCCI1 glucocorticoid induced transcript 1 Cytoplasm other
GLS glutaminase Cytoplasm enzyme
GOLGB1 golgin B1 Cytoplasm other
GRPEL1 GrpE-like 1, mitochondrial (E. coli) Cytoplasm other
GTF2A1 general transcription factor IIA, 1, 19/37kDa Cytoplasm transcription regulator
GTPBP3 GTP binding protein 3 (mitochondrial) Cytoplasm enzyme
HDAC1 histone deacetylase 1 Nucleus transcription regulator
HIPK1 homeodomain interacting protein kinase 1 Nucleus kinase
HIPK1 homeodomain interacting protein kinase 1 Nucleus kinase
HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) Cytoplasm enzyme
INTS3 integrator complex subunit 3 Nucleus other
ITFG2 integrin alpha FG-GAP repeat containing 2 unknown other
KDM4B lysine (K)-specific demethylase 4B unknown other
KHSRP KH-type splicing regulatory protein Nucleus enzyme
KIF22 kinesin family member 22 Nucleus other
LAPTM4A lysosomal protein transmembrane 4 alpha Cytoplasm other
LARP4B La ribonucleoprotein domain family, member 4B Cytoplasm other
LAS1L LAS1-like (S. cerevisiae) Nucleus other
MCM3 minichromosome maintenance complex component 3 Nucleus enzyme
MCM5 minichromosome maintenance complex component 5 Nucleus enzyme
MIA3 melanoma inhibitory activity family, member 3 Cytoplasm other
MIB1 mindbomb E3 ubiquitin protein ligase 1 Cytoplasm other
MMAB methylmalonic aciduria (cobalamin deficiency) cblB type Cytoplasm enzyme
MSH2 mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) Nucleus enzyme
MTMR4 myotubularin related protein 4 Cytoplasm phosphatase
NAP1L1 nucleosome assembly protein 1-like 1 Nucleus other
NCAPD3 non-SMC condensin II complex, subunit D3 Nucleus other
NFE2L1 nuclear factor (erythroid-derived 2)-like 1 Nucleus transcription regulator
NGRN neugrin, neurite outgrowth associated Nucleus other
NR1H2 nuclear receptor subfamily 1, group H, member 2 Nucleus ligand-dependent nuclear receptor
NR2C2 nuclear receptor subfamily 2, group C, member 2 Nucleus ligand-dependent nuclear receptor
NUP98 nucleoporin 98kDa Nucleus transporter
OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) Cytoplasm enzyme
ORC2 origin recognition complex, subunit 2 Nucleus other
OS9 osteosarcoma amplified 9, endoplasmic reticulum lectin Nucleus other
OSBPL3 oxysterol binding protein-like 3 Cytoplasm other
OXR1 oxidation resistance 1 Cytoplasm other
P2RX1 purinergic receptor P2X, ligand-gated ion channel, 1 Plasma Membrane ion channel
PBXIP1 pre-B-cell leukemia homeobox interacting protein 1 Nucleus transcription regulator
PCCB propionyl CoA carboxylase, beta polypeptide Cytoplasm enzyme
PHPT1 phosphohistidine phosphatase 1 Cytoplasm phosphatase
PIAS3 protein inhibitor of activated STAT, 3 Nucleus transcription regulator
PJA2 praja ring finger 2, E3 ubiquitin protein ligase Cytoplasm enzyme
PLCG1 phospholipase C, gamma 1 Cytoplasm enzyme
PNN pinin, desmosome associated protein Plasma Membrane other
POLD2 polymerase (DNA directed), delta 2, accessory subunit Nucleus enzyme
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POLR3K polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa Nucleus transcription regulator
PPP3CA protein phosphatase 3, catalytic subunit, alpha isozyme Cytoplasm phosphatase
PSAT1 phosphoserine aminotransferase 1 Cytoplasm enzyme
PTMA prothymosin, alpha Nucleus other
RAB5B RAB5B, member RAS oncogene family Cytoplasm enzyme
RCL1 RNA terminal phosphate cyclase-like 1 Nucleus enzyme
RFWD3 ring finger and WD repeat domain 3 Nucleus enzyme
RHEB Ras homolog enriched in brain Cytoplasm enzyme
RPS6 ribosomal protein S6 Cytoplasm other
RRAGC Ras-related GTP binding C Cytoplasm enzyme
RUNX3 runt-related transcription factor 3 Nucleus transcription regulator
RUVBL1 RuvB-like 1 (E. coli) Nucleus transcription regulator
SEC22C SEC22 vesicle trafficking protein homolog C (S. cerevisiae) Cytoplasm other
SEC31A SEC31 homolog A (S. cerevisiae) Cytoplasm other
SEC61G Sec61 gamma subunit Cytoplasm transporter
SFXN5 sideroflexin 5 Cytoplasm transporter
SLC25A37 solute carrier family 25 Cytoplasm transporter
SLC25A42 solute carrier family 25, member 42 Cytoplasm transporter
SLC39A3 solute carrier family 39 (zinc transporter), member 3 Plasma Membrane transporter
SNRPB small nuclear ribonucleoprotein polypeptides B and B1 Nucleus other
SNX11 sorting nexin 11 unknown transporter
SORT1 sortilin 1 Plasma Membrane transmembrane receptor
STAT2 signal transducer and activator of transcription 2, 113kDa Nucleus transcription regulator
STAT3 signal transducer and activator of transcription 3 Nucleus transcription regulator
STT3B STT3, subunit of the oligosaccharyltransferase complex Cytoplasm enzyme
SUCO SUN domain containing ossification factor unknown other
TCOF1 Treacher Collins-Franceschetti syndrome 1 Nucleus transporter
TLE4 transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) Nucleus transcription regulator
TMEM9 transmembrane protein 9 Cytoplasm other
TMEM97 transmembrane protein 97 Extracellular Space other
TMTC4 transmembrane and tetratricopeptide repeat containing 4 unknown other
TNIP1 TNFAIP3 interacting protein 1 Nucleus other
TP53BP1 tumor protein p53 binding protein 1 Nucleus transcription regulator
TSPAN31 tetraspanin 31 Plasma Membrane other
UBR1 ubiquitin protein ligase E3 component n-recognin 1 Cytoplasm enzyme
UGP2 UDP-glucose pyrophosphorylase 2 Cytoplasm enzyme
USP22 ubiquitin specific peptidase 22 Nucleus peptidase
UTP14C UTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast) Nucleus other
UVSSA UV-stimulated scaffold protein A unknown other
VAMP3 vesicle-associated membrane protein 3 (cellubrevin) Plasma Membrane other
WDR74 WD repeat domain 74 Nucleus other
YBX1 Y box binding protein 1 Nucleus transcription regulator
YPEL5 yippee-like 5 (Drosophila) unknown other
ZFP91 zinc finger protein 91 homolog (mouse) Nucleus transcription regulator
ZNF141 zinc finger protein 141 Nucleus other
ZNF211 zinc finger protein 211 Nucleus transcription regulator
ZNF599 zinc finger protein 599 unknown other
ZNF671 zinc finger protein 671 Nucleus other
ZNF688 zinc finger protein 688 unknown other
ZNF688 zinc finger protein 688 unknown other
ZNF688 zinc finger protein 688 unknown other
ZNF691 zinc finger protein 691 Nucleus other
ZNF695 zinc finger protein 695 Nucleus other
ZNF720 zinc finger protein 720 unknown other
ZNF91 zinc finger protein 91 unknown other
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NIPBL ChIP signals in HB2 cells on different repeat classes. 
RPKM measure (reads per kilobase per 10 million reads) was calculated similar to the 
RNA-seq analyses (Mortazavi et al. 2008a) and an enrichment compared to the input material (control) 
was calculated.
% of total    ChIP signal (RPKM)
 genomic 
class length (bp) sequence NIPBL ChIP control Enrichment
SINE-Alu 306745172 9.91 1.68 1.56 1.08
SINE-MIR 84349685 2.72 4.75 4.97 0.96
SINE-Other 571757 0.02 5.94 5.76 1.03
LINE-L1 512445461 16.55 2.08 1.96 1.07
LINE-L2 103990071 3.36 5.08 5.18 0.98
LINE-CR1 10860002 0.35 4.55 4.48 1.02
LINE-RTE 3643770 0.12 4.08 3.79 1.08
LINE-Other 201745 0.01 4.89 4.75 1.03
LTR-ERVL-MaLR 110849894 3.58 4 3.88 1.03
LTR-ERVL 56136298 1.81 4.86 4.81 1.01
LTR-ERV1 83494001 2.7 3.2 3.06 1.04
LTR-ERVK 8842596 0.29 1.94 1.72 1.13
LTR-Gypsy 2301837 0.07 5.28 5.15 1.03
LTR-ERV 191609 0.01 5.36 4.77 1.12
DNA-TcMar-Tigger 33986503 1.1 3.15 3.03 1.04
DNA-TcMar-Mariner 2830187 0.09 3.29 3.11 1.06
DNA-TcMar-Tc2 1669939 0.05 3.24 3.08 1.05
DNA-TcMar 318232 0.01 3.82 3.53 1.08
DNA-hAT-Charlie 45014464 1.45 4.17 4.03 1.04
DNA-hAT-Blackjack 3419498 0.11 4.31 4.22 1.02
DNA-hAT-Tip100 6614899 0.21 4.35 4.32 1.01
DNA-hAT 1687099 0.05 4.11 4.09 1.01
DNA-Other 2734962 0.09 4.06 3.79 1.07
Satellite-acro 31038 0 14.04 11.47 1.22
Satellite-centr 8243430 0.27 10.45 9.17 1.14
Satellite-telo 254147 0.01 3.2 4.27 0.75
Satellite 4025177 0.13 18.3 17.69 1.03
rRNA 175474 0.01 265.35 19.96 13.3
LSU-rRNA_Hsa 68641 0.002 442.08 28.92 15.28
SSU-rRNA_Hsa 16619 0.001 947.81 66.34 14.29
5S 90214 0.003 5.15 4.59 1.12
tRNA 102988 0 8.09 13.2 0.61
scRNA 122042 0 3.5 3.5 1
snRNA 337551 0.01 5.57 4.13 1.35
srpRNA 263136 0.01 4.09 4.24 0.96
RNA 118748 0 4.73 5.74 0.82
Low_complexity 16922589 0.55 2.79 2.35 1.19
Simple_repeat 26087578 0.84 2.78 3.15 0.88
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are involved in the formation of these contacts will be fundamental to elucidate how these 
VWUXFWXUHV LQÀXHQFH JHQHV ,Q WKLV WKHVLV ZH LQYHVWLJDWHG WZR FDQGLGDWH IDFWRUV IRU WKH
organization of topological domains, the cohesin complex and the chromatin insulator protein 
&7&)%RWK IDFWRUVDUHYHU\DEXQGDQWO\ERXQG WKURXJKRXWPDPPDOLDQJHQRPHVDQG WKH\




in Chapter 2) and WKH JHQRPHZLGHPHWKRG+L& WR VWXG\ WKH FRQVHTXHQFHVRI FRKHVLQ
RU&7&)GHSOHWLRQ IRUKLJKHURUGHUFKURPDWLQVWUXFWXUH:HVKRZHG WKDWERWKSURWHLQVDUH
important for the organization of topological domains but we also observed differences 
EHWZHHQWKHFRQWULEXWLRQVRIFRKHVLQDQG&7&)Chapter 3).
Cohesin-regulatory proteins and the cohesin complex are important during development as 
mutations of these factors can lead to different developmental syndromes. We studied the 
role of the cohesin loading factor NIPBL in the molecular etiology of the Cornelia de Lange 
Syndrome (CdLS) and showed a direct role of NIPBL in gene regulation. This suggest that 
defects in NIPBL might alter expression of developmental genes thereby contributing to the 
phenotype observed in CdLS patients (Chapter 4). 
Nuclear architecture at high resolution
Chromosomes are not randomly distributed in the nucleus but they occupy distinct territories 
(Stack, Brown et al., 1977). The position of the chromosomes within the nucleus is correlated 
with gene density (Boyle, Gilchrist et al., 2001) and transcriptional activity (Schneider and 
Grosschedl, 2007). Several microscopy studies showed an arrangement of the chromosome 
WHUULWRULHVLQ ORRSGRPDLQV7KHVHVWXGLHVKDYHDOVRWULHGWRXQGHUVWDQGKRZWKH¿EHUIROGV
ZLWKLQWKHWHUULWRU\DQGKRZWKLVLQÀXHQFHVJHQRPHIXQFWLRQ9LVVHU-DXQLQHWDO%UDQFR
and Pombo, 2006). However due to poor resolution and technical limitations these methods 
are not suitable to analyze the overall genome organization.
In the past decade, the development of chromosome capturing methods has facilitated the 
study of the organization of the genome at higher resolution when compared to previous 
microscopy methods. These technologies allow the analysis of interactions that occur between 
IUDJPHQWV RI LQWHUHVW &3&5T3&5 RU ZLWKLQ D VSHFL¿F ORFXV & & RU LQ WKH ZKROH
JHQRPH+L&&3&5T3&5'HNNHU5LSSHHWDO+DJHJH.ORXVHWDOZDV
WKH¿UVWWHFKQLTXHWREHGHYHORSHG,WLVODERULRXVUHTXLUHVVRPHNQRZOHGJHDERXWWKHORFXV
of interest and can investigate only one particular interaction at a time. Thus it is not suitable to 
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¿QGQRYHOFRQWDFWVEXWLWFDQEHXVHGWRFRQ¿UPDOUHDG\NQRZQLQWHUDFWLRQV7KH&DSSURDFK
(Simonis, Klous et al., 2006) can analyze all chromatin interactions with a chosen fragment 
(anchor or viewpoint). The detection of the unknown fragments ligated to the viewpoint is done 
E\PLFURDUUD\WKXVWKHFRYHUDJHRIWKHLQWHUDFWLRQVLVGHSHQGHQWRQWKHDUUD\XVHG7KH&
method (Dostie, Richmond et al., 2006) uses pools of oligonucleotides that WDUJHWDVSHFL¿FSDUW
of the genome to detect long-range interactions. It offers a higher coverage compared to 4C but 
the detection by oligonucleotides does not allow a genome-wide coverage of interactions due 
to the large number of oligonucletides that would be needed to detect all possible interactions. 





to have high resolution data making it very expensive. 
7RKDYHDPHWKRGWKDWFRPELQHVKLJKUHVROXWLRQDQGUHGXFWLRQRIWKHVHTXHQFLQJFRVWVZH
GHYHORSHG WKH PXOWLSOH[HG &VHT P&6HT WHFKQRORJ\ ZKLFK LV GHVFULEHG LQ GHWDLO LQ
Chapter 2. 
7KLVPHWKRGDOORZV WKHDQDO\VLVRIXS WRYLHZSRLQWVXVLQJRQHVHTXHQFLQJ ODQHDQG LQ
WRWDOYLHZSRLQWVSHU,OOXPLQD+L6HTSODWIRUPFDQEHDVVHVVHGLQSDUDOOHOJLYLQJWKH
possibility to study the region of interest at high resolution. This provides high throughput 
DQG WKH SRVVLELOLW\ WRPXOWLSOH[ WKH VDPSOHV KDV WKH DGYDQWDJH WR UHGXFH WKH VHTXHQFLQJ
costs. Novel interactions found in any of the “C” methods should be supported by alternative 
H[SHULPHQWVVXFKDV),6+
$QH[DPSOHRIWKHXVHRIWKHP&6HTLVSURYLGHGLQChapter 3 where six different viewpoints 
ZHUHSRROHGDQGVHTXHQFHGLQRQHODQH7KHVHGLIIHUHQWYLHZSRLQWVSUREHGDGRPDLQRI0E
on the human chromosome 11 providing a detailed interaction map for this chromosome 
region. 
All the “C” methods are fundamental to understand which factors promote functional contacts 
by correlating interactions with the genomic binding of particular proteins and analyzing 
chromosomal interactions after depletion of the candidate protein. 
Contribution of cohesin and CTCF to the organization of the human 
genome
Several chromosome conformation capturing studies have indicated the importance of the 
FRKHVLQFRPSOH[DQG&7&)IRUORQJUDQJHFKURPRVRPDOLQWHUDFWLRQV+DGMXU:LOOLDPVHWDO
0LVKLUR,VKLKDUDHWDO1DWLYLR:HQGWHWDO
Cohesin is a multisubunit protein complex highly conserved in eukaryotes. The complex is 
QHFHVVDU\ IRU VLVWHU FKURPDWLG FRKHVLRQ 0LFKDHOLV &LRVN HW DO  /RVDGD+LUDQR HW
DO  6XPDUD 9RUODXIHU HW DO  DQG LW LV DOVR UHTXLUHG IRU HI¿FLHQW '1$ GRXEOH
VWUDQGEUHDNUHSDLU6MRJUHQDQG1DVP\WK.LP.UDVLHYDHWDO6HYHUDOVWXGLHV
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have also demonstrated that the cohesin complex has a function in gene regulation (Donze, 
$GDPVHWDO5ROOLQV.RURPHWDO+RUV¿HOG$QDJQRVWRXHWDO6FKXOGLQHU
%HUGQLNHWDODQGWKH¿QGLQJWKDWFRKHVLQKLJKO\FRORFDOL]HVJHQRPHZLGHZLWK&7&)
in mammalian cells gave another important hint for a role of cohesin in regulation (Parelho, 
+DGMXUHWDO:HQGW<RVKLGDHWDO
&7&)LVNQRZQWRIXQFWLRQDVUHSUHVVRU/REDQHQNRY1LFRODVHWDODFWLYDWRU9RVWURY
and Quitschke, 1997) and insulator (Bell, West et al., 1999). Several experiments demonstrated 
WKDWFRKHVLQLVLPSRUWDQWWRPDLQWDLQ&7&)LQVXODWLRQIXQFWLRQDQG&7&)LVQHFHVVDU\WREULQJ
FRKHVLQWRWKHVKDUHGVLWHV:HQGW<RVKLGDHWDO+RZFRKHVLQDQG&7&)LQÀXHQFH
gene transcription is not known but different observations by chromosome conformation 
capturing methods suggested that both factors are involved in promoting long-range 
chromosomal interactions and their depletion leads to the loss of architecture and impaired 
JHQHWUDQVFULSWLRQ+DGMXU:LOOLDPVHWDO0LVKLUR,VKLKDUDHWDO1DWLYLR:HQGW
HWDO,WZDVSURSRVHGWKDW&7&)FDQEULQJFRKHVLQWRSDUWLFXODUUHJXODWRU\VLWHVDQG
cohesin might stabilize the architecture of the locus by embracing the DNA with its ring-like 
structure, as was suggested for the sister chromatid cohesion function (Haering, Lowe et al., 
*UXEHU+DHULQJHWDO5HFHQWO\JHQRPHZLGHVWXGLHVXVLQJ+L&WRDQDO\VHWKH
'VWUXFWXUHRIWKHPRXVHDQGKXPDQJHQRPHLGHQWL¿HGODUJHFKURPDWLQLQWHUDFWLRQGRPDLQV
termed topological domains. Boundaries between the domains were found to be enriched 
IRU&7&)DQGFRKHVLQVLWHVLQGLFDWLQJWKDWERWKSURWHLQVPLJKWEHLPSRUWDQWWRHVWDEOLVKWKH
RYHUDOO VWUXFWXUHRI WRSRORJLFDO GRPDLQV 'L[RQ6HOYDUDM HW DO &RKHVLQDQG&7&)
have already been involved in mediating long-range chromosomal interactions at individual 
ORFL+DGMXU:LOOLDPVHWDO0LVKLUR,VKLKDUDHWDO1DWLYLR:HQGWHWDO
but their role in shaping the topological domains throughout the genome is not known. In 
Chapter 3ZHHOXFLGDWHGWKHFRQWULEXWLRQRIERWKIDFWRUVWRWKHIROGLQJRIWKHFKURPDWLQ¿EHU
genome-wide. 
To establish the role of cohesin, we depleted the complex from interphase chromosomes by 
proteolytic cleavage of the subunit RAD21. The use of this cleavable cohesin system has 
VRPHDGYDQWDJHVFRPSDUHG WR WKHFODVVLFDOFRKHVLQGHSOHWLRQE\51$L¿UVW WKHFOHDYDJH
of cohesin occurs when the complex is functionally bound to the chromatin and second the 
FOHDYDJHRFFXUVYHU\UDSLGO\WDNLQJRQO\KRXUVFRPSDUHGWRWKHKRXUVUHTXLUHGIRU51$L
treatment. This rapid release of cohesin allows studying the immediate effects of cohesin loss 
on chromatin structure, without interfering with the function of cohesin in cell division. 
In order to study local changes in chromatin structure after cohesin depletion we performed 
P&VHT WR SUREH WKH LQWHULRU DQG WKH ERUGHUV RI RQH WRSRORJLFDO GRPDLQ DW WKH KXPDQ
chromosome 11 p15.5 region comprising the Igf2/H19 locus and other imprinted genes. To 
LQYHVWLJDWHJHQRPHZLGHFKDQJHVDIWHUFRKHVLQFOHDYDJHZHSHUIRUPHG+L&7KHP&VHT
SUR¿OHVUHYHDOHGWKDWFRKHVLQFOHDYDJHFDXVHVDGUDPDWLFORVVRILQWHUDFWLRQLQWKHGRPDLQ
analysed, indicating that the complex is important to maintain the organization of this area. The 
loss of interaction within domains was also observed by Hi-C throughout the entire genome. 
The Hi-C data also showed a loss of interaction between domains. Interestingly, the domain 
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boundaries can be still observed after RAD21 cleavage suggesting that the cohesin complex 





to that seen with cohesin cleavage, but the remarkable difference was a gain of interactions 
EHWZHHQGLIIHUHQWGRPDLQV7KHVHREVHUYDWLRQV LQGLFDWHG WKDW&7&)PLJKWEH LPSRUWDQW WR
maintain the domain boundaries to ensure the integrity of the domains. 
,W ZDV DOUHDG\ SURSRVHG WKDW &7&) PLJKW IXQFWLRQ DV EDUULHU HOHPHQW DW WKH ERXQGDULHV
preventing the formation of contacts across the boundaries (Dixon, Selvaraj et al., 2012). 
7KLVZRXOG DJUHHZLWK WKH JDLQ RI LQWHUDFWLRQV REVHUYHG DIWHU&7&)GHSOHWLRQ KRZHYHU LW
FRXOGDOVREHGXHWRGHORFDOL]DWLRQRIFRKHVLQIURP&7&)VLWHV,WZDVDOUHDG\VKRZQWKDW
&7&) LV LPSRUWDQW WR SRVLWLRQ FRKHVLQ WR WKH VKDUHG VLWHV DQG GHSOHWLRQ RI &7&) DIIHFWV
cohesin enrichment at the binding sites but not its binding to chromatin (Wendt, Yoshida et 
al., 2008). The combination of these observation suggests that cohesin could be present at 
QRYHOGLIIHUHQWORFDWLRQVLQDEVHQFHRI&7&)SURPRWLQJQRYHOLQWHUDFWLRQV
7KH+L& UHVXOWV LQGLFDWH WKDWFRKHVLQDQG&7&)DUH LPSRUWDQW IRU WKH WRSRORJLFDOGRPDLQ
organization in a non-redundant manner. This would imply that the simultaneous depletion 
of both factors would lead to a complete loss of structure, which remains to be investigated. 
Long-range chromosomal contacts were already linked to gene regulation since DNA 
regulatory elements such as enhancers, silencers, locus control regions (LCR) or insulator 










In contrast, genes misregulated after cohesin depletion do not have cohesin enriched at the 
promoter. Instead, we observed that these genes more likely loose the interactions with distal 
DNase hypersensitive sites compared to non-cohesin regulated genes. These sites are marks 
IRU'1$UHJXODWRU\UHJLRQVWKXVWKHDOWHUHGJHQHUHJXODWLRQDIWHUFRKHVLQUHPRYDOPLJKWRFFXU
due to the loss of interactions with regulatory elements.
One example for such a mechanism could be the observation that cohesin cleavage 
caused a loss of interactions in the HOXA and HOXB gene clusters that coincide also with 
altered transcription of several HOX genes. The HOX genes encode a family of conserved 
transcription factors that play important roles in specifying anterior-posterior body patterning 
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during development. The expression levels of HOX genes are controlled throughout 




development is very interesting because mutations in cohesin-regulatory proteins or in the 
cohesin complex are linked to the human developmental diseases 5REHUWV6&SKRFRPHOLD
syndrome (RBS) and Cornelia de Lange Syndrome (CdLS). Among other defects, both 
syndromes show severe limb abnormalities. Alteration in human HOX genes have also been 
linked to limb abnormalities (Del Campo, Jones et al., 1999) and it will therefore be interesting to 
VWXG\ZKHWKHUGHIHFWVLQFRKHVLQRUFRKHVLQUHJXODWRUVFRXOGLQÀXHQFHWKHSURSHUH[SUHVVLRQ
of HOX genes during development.
Insight into Cornelia de Lange syndrome (CdLS)
Defects in cohesin regulatory proteins and in the cohesin complex have been linked to several 
human developmental diseases also referred as “cohesinopathies”. CdLS is a cohesinopathy 
characterized by growth defects, developmental abnormalities and mental retardation. In 60% 
of the cases mutations of the cohesin loading factor NIPBL are observed (Krantz, McCallum 
et al., 2004). In a smaller fraction of patients mutations are found in the cohesin core subunits 
SMC1A (5%) or SMC3 (<1%) and recently in the SMC3-deacetylase HDAC8 (Musio, Selicorni 
HWDO'HDUGRUII.DXUHWDO'HDUGRUII%DQGRHWDO
The most severe phenotype of the syndrome is linked to mutations of NIPBL while mutations 
of SMC1A or SMC3 correspond to a milder phenotype. Patients affected by CdLS do not 
show cohesion defects, suggesting that the developmental abnormalities are likely due to 
alteration in cohesin functions that affect gene expression (reviewed in Dorsett and Krantz, 
2009). This is supported by a study on O\PSKREODVWRLGFHOOVOLQHV (LCLs) derived from CdLS 
patients with NIPBL mutations showing that several misregulated genes in these patients lose 
cohesin binding next to the transcription start sites. These data suggested that the absence 
of cohesin, due to NIPBL mutation, might affect transcriptional regulation contributing to 
the CdLS phenotype (Liu, Zhang et al., 2009). On the other hand, the majority of the cases 
of CdLS are caused by NIPBL mutations but to date no direct link of NIPBL to the altered 
transcription found in CdLS patients has been shown. NIPBL has already been linked to gene 
regulation. In Drosophila it was found to facilitate activation of the cut and 8OWUDELWKRUD[ genes 
by remote enhancers (Rollins, Korom et al., 2004). A study in mouse embryonic stem cells 
reported that NIPBL co-localizes with cohesin and the Mediator complex to the promoters of 
actively transcribed genes (Kagey, Newman et al., 2010).
In Chapter 4 we analysed the localization of NIPBL in the human genome and elucidated 
whether NIPBL has a role in the altered gene expression pattern observed in CdLS patients. 
NIPBL is crucial for the association of cohesin with chromatin. Therefore we were expecting 
WR ¿QG D FRORFDOL]DWLRQ RI1,3%/ZLWK FRKHVLQ LI 1,3%/ZRXOG ORDG FRKHVLQ GLUHFWO\ WR LWV
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binding sites. Surprisingly, this was not observed suggesting that NIPBL and cohesin 
might only transiently associate during cohesin loading. Instead, we observed that NIPBL 
ELQGVSUHIHUHQWLDOO\ WR WKHSURPRWHUVRIDFWLYHJHQHV)XUWKHU1,3%/GHSOHWLRQDOWHUHG WKH
transcription of these genes, suggesting a direct role for NIPBL in gene regulation. 
This observation prompted us to identify the localization of NIPBL in lymphoblastoid cells 
lines (LCLs) derived from controls and CdLS patients to understand whether NIPBL could 
EHLQYROYHGLQWKHGLIIHUHQWLDOJHQHH[SUHVVLRQSDWWHUQREVHUYHGLQ/&/¶VGHULYHGIURP&G/6
SDWLHQWVFRPSDUHGWRFRQWUROV&RQVLVWHQWZLWKRXUSUHYLRXVUHVXOWVZHREVHUYHGDOVRLQ/&/¶V
that NIPBL was preferentially bound to promoters and found reduced binding levels of NIPBL 
LQ&G/6SDWLHQWVFHOOV7KHUHIRUHZHK\SRWKHVL]HGWKDWWKH1,3%/KDSORLQVXI¿FLHQF\REVHUYHG
in CdLS probands could be linked to the altered transcription that contributes to the phenotype 
of the syndrome. Our comparison of the NIPBL associated genes with a published list of 
misregulated genes found in cells from CdLS patients (Liu, Zhang et al., 2009) showed that 
DVLJQL¿FDQWSHUFHQWDJHRIWKHVHJHQHVKDYH1,3%/ERXQGWRWKHSURPRWHULQGLFDWLQJWKDWDW
least part of the altered genes in CdLS might be a direct target of NIPBL. Nevertheless, NIPBL 
PLJKWDOVRLQÀXHQFHWUDQVFULSWLRQLQGLUHFWO\YLDWKHORDGLQJRIFRKHVLQZKLFKLQWXUQUHJXODWHV
genes by promoting long-range chromosomal interactions, as we observed in Chapter 3. An 
example of a cohesin-dependent structure sensitive to the partial reduction of NIPBL was 
shown by Chien et al. for the mouse E-globin locus (Chien, Zeng et al., 2011). During the 
differentiation of mouse erythroleukemia cells (MEL) into mature erythroid cells, cohesin and 
NIPBL bind at the LCR and to the E-major and E-minor promoters. This also correlates with 
the formation of interactions between the LCR and E-major promoter and with an increase in 
expression of the adult EJORELQJHQH&KLHQ=HQJHWDO)XUWKHUPRUHWKHDQDO\VLV
of liver tissue from NIPBL heterozygous knockout mice (1LSEO) showed a decrease of 
all cohesin binding sites at the mouse E-globin locus resulting in a reduction of interaction 
between the LCR and E-globin promoters as well as reduced E-major and E-minor expression. 
It will be interesting to study whether in CdLS patients with NIPBL mutation the chromatin 
VWUXFWXUHDURXQGVSHFL¿FJHQHVLVLPSDLUHGWROLQNWKHDOWHUHGH[SUHVVLRQZLWKFKDQJLQJLQWKH
structure. 
The data presented in this thesis have improved our understanding of the functional 
RUJDQL]DWLRQ RI WKH KXPDQ JHQRPH DQG KDYH KLJKOLJKWHG WKH UROHV RI FRKHVLQ DQG&7&)
as factors important for the organization of the topological domains that constitute a basic 
VWUXFWXUDOIHDWXUHRIWKHJHQRPH)XUWKHUPRUHZHSURSRVHGWKDWWKHFRKHVLQORDGLQJIDFWRU
1,3%/PLJKWGLUHFWO\LQÀXHQFHJHQHH[SUHVVLRQE\ELQGLQJWRWKHSURPRWHURIJHQHV
The future prospective will be to study the roles of cohesin and cohesin-regulators in organizing 
higher-order chromatin structure during development to elucidate the function of the complex 
in the molecular etiology of CdLS.
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